0001410578-22-002008.txt : 20220801 0001410578-22-002008.hdr.sgml : 20220801 20220801170534 ACCESSION NUMBER: 0001410578-22-002008 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220801 DATE AS OF CHANGE: 20220801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lakeshore Acquisition II Corp. CENTRAL INDEX KEY: 0001867287 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41317 FILM NUMBER: 221125636 BUSINESS ADDRESS: STREET 1: SUITE A-2F, 555 SHIHUI ROAD STREET 2: SONGJIANG DISTRICT CITY: SHANGHAI STATE: F4 ZIP: 2001100 BUSINESS PHONE: 86 13816100700 MAIL ADDRESS: STREET 1: SUITE A-2F, 555 SHIHUI ROAD STREET 2: SONGJIANG DISTRICT CITY: SHANGHAI STATE: F4 ZIP: 2001100 10-Q 1 lbbbu-20220630x10q.htm FORM 10-Q
690000022415002044602125000012500000.930.021.990.016900000224150042696132044602125000012500000.020.931.990.010.0200-00000000001867287--12-312022Q2false224150017250000.50.10.10.50022415000.1true0001867287lbbb:SponsorMember2022-01-012022-06-300001867287us-gaap:CommonClassAMember2021-02-192021-02-190001867287lbbb:FounderSharesMemberlbbb:SponsorMember2021-02-192021-02-190001867287us-gaap:RetainedEarningsMember2022-06-300001867287us-gaap:RetainedEarningsMember2022-03-3100018672872022-03-310001867287us-gaap:RetainedEarningsMember2021-12-310001867287us-gaap:AdditionalPaidInCapitalMember2021-12-310001867287us-gaap:RetainedEarningsMember2021-06-300001867287us-gaap:AdditionalPaidInCapitalMember2021-06-300001867287us-gaap:RetainedEarningsMember2021-03-310001867287us-gaap:AdditionalPaidInCapitalMember2021-03-3100018672872021-03-310001867287us-gaap:RetainedEarningsMember2021-02-180001867287us-gaap:AdditionalPaidInCapitalMember2021-02-180001867287lbbb:SponsorMemberus-gaap:PrivatePlacementMember2022-03-110001867287lbbb:PromissoryNoteWithRelatedPartyMember2022-03-110001867287us-gaap:CommonStockMember2022-06-300001867287us-gaap:CommonStockMember2022-03-310001867287us-gaap:CommonStockMember2021-12-310001867287us-gaap:CommonStockMember2021-06-300001867287us-gaap:CommonStockMember2021-03-310001867287us-gaap:CommonStockMember2021-02-180001867287lbbb:FounderSharesMemberlbbb:SponsorMember2021-02-190001867287us-gaap:CommonClassAMember2021-02-190001867287us-gaap:IPOMember2022-03-110001867287lbbb:SponsorMemberlbbb:IpoAndPrivatePlacementMember2022-03-112022-03-110001867287us-gaap:RetainedEarningsMember2021-04-012021-06-300001867287us-gaap:RetainedEarningsMember2021-02-192021-03-3100018672872021-02-192021-03-3100018672872021-04-012021-06-300001867287lbbb:FounderSharesMember2021-12-2000018672872021-12-2000018672872021-02-1900018672872021-06-3000018672872021-02-180001867287lbbb:MarketableSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001867287us-gaap:CommonClassAMemberus-gaap:IPOMember2022-03-112022-03-110001867287lbbb:SponsorMemberus-gaap:PrivatePlacementMember2022-03-112022-03-110001867287lbbb:AdministrativeSupportAgreementMember2021-05-062021-05-060001867287us-gaap:AdditionalPaidInCapitalMember2021-02-192021-03-310001867287us-gaap:CommonStockMember2021-02-192021-03-310001867287us-gaap:IPOMember2022-03-112022-03-110001867287lbbb:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2022-01-012022-06-300001867287lbbb:PromissoryNoteWithRelatedPartyMember2022-03-112022-03-1100018672872021-12-312021-12-3100018672872021-06-302021-06-3000018672872021-03-312021-03-310001867287lbbb:FounderSharesMember2022-03-112022-03-110001867287lbbb:NonRedeemableOrdinarySharesMember2022-04-012022-06-300001867287lbbb:NonRedeemableOrdinarySharesMember2022-01-012022-06-300001867287lbbb:NonRedeemableOrdinarySharesMember2021-04-012021-06-300001867287lbbb:NonRedeemableOrdinarySharesMember2021-02-192021-06-300001867287lbbb:SponsorMember2022-06-300001867287lbbb:PromissoryNoteWithRelatedPartyMember2022-03-070001867287lbbb:PromissoryNoteWithRelatedPartyMember2022-01-310001867287lbbb:PromissoryNoteWithRelatedPartyMember2021-05-1100018672872022-03-112022-03-110001867287lbbb:RedeemableOrdinarySharesMember2022-04-012022-06-300001867287lbbb:RedeemableOrdinarySharesMember2022-01-012022-06-300001867287lbbb:FounderSharesMember2021-12-202021-12-2000018672872021-12-202021-12-200001867287us-gaap:IPOMember2022-06-3000018672872022-03-1100018672872021-02-192021-06-300001867287us-gaap:CommonStockMember2022-01-012022-03-310001867287us-gaap:RetainedEarningsMember2022-04-012022-06-3000018672872022-04-012022-06-300001867287us-gaap:RetainedEarningsMember2022-01-012022-03-3100018672872021-02-192021-02-190001867287lbbb:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Memberus-gaap:WarrantMember2022-01-012022-06-300001867287lbbb:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2022-06-300001867287lbbb:RelatedPartyLoansMember2022-06-300001867287us-gaap:WarrantMember2022-01-012022-06-300001867287lbbb:RedemptionOfWarrantsIfPricePerClassOrdinaryShareEqualsOrExceeds9.20Memberus-gaap:WarrantMember2022-01-012022-06-300001867287lbbb:AdministrativeSupportAgreementMember2022-02-192022-06-300001867287lbbb:PublicWarrantsMember2022-03-112022-03-110001867287lbbb:PublicSharesMember2022-03-112022-03-110001867287us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-3100018672872022-01-012022-03-3100018672872022-06-3000018672872021-12-310001867287us-gaap:WarrantMember2022-01-012022-06-300001867287us-gaap:RightsMember2022-01-012022-06-300001867287us-gaap:MemberUnitsMember2022-01-012022-06-300001867287us-gaap:CommonStockMember2022-01-012022-06-3000018672872022-08-0100018672872022-01-012022-06-30xbrli:sharesiso4217:USDxbrli:pureiso4217:USDxbrli:shareslbbb:item

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2022

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File No. 001-41317

LAKESHORE ACQUISITION II CORP.

(Exact name of registrant as specified in its charter)

Cayman Islands

    

N/A

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

667 Madison Avenue, New York, NY, 10065

(Address of Principal Executive Offices, including zip code)

(917) 327-9933

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol(s)

    

Name of each exchange on which
registered

Ordinary Shares

LBBB

The Nasdaq Global Market

Warrants

LBBBW

The Nasdaq Global Market

Rights

LBBBR

The Nasdaq Global Market

Units

LBBBU

The Nasdaq Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes No

As of August 1, 2022, there were 9,141,500 shares of the Company’s common stock, including shares of common stock underlying the units, warrants and rights, $0.0001 par value per share, issued and outstanding.

TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION

1

Item 1.

Condensed Financial Statements

1

Unaudited Condensed Balance Sheet as of June 30, 2022 and Condensed Balance Sheet as of December 31, 2021

1

Unaudited Condensed Statements of Operations for the three months ended June 30, 2022, the six months ended June 30, 2022, the three months ended June 30, 2021 and the period from February 19, 2021 (Inception) to June 30, 2021

2

Unaudited Condensed Statements of Changes in Shareholders’ Equity for the three months ended June 30, 2022 , the six months ended June 30, 2022, the three months ended June 30, 2021 and the period from February 19, 2021 (Inception) to June 30, 2021

3

Unaudited Condensed Statements of Cash Flows for the six months ended June 30, 2022 and the period from February 19, 2021 (Inception) to June 30, 2021

4

Notes to Unaudited Condensed Financial Statements

5

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

17

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

20

Item 4.

Controls and Procedures

20

PART II. OTHER INFORMATION

21

Item 1.

Legal Proceedings

21

Item 1A.

Risk Factors

21

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

21

Item 3.

Defaults Upon Senior Securities

22

Item 4.

Mine Safety Disclosures

22

Item 5.

Other Information

22

Item 6.

Exhibits

22

SIGNATURES

23

PART I – FINANCIAL INFORMATION

Item 1. Condensed Financial Statements

LAKESHORE ACQUISITION II CORP.

Condensed Balance Sheets

    

June 30, 

    

December 31, 

2022

2021

Unaudited

ASSETS

 

  

 

  

Current assets

 

  

 

  

Cash and cash equivalent

$

263,760

$

65,790

Deferred offering costs

 

 

223,822

Prepaid expenses

40,000

Marketable securities held in trust account

 

70,134,603

 

Total Current Assets

 

70,438,363

 

289,612

Total Assets

$

70,438,363

$

289,612

LIABILITIES AND SHAREHOLDERS’ DEFICIT

 

  

 

  

Notes payable — related party

$

$

300,000

Deferred underwriting fee payable

 

2,415,000

 

Accrued offering costs and other expenses

 

25,000

 

50,000

Total Current Liabilities

 

2,440,000

 

350,000

Total Liabilities

 

2,440,000

 

350,000

Commitments and contingencies

 

  

 

  

Redeemable Ordinary Shares

 

  

 

  

Ordinary share subject to possible redemption: 6,900,000 shares (at redemption value of $10.16 per share)

 

70,134,603

 

Shareholders’ Deficit

 

  

 

  

Ordinary share, $0.0001 par value; 500,000,000 shares authorized; 2,241,500 and 1,725,000 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively (1)

 

224

 

173

Additional paid-in capital

 

 

24,827

Accumulated deficit

 

(2,136,464)

 

(85,388)

Total Shareholders’ Deficit

 

(2,136,240)

 

(60,388)

Total Liabilities and Shareholders’ Deficit

$

70,438,363

$

289,612

(1)The number of ordinary shares issued and outstanding at December 31, 2021 includes an aggregate of up to 225,500 shares of non-redeemable founder shares that are subject to forfeiture if the underwriter does not exercise over-allotment option. In connection with the closing of the initial public offering and the underwriter’s full exercise of over-allotment option on March 11, 2022, the 225,000 founder shares were no longer subject to forfeiture.

The accompanying notes are an integral part of these unaudited condensed financial statements.

1

LAKESHORE ACQUISITION II CORP.

Unaudited Condensed Statements of Operations

    

    

    

    

For The

Period From

February 19

For The

For The

For The

2021

Three Months

Six Months

Three Months

(Inception)

 Ended

 Ended

 Ended

To

June 30, 

June 30, 

June 30, 

June 30, 

2022

2022

2021

2021

Formation, general and administrative expenses

$

151,018

$

203,416

$

17,997

$

21,574

Loss from operations

 

(151,018)

(203,416)

(17,997)

 

(21,574)

Other income

 

  

 

  

Interest income on marketable securities held in trust account

 

94,587

99,603

 

Net Loss

$

(56,431)

$

(103,813)

$

(17,997)

$

(21,574)

Basic and diluted weighted average shares outstanding

 

  

 

  

Redeemable ordinary shares-basic and diluted

 

6,900,000

4,269,613

 

Non-redeemable ordinary shares-basic and diluted (1)

 

2,241,500

2,044,602

1,250,000

 

1,250,000

Basic and diluted net loss per share

 

  

 

  

Redeemable ordinary shares-basic and diluted

$

$

0.93

$

N/A

$

N/A

Non-redeemable ordinary shares-basic and diluted

$

(0.02)

$

(1.99)

$

(0.01)

$

(0.02)

(1)The number of weighted-average shares outstanding for the period from February 19, 2021 (Inception) to June 30, 2021 excludes an aggregate of up to 187,500 shares of non-redeemable founder shares that are subject to forfeiture if the underwriter does not exercise over-allotment option. In connection with the increase in the size of the offering, on December 20, 2021, the Company declared a 20% share dividend on each founder share, thereby increasing the number of issued and outstanding founder shares to 1,725,000, including up to an aggregate of 225,000 founder shares subject to forfeiture. In connection with the closing of the initial public offering and the underwriter’s full exercise of over-allotment option on March 11, 2022, the 225,000 founder shares were no longer subject to forfeiture. These shares were excluded from the calculation of weighted average shares outstanding until they were no longer subject to forfeiture.

The accompanying notes are an integral part of these unaudited condensed financial statements.

2

LAKESHORE ACQUISITION II CORP.

Unaudited Condensed Statements of Changes in Shareholders’ Deficit

    

    

    

Additional

    

    

    

Total

Ordinary Shares

Paid-in

Accumulated

Shareholders’

Shares

Amount

Capital

Deficit

Equity

Balances, February 19, 2021 (Inception)

 

$

$

$

$

Issuance of ordinary shares to the initial shareholder in February 2021

 

1,437,500

 

144

 

24,856

 

 

25,000

Share dividend of 0.2 shares for each outstanding share in December 2021

 

287,500

 

29

 

(29)

 

 

Net loss

 

 

 

 

(3,577)

 

(3,577)

Balances, March 31, 2021 (1)

1,725,000

173

24,827

(3,577)

21,423

Net loss

(17,997)

(17,997)

Balances, June 30, 2022 (1)

 

1,725,000

$

173

$

24,827

$

(21,574)

$

3,426

    

    

    

Additional

    

    

Total

Ordinary Shares

Paid-in

Accumulated

Shareholders’

Shares

Amount

Capital

Deficit

Deficit

Balances, December 31, 2021

 

1,725,000

$

173

$

24,827

$

(85,388)

$

(60,388)

Issuance of public units

 

6,900,000

 

690

 

68,999,310

 

 

69,000,000

Issuance of private units

 

351,500

 

35

 

3,514,965

 

 

3,515,000

Issuance of representative shares

 

165,000

 

16

 

1,262,234

 

 

1,262,250

Deduction of offering costs

 

 

 

(5,614,686)

 

 

(5,614,686)

Deduction for value of ordinary shares subject to redemption

 

(6,900,000)

 

(690)

 

(62,789,310)

 

 

(62,790,000)

Allocation of offering costs to ordinary shares subject to redemption

 

 

 

5,109,364

 

 

5,109,364

Deduction for increases of carrying value of redeemable shares

 

 

 

(10,506,704)

 

(1,847,660)

 

(12,354,364)

Net loss

 

 

 

 

(47,382)

 

(47,382)

Balances, March 31, 2022 (1)

2,241,500

224

(1,980,430)

(1,980,206)

Deduction for increases of carrying value of redeemable shares

(99,603)

(99,603)

Net loss

(56,431)

(56,431)

Balances, June 30, 2022 (1)

 

2,241,500

$

224

$

$

(2,136,464)

$

(2,136,240)

(1)The number of ordinary shares outstanding at March 31, 2021 and June 30, 2021 includes an aggregate of up to 187,500 shares of non-redeemable founder shares that are subject to forfeiture if the underwriter does not exercise over-allotment option. In connection with the increase in the size of the offering, on December 20, 2021, the Company declared a 20% share dividend on each founder share, thereby increasing the number of issued and outstanding founder shares to 1,725,000, including up to an aggregate of 225,000 founder shares subject to forfeiture, and the result of share dividend has been presented retroactively for the period from February 19,2021 (Inception) to June 30, 2021. In connection with the closing of the initial public offering and the underwriter’s full exercise of over-allotment option on March 11, 2022, the 225,000 founder shares were no longer subject to forfeiture.

The accompanying notes are an integral part of these unaudited condensed financial statements.

3

LAKESHORE ACQUISITION II CORP.

Unaudited Condensed Statements of Cash Flows

    

    

For the

Period From

February 19,

2021

For the

(Inception)

Six Months Ended

To

June 30, 

June 30, 

2022

2021

Cash flow from operating activities

 

  

 

  

Net loss

$

(103,813)

$

(21,574)

Adjustments to reconcile net loss to net cash used in operating activities:

 

  

 

  

Interest income earned in trust account

 

(99,603)

 

Change in operating assets and liabilities:

 

  

 

  

Change in prepaid expenses

(40,000)

Change in accrued expense and other current liabilities

 

25,000

 

18,000

Net cash used in operating activities

 

(218,416)

 

(3,574)

Cash flow from investing activities

 

  

 

  

Cash deposited in trust account

 

(70,035,000)

 

Net cash used in investing activities

 

(70,035,000)

 

Cash flow from financing activities

 

  

 

  

Proceeds from sale of ordinary shares

25,000

Proceeds from note payable to a related party

 

200,000

 

300,000

Proceeds from issuance of public units

 

69,000,000

 

  

Proceeds from issuance of private units (1)

 

3,015,000

 

Payment of underwriting fee

 

(1,380,000)

 

Payment of other offering costs

 

(383,614)

 

(110,000)

Net cash provided by financing activities

 

70,451,386

 

215,000

Net change in cash

 

197,970

 

211,426

Cash at beginning of period

 

65,790

 

Cash at end of period

$

263,760

$

211,426

Non-cash investing and financial activities:

 

  

 

  

Deferred offering costs accrued

$

$

50,000

Note payable to a related party converted to subscription of private units

 

500,000

 

Deferred underwriting commission charged to additional paid in capital

 

2,415,000

 

Issuance of representative shares charged to additional paid in capital

 

1,262,250

 

Initial value of public shares subject to possible redemption

 

62,790,000

 

Reclassification of offering cost related to public shares

 

(5,109,364)

 

Subsequent measurement of public shares subject to possible redemption

 

12,453,967

 

(1)On March 11, 2022, a total of $500,000 under promissory note payable to a related party was converted into part of the subscription of $3,515,000 private placement at a price of $10.00 per unit.

The accompanying notes are an integral part of these unaudited condensed financial statements.

4

LAKESHORE ACQUISITION II CORP.

Notes to Unaudited Condensed Financial Statements

Note 1 — Organization and Business Operations

Organization and General

Lakeshore Acquisition II Corp. (the “Company”) was incorporated in the Cayman Islands on February 19, 2021 as a blank check company whose objective is to acquire, through a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The Company’s efforts to identify a prospective target business will not be limited to any particular industry or geographic region except that according to the Company’s amended and restated memorandum and articles of association, the Company will not effectuate its initial Business Combination with a company that is headquartered in the People’s Republic of China (“China”), the Hong Kong Special Administrative Region of China (“Hong Kong”) or the Macau Special Administrative Region of China (“Macau”) or conducts a majority of its operations in China, Hong Kong or Macau.

As of June 30, 2022, the Company had not yet commenced any operations and had not generated revenue. All activity for the period from February 19, 2021 (inception) through June 30, 2022 relates to the Company’s formation and the initial public offering (the “IPO”) described below and its effort in seeking a target business. The Company will not generate any operating revenue until after its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year-end.

The Company’s sponsor is RedOne Investment Limited, a BVI limited liability company (the “sponsor”).

Financing

The registration statement for the Company’s IPO (as described in Note 3) was declared effective on March 8, 2022 (the “Effective Date”). On March 11, 2022, the Company consummated an IPO of 6,900,000 units, which includes the full exercise of the over-allotment option by the underwriter in the IPO, at $10.00 per unit (the “Public Units”), generating total gross proceeds of $69,000,000.

Simultaneously with the IPO, the Company sold to its sponsor 351,500 units at $10.00 per unit (the “Private Units”) in a private placement (as described in Note 4), generating total gross proceeds of $ 3,515,000.

Offering costs amounted to $5,614,686 consisting of $1,380,000 of underwriting commissions, $2,415,000 of deferred underwriting commissions, and $1,819,686 of other offering costs (which includes $1,262,250 of representative shares, as described in Note 8). Except for the $25,000 of subscription of founder shares, the Company received net proceeds of $68,162,564 from the IPO and the private placement.

Trust Account

Upon the closing of the IPO and the private placement, $70,035,000 was placed in a trust account (the “Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee.

The funds held in the trust account can be invested in United States government treasury bills, notes or bonds having a maturity of 185 days or less or in money market funds meeting the applicable conditions under Rule 2a-7 promulgated under the Investment Company Act of 1940, as amended, until the earlier of the consummation of its first business combination and the Company’s failure to consummate a business combination within 12 months (or 15 months as applicable) from the consummation of the IPO.

Placing funds in the trust account may not protect those funds from third party claims against the Company. Although the Company will seek to have all vendors, service providers, prospective target businesses or other entities it engages, execute agreements with the Company waiving any claim of any kind in or to any monies held in the Trust Account, there is no guarantee that such persons will execute such agreements.

5

In addition, interest income earned on the funds in the Trust account may be released to the Company to pay its income or other tax obligations. With these exceptions, expenses incurred by the Company may be paid prior to a business combination only from the net proceeds of the IPO and private placement not held in the Trust account.

Business Combination

Pursuant to Nasdaq listing rules, the Company’s initial business combination must occur with one or more target businesses having an aggregate fair market value equal to at least 80% of the value of the funds in the Trust account (excluding any deferred underwriting commissions payable and any taxes payable on the income earned on the Trust account), which the Company refers to as the 80% test, at the time of the execution of a definitive agreement for its initial business combination, although the Company may structure a business combination with one or more target businesses whose fair market value significantly exceeds 80% of the trust account balance. If the Company is no longer listed on Nasdaq, it will not be required to satisfy the 80% test.

The Company currently anticipates structuring a business combination to acquire 100% of the equity interests or assets of the target business or businesses. The Company may, however, structure a business combination where the Company merges directly with the target business or where the Company acquires less than 100% of such interests or assets of the target business in order to meet certain objectives of the target management team or shareholders or for other reasons, but the Company will only complete such business combination if the post-transaction company owns 50% or more of the outstanding voting securities of the target or otherwise owns a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. If less than 100% of the equity interests or assets of a target business or businesses are owned or acquired by the post-transaction company, the portion of such business or businesses that is owned or acquired is what will be valued for purposes of the 80% test.

The Company will either seek shareholder approval of any business combination at a meeting called for such purpose at which shareholders may seek to convert their shares into their pro rata share of the aggregate amount then on deposit in the Trust account, less any taxes then due but not yet paid, or provide shareholders with the opportunity to sell their shares to the Company by means of a tender offer for an amount equal to their pro rata share of the aggregate amount then on deposit in the trust account, less any taxes then due but not yet paid.

The Company will proceed with a business combination only if it will have net tangible assets of at least $5,000,001 upon consummation of the business combination and, solely if shareholder approval is sought, an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company will be required to approve the business combination.

Notwithstanding the foregoing, a public shareholder, together with any affiliate of his or any other person with whom he is acting in concert or as a “group” (as defined in Section 13(d)(3) of the Exchange Act) will be restricted from seeking conversion rights with respect to 20% or more of the ordinary shares sold in this offering without the Company’s prior written consent.

In connection with any shareholder vote required to approve any business combination, the initial shareholders will agree (i) to vote any of their respective shares in favor of the initial business combination and (ii) not to convert such respective shares into a pro rata portion of the trust account or seek to sell their shares in connection with any tender offer the Company engages in.

Liquidation

Pursuant to the amended and restated memorandum and articles of association, if the Company is unable to complete its initial business combination within 12 months (or 15 months, as applicable) from the effective date of the IPO, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than five business days thereafter, redeem 100% of the outstanding public shares and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining holders of ordinary shares and the Company’s board of directors, liquidate and dissolve.

Liquidity and Capital Resources

As of June 30, 2022, the Company had $263,760 in cash held outside its Trust Account available for the Company’s working capital purposes.

6

The Company’s liquidity needs prior to the consummation of the IPO had been satisfied through a payment from the sponsor of $25,000 (see Note 8) for the founder shares and the loan under several unsecured promissory notes from the sponsor of $500,000 in total (see Note 5). On March 11, 2022, the $500,000 loan was converted into part of the subscription of $3,515,000 private placement at a price of $10.00 per unit. The promissory notes were canceled and no amounts were owed under the notes at June 30, 2022.

Upon the consummation of the IPO and the full exercise of over-allotment and associated private placements (see Note 3 and Note 4) on March 11, 2022, $70,035,000 of cash was placed in the Trust Account.

In order to meet its working capital needs following the consummation of the IPO, the Company’s initial shareholders, officers and directors or their affiliates may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each working capital loan would be evidenced by a promissory note and would either be paid upon consummation of the Company’s initial business combination, without interest, or, at the lender’s discretion, up to certain amount of the working capital loan may be converted upon consummation of the Company’s business combination into additional private units at a price of $10.00 per unit. If the Company does not complete a business combination, the working capital loan will only be repaid with funds not held in the trust account and only to the extent available (see Note 5). To date, there were no amounts outstanding under any working capital loans.

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a business combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the business combination.

Going Concern

The Company performed an assessment on its ability to continue as a going concern in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern”. There is no assurance that the Company will be able to consummate the initial business combination within 12 months (or 15 months, as applicable) from the date of the IPO. In the event that the Company fails to consummate business combination within the required period, the Company will face mandatory liquidation and dissolution subject to certain obligations under applicable laws or regulations. This uncertainty raises substantial doubt about the Company’s ability as a going concern one year from the date the financial statement is issued. No adjustments have been made to the carrying amounts of assets or liabilities regarding the possibility of the Company not continuing as a going concern, as a result of failing to consummate business combination within 12 months (or 15 months, as applicable) from the date of the IPO. Management plans to continue its efforts to consummate a business combination within 12 months (or 15 months, as applicable) from the date of the IPO.

Note 2 — Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements are presented in U.S. Dollars and in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three months and for the six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and the final prospectus filed by the Company with the SEC on March 17, 2022 and March 10, 2022, respectively.

7

Emerging Growth Company

Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) permits emerging growth companies to delay complying with new or revised financial accounting standards that do not yet apply to private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act). The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company, which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of June 30, 2022 and December 31, 2021.

Marketable Securities Held in the Trust Account

As of June 30, 2022 and December 31, 2021, The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. (See Note 6).

Ordinary Shares Subject to Possible Redemption

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s public shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital equals to zero. Accordingly, as of June 30, 2022, ordinary shares subject to possible redemption are presented at redemption value of $10.16 per share as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

Offering Costs Associated with the IPO

Offering costs consist of underwriting, legal, accounting, registration and other expenses incurred through the balance sheet date that are directly related to the IPO. As of March 11, 2022, offering costs totaled $5,614,686. The amount was consisted of $1,380,000 of underwriting commissions, $2,415,000 of deferred underwriting commissions, and $1,819,686 of other offering costs (which includes $1,262,250 of representative shares, as described in Note 8. The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A – “Expenses of Offering”. Offering costs were charged to shareholders’ equity upon the completion of the IPO. The Company allocates offering costs between public shares, public warrants and public rights based on the estimated fair values of them at the date of issuance. Accordingly, $5,109,364 was allocated to public shares and was charged to temporary equity, and a sum of $505,322 was allocated to public warrants and public rights, and was charged to shareholders’ equity.

8

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 825, “Financial Instruments,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution that at times may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Net Income (Loss) per Share

The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less interest income in trust account less any dividends paid. We then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public shareholders. For the six months ended June 30, 2022 and for the period from February 19, 2021 (inception) to June 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary

9

shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.

The net income (loss) per share presented in the condensed statement of operations is based on the following:

    

    

    

    

For The 

Period From

February 19,

For The

For The

For The

2021

 Three Months

Six Months

Three Months

(Inception)

Ended

Ended

Ended

To

June 30,

June 30,

June 30,

June 30,

2022

2022

2021

2021

Net loss

$

(56,431)

$

(103,813)

$

(17,997)

$

(21,574)

Accretion of temporary equity to initial redemption value ($10.15 per share)

 

(12,354,364)

 

Interest earned from trust account

(94,587)

(99,603)

Net loss including accretion of temporary equity to redemption value

$

(151,018)

$

(12,557,780)

$

(17,997)

$

(21,574)

    

For The Three Months 

    

For The Six Months 

    

For The Three Months 

    

For The Period From February 19,

Ended

Ended

Ended

2021

June 30, 2022

June 30, 2022

June 30, 2021

 (Inception) To June 30, 2021

Redeemable

Non-redeemable

Redeemable 

Non-redeemable 

Redeemable

    

Non-redeemable

Redeemable

 

Non-redeemable

shares

    

shares

    

shares

    

shares

    

shares

    

shares

    

shares

    

shares

Basic and diluted net income/(loss) per share:

 

  

 

  

 

  

 

  

Numerators:

 

  

 

  

 

  

 

  

Allocation of net loss including accretion of temporary equity

$

(113,988)

$

(37,030)

$

(8,491,458)

$

(4,066,322)

$

$

(17,997)

$

$

(21,574)

Accretion of temporary equity to initial redemption value ($10.15 per share)

 

 

12,354,364

 

 

Interest earned from trust account

94,587

99,603

Allocation of net income/(loss)

$

(19,401)

$

(37,030)

$

3,962,509

$

(4,066,322)

$

$

(17,997)

$

$

(21,574)

Denominators:

 

  

 

  

 

  

 

  

Weighted-average shares outstanding

 

6,900,000

2,241,500

 

4,269,613

2,044,602

 

1,250,000

 

1,250,000

Basic and diluted net income/(loss) per share

$

$

(0.02)

$

0.93

$

(1.99)

$

N/A

$

(0.01)

$

N/A

$

(0.02)

The number of weighted-average shares outstanding for the period from February 19, 2021 (Inception) to June 30, 2021 excludes an aggregate of up to 187,500 shares of non-redeemable shares that are subject to forfeiture if the underwriter does not exercise over-allotment option.

In connection with the increase in the size of the offering, on December 20, 2021, the Company declared a 20% share dividend on each founder share, thereby increasing the number of issued and outstanding founder shares to 1,725,000, including up to an aggregate of 225,000 founder shares subject to forfeiture.

10

In connection with the closing of the IPO and the underwriter’s full exercise of over-allotment option on March 11, 2022, the 225,000 founder shares were no longer subject to forfeiture. These shares were excluded from the calculation of weighted average shares outstanding until they were no longer subject to forfeiture.

Warrants

The Company evaluates the public and private warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. Pursuant to such evaluation, both public and private warrants are classified in shareholders’ equity.

Income Taxes

The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company has identified Cayman Islands as its only “major” tax jurisdiction, as defined. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. Since the Company was incorporated on February 19, 2021, the evaluation was performed for the period ended December 31, 2021 and the upcoming 2022 tax year. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in a material changes to its financial position. The Company’s policy for recording interest and penalties associated with audits is to record such items as a component of income tax expense.

The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws.

The Company’s tax provision was nil and it had no deferred tax assets for the period presented. The Company is considered to be an exempted Cayman Islands Company, and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States.

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Note 3 — Initial Public Offering

Pursuant to the IPO on March 11, 2022, the Company sold 6,900,000 Public Units, which includes the full exercise of the underwriter’s over-allotment option, at a price of $10.00 per Public Unit. Each unit consists of one ordinary share, one-half of one redeemable warrant and one right. Each whole warrant entitles the holder thereof to purchase one ordinary share for $11.50 per share, subject to certain adjustment. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Each right entitles the holder to receive one-tenth of one ordinary share upon consummation of the Company’s initial business combination (See Note 8).

11

All of the 6,900,000 public shares sold as part of the Public Units in the IPO contain a redemption feature which allows for the redemption of such public shares if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation, or in connection with the Company’s liquidation. In accordance with the Securities and Exchange Commission (the “SEC”) and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity.

As of June 30, 2022, the ordinary shares reflected on the balance sheet are reconciled in the following table.

    

As of June 30, 2022

Gross proceeds

$

69,000,000

Less:

 

  

Proceeds allocated to public warrants and public rights

 

(6,210,000)

Offering costs of public shares

 

(5,109,364)

Plus:

 

  

Accretion of carrying value to redemption value

 

12,453,967

Ordinary share subject to possible redemption

$

70,134,603

Note 4 — Private Placement

Simultaneously with the closing of the IPO, RedOne Investment Limited, the Company’s sponsor, purchased an aggregate of 351,500 Private Units in a private placement at $10.00 per Private Unit. The Private Units are identical to the units sold in the IPO, as each private unit consists of one share of ordinary shares in the Company, and one right to receive one tenth (1/10) of a share of ordinary shares automatically upon the consummation of an initial business combination, and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one ordinary share for $11.50 per share.

The holders of the private units have agreed (A) to vote the shares underlying their private units in favor of any proposed business combination, (B) not to propose, or vote in favor of, an amendment to the Company’s amended and restated certificate of incorporation with respect to the Company’s pre-business combination activities prior to the consummation of such a business combination unless the Company provides public shareholders with the opportunity to convert their public shares in connection with any such vote, (C) not to convert any shares underlying the private units into the right to receive cash from the trust account in connection with a shareholder vote to approve an initial business combination or a vote to amend the provisions of the Company’s amended and restated certificate of incorporation relating to shareholders’ rights or pre-business combination activity or sell their shares to the Company in connection with a tender offer the Company engages in and (D) that the shares underlying the private units shall not participate in any liquidating distribution upon winding up if a business combination is not consummated. Subject to certain limited exceptions, the purchasers have also agreed not to transfer, assign or sell any of the private units or underlying securities (except to transferees that agree to the same terms and restrictions) until 30 days after the completion of an initial business combination.

Note 5 — Related Party Transactions

Founder Shares

On February 19, 2021, 1,437,500 shares of the Company’s ordinary shares were issued to the sponsor at a price of approximately $0.017 per share for an aggregate amount of $25,000. In connection with the increase in the size of the offering, on December 20, 2021, the Company declared a 20% share dividend on each founder share thereby increasing the number of issued and outstanding founder shares to 1,725,000 (up to 225,000 of which are subject to forfeiture) so as to maintain the number of founder shares at 20% of the outstanding ordinary shares upon the consummation of this offering, resulting in an effective purchase price per founder share after the share dividend of approximately $0.014. The per share purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the aggregate number of founder shares issued. The number of founder shares issued was determined based on the expectation that the founder shares would represent 20% of the outstanding shares after this offering (not including the shares issued to the underwriter at closing or the shares underlying the private placement units). Since the over-allotment option has been fully exercised, the 225,000 founder shares were no longer subject to forfeiture on March 11, 2022.

12

Administrative Service Fee

The Company has agreed, commencing on the signing of the engagement letter with the underwriter on May 6, 2021, to pay the sponsor a monthly fee of up to $10,000 up to the consummation of business combination, for the Company’s use of its personnel and other administrative resources. Since inception through June 30, 2022, the Company had paid an aggregate of $138,000 to the sponsor.

Related Party Loans

On May 11, 2021, the Company issued a $300,000 principal amount unsecured promissory note to the Company’s sponsor, On January 31, 2022, the Company issued a $100,000 principal amount unsecured promissory note to the Company’s sponsor, On March 7, 2022, the Company issued a $100,000 principal amount unsecured promissory note to the Company’s sponsor, and the Company had received such amounts as of issuance dates. The notes are non-interest bearing, and due after the date on which this offering is consummated or the Company determines to abandon this offering. On March 11, 2022, the $500,000 loan was converted into part of the subscription of $3,515,000 private placement at a price of $10.00 per unit. The promissory notes were canceled and no amounts were owed under the notes.

As mentioned in Note 1, in order to meet its working capital needs following the consummation of the IPO, the Company’s initial shareholders, officers and directors or their affiliates may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each working capital loan would be evidenced by a promissory note and would either be paid upon consummation of the Company’s initial business combination, without interest, or, at the lender’s discretion, up to $500,000 of the working capital loan may be converted upon consummation of the Company’s business combination into additional private units at a price of $10.00 per unit. If the Company does not complete a business combination, the working capital loan will only be repaid with funds not held in the trust account and only to the extent available. As of June 30, 2022, there was nil working capital loan outstanding.

Note 6 — Fair Value Measurements

The Company follows the guidance in FASB ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1:Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2:Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3:Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

13

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at June 30, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

Description

    

Level

    

June 30, 2022

Assets:

 

  

 

  

Marketable securities held in Trust Account

 

1

$

70,134,603

Except for the foregoing, the Company does not have any assets measured at fair value on a recurring basis at June 30, 2022 and December  31, 2021.

Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. No such transfers took place for the period presented.

Note 7 — Commitments and Contingencies

Risks and Uncertainties

Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of this financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Underwriting Agreement

A deferred underwriting commission of $0.35 per Public Unit sold, totaling $2,415,000 will be payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, without accrued interest. In the event that the Company does not close a Business Combination, the representative underwriter forfeits its right to receive the commission.

Registration Rights

The initial shareholders will be entitled to registration rights with respect to their initial shares, as well as the holders of the Private Units and holders of any securities issued to the Company’s initial shareholders, officers, directors or their affiliates in payment of working capital loans or extension loans made to the Company, will be entitled to registration rights with respect to the Private Units (and underlying securities), pursuant to an agreement signed on the effective date of the IPO. The holders of such securities are entitled to demand that the Company register these securities at any time after the Company consummates a business combination. In addition, the holders have certain “piggy-back” registration rights on registration statements filed after the Company’s consummation of a business combination.

Note 8 — Shareholder’s Equity

Ordinary shares

The Company is authorized to issue 500,000,000 ordinary shares with a par value of $0.0001 per share.

On February 19, 2021, 1,437,500 shares of the Company’s ordinary shares were issued to the sponsor at a price of approximately $0.017 per share for an aggregate of $25,000. In connection with the increase in the size of the offering, on December 20, 2021, the Company declared a 20% share dividend on each founder share thereby increasing the number of issued and outstanding founder shares to 1,725,000 (up to 225,000 of which are subject to forfeiture) so as to maintain the number of founder shares at 20% of the outstanding shares of our ordinary shares upon the consummation of this offering, resulting in an effective purchase price per founder share after the share dividend of approximately $0.014. The per share purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the aggregate number of founder shares issued. The number of founder shares issued was determined based on the expectation that the founder shares would represent 20% of the outstanding shares after this offering (not including the

14

shares issued to the underwriter at closing or the shares underlying the private placement units). Since the over-allotment option has been fully exercised, the 225,000 founder shares were no longer subject to forfeiture on March 11, 2022.

On March 11, 2022, the Company sold 6,900,000 units, which includes the full exercise of the over-allotment option by the underwriter of in the IPO at a price of $10.00 per Public Unit in the IPO; and the Company sold to its sponsor an aggregate of 351,500 Private Units at $10.00 per Private Unit. Each Public Unit and Private Unit consists of one ordinary share, one-half of one redeemable warrant and one right.

The Company issued to the underwriter 165,000 shares of ordinary shares (the “Representative Shares”) upon the closing of the IPO on March 11, 2022. The Company estimates the fair value of Representative Shares to be $1,262,250 in total, or $7.65 per Representative Share. The Company accounted for the Representative Shares as an expense of the IPO, resulting in a charge directly to stockholder’s equity. The underwriter has agreed not to transfer, assign, sell, pledge, or hypothecate any such Representative Shares, or subject such Representative Shares to hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person until the completion of our initial business combination. In addition, the underwriter has agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of our initial business combination and (ii) to waive its rights to liquidating distributions from the trust account with respect to such shares if we fail to complete our initial business combination within 12 months (or 15 months, as applicable) from the closing of this offering.

As of June 30, 2022, there were 2,241,500 shares of ordinary shares issued and outstanding excluding 6,900,000 shares subject to possible redemption.

Warrants

Each whole warrant entitles the holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment as described below, commencing 30 days after the completion of its initial business combination, and expiring five years from after the completion of an initial business combination. No fractional warrant will be issued and only whole warrants will trade.

The Company may redeem the warrants at a price of $0.01 per warrant upon 30 days’ notice, only in the event that the last sale price of the ordinary shares is at least $18.00 (as adjusted for share sub-divisions, share dividends, reorganizations and recapitalizations) per share for any 20 trading days within a 30-trading day period ending on the third day prior to the date on which notice of redemption is given, provided there is an effective registration statement and current prospectus in effect with respect to the ordinary shares underlying such warrants during the 30 day redemption period. If the Company redeems the warrants as described above, management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” If a registration statement is not effective within 90 days following the consummation of a business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their warrants on a cashless basis and in no event (whether in the case of a registration statement being effective or otherwise) will the Company be required to net cash settle the warrant exercise. If an initial business combination is not consummated, the warrants will expire and will be worthless.

In addition, if (a) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at a newly issued price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by our board of directors and, in the case of any such issuance to our initial shareholders or their affiliates, without taking into account any founders’ shares held by the Company’s initial shareholders or such affiliates, as applicable, prior to such issuance), (b) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination on the date of the consummation of the Company’s initial business combination (net of redemptions), and (c) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial business combination is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the market value and the newly issued price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the market value and the newly issued price.

15

Rights

Except in cases where the Company is not the surviving company in a business combination, each holder of a right will automatically receive one-tenth (1/10) of an ordinary share upon consummation of an initial business combination, even if the holder of a public right converted all ordinary shares held by him, her or it in connection with the initial business combination or an amendment to our certificate of incorporation with respect to the Company’s pre-business combination activities. In the event the Company will not be the surviving company upon completion of our initial business combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one- tenth (1/10) of a share underlying each right upon consummation of the business combination. No additional consideration will be required to be paid by a holder of rights in order to receive his, her or its additional ordinary shares upon consummation of an initial business combination. The shares issuable upon exchange of the rights will be freely tradable (except to the extent held by affiliates of the Company). If the Company enters into a definitive agreement for a business combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the holders of the ordinary shares will receive in the transaction on an as-converted into ordinary share basis.

The Company will not issue fractional shares in connection with an exchange of rights. As a result, holders of rights must hold rights in multiples of 10 in order to receive shares for all of the holders’ rights upon closing of a business combination. If the Company are unable to complete an initial business combination within the required time period and liquidate the funds held in the trust account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from our assets held outside of the trust account with respect to such rights, and the rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of an initial business combination. Additionally, in no event will the Company be required to net cash settle the rights.

Note 9 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to August 1, 2022, the date that the unaudited condensed financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

16

Item 2. Management’s Discussion and Analysis.

References to “we”, “us”, “our” or the “Company” are to Lakeshore Acquisition II Corp., except where the context requires otherwise. The following discussion should be read in conjunction with our unaudited condensed financial statements and related notes thereto included elsewhere in this report.

Forward-Looking Statements

This quarterly report on Form 10-Q includes forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (the “SEC”) filings.

Overview

We were formed on February 19, 2021 for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses. Our efforts to identify a prospective target business will not be limited to any particular industry or geographic region. We intend to utilize cash derived from the proceeds of our initial public offering (the “IPO”) in effecting our initial business combination.

We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies.

We presently have no revenue. All activities for the period from February 19, 2021 (inception) through June 30, 2022 relate to the formation and the IPO and seeking of a target business. We will have no operations other than the active solicitation of a target business with which to complete a business combination, and we will not generate any operating revenue until after its initial business combination, at the earliest. We will have non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO.

On March 11, 2022, we consummated the IPO of 6,900,000 Public Units, which includes the full exercise of the over-allotment option by the underwriter in the IPO, at a price of $10.00 per Public Unit, generating gross proceeds of $69,000,000. Simultaneously with the closing of the IPO, we consummated the sale of 351,500 Private Units, at a price of $10.00 per Private Unit, in a private placement to the sponsor, generating gross proceeds of $3,515,000.

Upon the consummation of the IPO and the underwriters’ partial exercise of the over-allotment option, and associated private placements, $70,035,000 of cash was placed in the Trust Account. This amount equals 6,900,000 ordinary shares subject to possible redemption multiplied by redemption value of $10.15 per share.

As indicated in the accompanying unaudited condensed financial statements, as of June 30, 2022, we had $263,760 in cash held outside its Trust Account available for working capital purposes.

We cannot assure you that our plans to complete our Initial Business Combination will be successful. If we are unable to complete our initial business combination within 12 months (or 15 months as applicable) from the date of the IPO, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than five business days thereafter, redeem 100% of the outstanding public shares and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining holders of ordinary shares and our board of directors, liquidate and dissolve. In the event of liquidation, the holders of the founder shares and Private Units will not participate in any redemption distribution with respect to their founder shares or Private Units, until all of the claims of any redeeming shareholders and creditors are fully satisfied (and then only from funds held outside the Trust Account).

17

Results of Operations

Our entire activity from February 19, 2021 (inception) up to the consummation of the IPO was in preparation for the IPO. Since the IPO, our activity has been limited to the evaluation of business combination candidates, and we will not be generating any operating revenues until the closing and completion of our initial business combination. We expect to generate small amounts of non-operating income in the form of interest income on cash and marketable securities held in Trust Account. We will incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the six months ended June 30, 2022, we had a net loss of $103,813. We incurred $203,416 of general and administrative expenses and earned $99,603 of interest income from investments in our Trust Account.

For the period from February 19, 2021 (inception) to June 30, 2021, we had a net loss of $21,574, which consisted of $21,574 in formation, general and administrative expenses.

Liquidity and Capital Resources

As of June 30, 2022, we had $263,760 in cash held outside its Trust Account available for our working capital purposes.

Prior to the consummation of the IPO, our liquidity needs had been satisfied through a payment from the sponsor of $25,000 for the founder shares, the loan under an unsecured promissory note from the sponsor of $500,000. The promissory note from the sponsor was converted into part of the subscription of $3,515,000 private placement on March 11, 2022.

Upon the consummation of the IPO and underwriter’s full exercise of over-allotment option on March 11, 2022, and associated private placements, $70,035,000 of cash was placed in the Trust Account. As of June 30, 2022, an aggregate of $70,134,603 was held in the Trust Account in money market funds that invest in cash, U.S. Treasury Bills, notes, and other obligations issued or guaranteed as to principal and interest by the U.S. Treasury.

In order to meet its working capital needs following the consummation of the IPO, the Company’s initial shareholders, officers and directors or their affiliates may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each working capital loan would be evidenced by a promissory note and would either be paid upon consummation of the Company’s initial business combination, without interest, or, at the lender’s discretion, up to certain amount of the working capital loan may be converted upon consummation of the Company’s business combination into additional private units at a price of $10.00 per unit. If the Company does not complete a business combination, the working capital loan will only be repaid with funds not held in the trust account and only to the extent available (see Note 5). To date, there were no amounts outstanding under any working capital loans.

Based on the foregoing, management believes that we will have sufficient working capital and borrowing capacity to meet our needs through the earlier of the consummation of a business combination or one year from this filing. Over this time period, we will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the business combination.

If our estimates of the costs of undertaking due diligence and negotiating our initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination. Moreover, we may need to obtain additional financing either to consummate our initial business combination or because we become obligated to convert a significant number of our public shares upon consummation of our initial business combination, in which case we may issue additional securities or incur debt in connection with such business combination. Subject to compliance with applicable securities laws, we would only consummate such financing simultaneously with the consummation of our initial business combination. Following our initial business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

We performed an assessment on its ability to continue as a going concern in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern”. There is no assurance that we will be able to consummate the initial business combination within 12 months (or 15 months, as applicable) from the date of the IPO. In the event that we fails to consummate business combination within the required period, we

18

will face mandatory liquidation and dissolution subject to certain obligations under applicable laws or regulations. This uncertainty raises substantial doubt about our ability as a going concern one year from the date the financial statement is issued. No adjustments have been made to the carrying amounts of assets or liabilities regarding the possibility of us not continuing as a going concern, as a result of failing to consummate business combination within 12 months (or 15 months, as applicable) from the date of the IPO. Management plans to continue its efforts to consummate a business combination within 12 months (or 15 months, as applicable) from the date of the IPO.

Critical Accounting Policies

The preparation of these unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. Actual results could differ from those estimates.

Offering Costs Associated with the IPO

Offering costs consist of underwriting, legal, accounting, registration and other expenses incurred through the balance sheet date that are directly related to the IPO. As of March 11, 2022, offering costs totaled $5,614,686. The amount was consisted of $1,380,000 of underwriting commissions, $2,415,000 of deferred underwriting commissions, and $1,819,686 of other offering costs (which includes $1,262,250 of representative shares, as described in Note 8). The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A – “Expenses of Offering”. Offering costs were charged to shareholders’ equity upon the completion of the IPO. The Company allocates offering costs between public shares, public warrants and public rights based on the estimated fair values of them at the date of issuance. Accordingly, $5,109,364 was allocated to public shares and was charged to temporary equity, and a sum of $505,322 was allocated to public warrants and public rights, and was charged to shareholders’ equity.

Ordinary Shares Subject to Possible Redemption

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s public shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital equals to zero. Accordingly, as of June 30, 2022, ordinary shares subject to possible redemption are presented at redemption value of $10.16 per share as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

Net Income (Loss) per Share

We comply with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. We then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public shareholders.

For the six months ended June 30, 2022 and for the period from February 19, 2021 (inception) to June 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. The calculation of diluted loss per share does not consider the effect of the warrants issued in connection with the IPO and the private placement since the exercise of warrants are contingent on the occurrence of future events.

19

Warrants

The Company evaluates the public and private warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. Pursuant to such evaluation, both public and private warrants are classified in shareholders’ equity.

Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.

Off-Balance Sheet Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of June 30, 2022. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

Underwriting Agreement

A deferred underwriting commission of $0.35 per Public Unit sold, totaling $2,415,000 will be payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, without accrued interest. In the event that the Company does not close a Business Combination, the representative underwriter forfeits its right to receive the commission.

Registration Rights

The initial shareholders will be entitled to registration rights with respect to their initial shares, as well as the holders of the Private Units and holders of any securities issued to the Company’s initial shareholders, officers, directors or their affiliates in payment of working capital loans or extension loans made to the Company, will be entitled to registration rights with respect to the Private Units (and underlying securities), pursuant to an agreement signed on the effective date of the IPO. The holders of such securities are entitled to demand that the Company register these securities at any time after the Company consummates a business combination. In addition, the holders have certain “piggy-back” registration rights on registration statements filed after the Company’s consummation of a business combination.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not required for smaller reporting companies.

Item 4. Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

20

Evaluation of Disclosure Controls and Procedures

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2022. Based upon his evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were effective.

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the three months ended June 30, 2022 covered by this quarterly report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1.   Legal Proceedings

None.

Item 1A. Risk Factors

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our final prospectus for our Initial Public Offering filed with the SEC on March 10, 2022. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our final prospectus for our Initial Public Offering filed with the SEC on March 10, 2022.

Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities

On March 11, 2022, Lakeshore Acquisition II Corp. (the “Company”) consummated its initial public offering (the “IPO”) of 6,900,000 units (the “Units”), which includes full exercise of the underwriter’s over-allotment option. Each Unit consists of one ordinary share of the Company, par value $0.0001 per share (the “Ordinary Shares”), one-half of one redeemable warrant (“Warrant”), with each whole Warrant entitling the holder thereof to purchase one Ordinary Share for $11.50 per share, and one right that entitles the holder thereof to receive one-tenth (1/10) of one Ordinary Share upon consummation of the Company’s initial business combination (“Right”). The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $69,000,000.The securities in the offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333- 262381). The SEC declared the registration statement effective on March 8, 2022.

Simultaneously with the closing of the IPO, the Company consummated a private placement (the “Private Placement”) in which RedOne Investment Limited (the “Sponsor”), which purchased 351,500 private units (the “Private Placement Units”) at a price of $10.00 per Private Unit, generating total proceeds of $3,515,000.

A total of $70,035,000 of the proceeds from the IPO and the sale of the Private Placement Units were placed in a U.S.-based trust account at Morgan Stanley Wealth Management, maintained by Continental Stock Transfer & Trust Company, acting as trustee.

We paid a total of $1,380,000 underwriting discounts and commissions and $715,000 for other offering costs and expenses related to the Initial Public Offering. In addition, the underwriters agreed to defer $2,415,000 in underwriting discounts and commissions.

As of June 30, 2022, we had $263,760 in cash held outside its Trust Account available for the working capital purposes.

There has been no material change in the planned use of the proceeds from the IPO and private placement as is described in our final prospectus related to the IPO.

21

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not Applicable.

Item 5. Other Information.

None.

ITEM 6.    EXHIBITS

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

No.

    

Description of Exhibit 

31.1*

 

Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2*

 

Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1**

 

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2**

 

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS*

 

XBRL Instance Document

101.CAL*

 

XBRL Taxonomy Extension Calculation Linkbase Document

101.SCH*

 

XBRL Taxonomy Extension Schema Document

101.DEF*

 

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*

 

XBRL Taxonomy Extension Labels Linkbase Document

101.PRE*

 

XBRL Taxonomy Extension Presentation Linkbase Document

* Filed herewith.

** Furnished.

22

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Lakeshore Acquisition II Corp.

 

 

 

Date: August 1, 2022

By:

/s/ Deyin (Bill) Chen

 

Name:

Deyin (Bill) Chen

 

Title:

Chief Executive Officer and Chief Financial Officer

 

 

(Principal Executive Officer, Principal Financial and Accounting Officer)

23

EX-31.1 2 lbbbu-20220630xex31d1.htm EXHIBIT 31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Deyin (Bill) Chen, certify that:

1I have reviewed this quarterly report on Form 10-Q of Lakeshore Acquisition II Corp.;

2

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

b)

(Paragraph omitted pursuant to Exchange Act Rules 13a-14(a) and 15d-15(a));

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 1, 2022

/s/ Deyin (Bill) Chen

Deyin (Bill) Chen

Chief Executive Officer

(Principal Executive Officer)


EX-31.2 3 lbbbu-20220630xex31d2.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Deyin (Bill) Chen, certify that:

1

I have reviewed this quarterly report on Form 10-Q of Lakeshore Acquisition II Corp.;

2

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

b)(Paragraph omitted pursuant to Exchange Act Rules 13a-14(a) and 15d-15(a);

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 1, 2022

/s/ Deyin (Bill) Chen

Deyin (Bill) Chen

Chief Financial Officer

(Principal Financial and Accounting Officer)


EX-32.1 4 lbbbu-20220630xex32d1.htm EXHIBIT 32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Lakeshore Acquisition II Corp. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2022, as filed with the Securities and Exchange Commission (the “Report”), I, Deyin (Bill) Chen, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 1, 2022

/s/ Deyin (Bill) Chen

Deyin (Bill) Chen

Chief Executive Officer

(Principal Executive Officer)


EX-32.2 5 lbbbu-20220630xex32d2.htm EXHIBIT 32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Lakeshore Acquisition II Corp. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2022, as filed with the Securities and Exchange Commission (the “Report”), I, Deyin (Bill) Chen, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 1, 2022

/s/ Deyin (Bill) Chen

Deyin (Bill) Chen

Chief Financial Officer

(Principal Financial and Accounting Officer)


EX-101.SCH 6 lbbbu-20220630.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - Condensed Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Unaudited Condensed Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Unaudited Condensed Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Organization and Business Operations (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Significant Accounting Policies - Reconciliation of Net Income (Loss) per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Unaudited Condensed Statements of Changes in Shareholders' Deficit link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - Unaudited Condensed Statements of Changes in Shareholders' Deficit (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00405 - Statement - Unaudited Condensed Statements of Cash Flows (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Private Placement link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Initial Public Offering (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Private Placement (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Related Party Transactions - Founder Shares (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Shareholders' Equity - Common Stock Shares (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - Shareholders' Equity - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 40803 - Disclosure - Shareholders' Equity - Rights (Details) link:presentationLink link:calculationLink link:definitionLink 00205 - Statement - Unaudited Condensed Statements of Operations (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Organization and Business Operations link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Initial Public Offering link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Initial Public Offering (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - Initial Public Offering - Ordinary shares reflected on the balance sheet (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 lbbbu-20220630_cal.xml EX-101.CAL EX-101.DEF 8 lbbbu-20220630_def.xml EX-101.DEF EX-101.LAB 9 lbbbu-20220630_lab.xml EX-101.LAB EX-101.PRE 10 lbbbu-20220630_pre.xml EX-101.PRE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2022
Aug. 01, 2022
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2022  
Document Transition Report false  
Entity File Number 001-41317  
Entity Registrant Name LAKESHORE ACQUISITION II CORP.  
Entity Incorporation, State or Country Code E9  
Entity Tax Identification Number 00-0000000  
Entity Address, Address Line One 667 Madison Avenue  
Entity Address, City or Town New York  
Entity Address State Or Province NY  
Entity Address, Postal Zip Code 10065  
City Area Code 917  
Local Phone Number 327-9933  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company true  
Entity Common Stock, Shares Outstanding   9,141,500
Entity Central Index Key 0001867287  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Rights    
Document Information [Line Items]    
Title of 12(b) Security Rights  
Trading Symbol LBBBR  
Security Exchange Name NASDAQ  
Ordinary Shares    
Document Information [Line Items]    
Title of 12(b) Security Ordinary Shares  
Trading Symbol LBBB  
Security Exchange Name NASDAQ  
Units    
Document Information [Line Items]    
Title of 12(b) Security Units  
Trading Symbol LBBBU  
Security Exchange Name NASDAQ  
Warrants    
Document Information [Line Items]    
Title of 12(b) Security Warrants  
Trading Symbol LBBBW  
Security Exchange Name NASDAQ  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Balance Sheets - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalent $ 263,760 $ 65,790
Deferred offering costs   223,822
Prepaid expenses 40,000  
Marketable securities held in trust account 70,134,603  
Total Current Assets 70,438,363 289,612
Total Assets 70,438,363 289,612
Current Liabilities    
Notes payable - related party   300,000
Deferred underwriting fee payable 2,415,000  
Accrued offering costs and other expenses 25,000 50,000
Total Current Liabilities 2,440,000 350,000
Total Liabilities 2,440,000 350,000
Commitments and contingencies
Redeemable Ordinary Shares    
Ordinary share subject to possible redemption: 6,900,000 shares (at redemption value of $10.16 per share) 70,134,603  
Shareholders' Deficit    
Ordinary share, $0.0001 par value; 500,000,000 shares authorized; 2,241,500 and 1,725,000 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively (1) 224 173
Additional paid-in capital   24,827
Accumulated deficit (2,136,464) (85,388)
Total Shareholders' Deficit (2,136,240) (60,388)
Total Liabilities and Shareholders' Deficit $ 70,438,363 $ 289,612
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Balance Sheets (Parenthetical) - $ / shares
4 Months Ended
Mar. 11, 2022
Dec. 31, 2021
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2021
Jun. 30, 2022
Feb. 19, 2021
Condensed Balance Sheets              
Common shares, par value, (per share)   $ 0.0001       $ 0.0001  
Common shares, shares authorized   500,000,000       500,000,000  
Common shares, shares issued   1,725,000       2,241,500 1,437,500
Common shares, shares outstanding   1,725,000       2,241,500  
Temporary equity, par value (per share)   $ 10.16          
Temporary equity, shares outstanding 6,900,000 6,900,000       6,900,000  
Nonredeemable founder shares subject to forfeiture   225,500 187,500 187,500 187,500    
Nonredeemable founder shares no longer subject to forfeiture 225,000            
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Unaudited Condensed Statements of Operations - USD ($)
3 Months Ended 4 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2021
Jun. 30, 2022
Formation, general and administrative expenses $ 151,018 $ 17,997 $ 21,574 $ 203,416
Loss from operations (151,018) (17,997) (21,574)  
Other income        
Interest income on marketable securities held in trust account 94,587   0 99,603
Net Loss (56,431) (17,997) (21,574) (103,813)
Redeemable ordinary shares        
Other income        
Net Loss $ (19,401)     $ 3,962,509
Basic and diluted weighted average shares outstanding        
Ordinary shares-basic 6,900,000     4,269,613
Ordinary shares-diluted 6,900,000     4,269,613
Basic and diluted net loss per share        
Ordinary shares-basic       $ 0.93
Ordinary shares-diluted       $ 0.93
Non-redeemable ordinary shares        
Other income        
Net Loss $ (37,030) $ (17,997) $ (21,574) $ (4,066,322)
Basic and diluted weighted average shares outstanding        
Ordinary shares-basic 2,241,500 1,250,000 1,250,000 2,044,602
Ordinary shares-diluted 2,241,500 1,250,000 1,250,000 2,044,602
Basic and diluted net loss per share        
Ordinary shares-basic $ (0.02) $ (0.01) $ (0.02) $ (1.99)
Ordinary shares-diluted $ (0.02) $ (0.01) $ (0.02) $ (1.99)
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Unaudited Condensed Statements of Operations (Parenthetical) - shares
4 Months Ended
Mar. 11, 2022
Dec. 31, 2021
Dec. 20, 2021
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2021
Unaudited Condensed Statements of Operations            
Nonredeemable founder shares subject to forfeiture   225,500   187,500 187,500 187,500
Percentage of share dividend on each founder share     20.00%      
Founder shares     1,725,000      
Nonredeemable founder shares forfeited 225,000   225,000      
Nonredeemable founder shares no longer subject to forfeiture 225,000          
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Unaudited Condensed Statements of Changes in Shareholders' Deficit - USD ($)
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning at Feb. 18, 2021 $ 0 $ 0 $ 0 $ 0
Balance at the beginning (in shares) at Feb. 18, 2021 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of public units $ 144 24,856   25,000
Issuance of public units (in shares) 1,437,500      
Share dividend of 0.2 shares for each outstanding share in December 2021 $ 29 (29)    
Share dividend of 0.2 shares for each outstanding share in December 2021 (in shares) 287,500      
Net loss     (3,577) (3,577)
Balance at the end at Mar. 31, 2021 $ 173 24,827 (3,577) 21,423
Balance at the end (in shares) at Mar. 31, 2021 1,725,000      
Balance at the beginning at Feb. 18, 2021 $ 0 0 0 0
Balance at the beginning (in shares) at Feb. 18, 2021 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       (21,574)
Balance at the end at Jun. 30, 2021 $ 173 24,827 (21,574) 3,426
Balance at the end (in shares) at Jun. 30, 2021 1,725,000      
Balance at the beginning at Mar. 31, 2021 $ 173 24,827 (3,577) 21,423
Balance at the beginning (in shares) at Mar. 31, 2021 1,725,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss     (17,997) (17,997)
Balance at the end at Jun. 30, 2021 $ 173 24,827 (21,574) 3,426
Balance at the end (in shares) at Jun. 30, 2021 1,725,000      
Balance at the beginning at Dec. 31, 2021 $ 173 24,827 (85,388) (60,388)
Balance at the beginning (in shares) at Dec. 31, 2021 1,725,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of public units $ 690 68,999,310   69,000,000
Issuance of public units (in shares) 6,900,000      
Issuance of private units $ 35 3,514,965   3,515,000
Issuance of private units (in shares) 351,500      
Issuance of representative shares $ 16 1,262,234   1,262,250
Issuance of representative shares (in shares) 165,000      
Deduction of offering costs   (5,614,686)   (5,614,686)
Deduction for value of ordinary shares subject to redemption $ (690) (62,789,310)   (62,790,000)
Deduction for value of ordinary shares subject to redemption (in shares) (6,900,000)      
Allocation of offering costs to ordinary shares subject to redemption   5,109,364   5,109,364
Deduction for increases of carrying value of redeemable shares   (10,506,704) (1,847,660) (12,354,364)
Net loss     (47,382) (47,382)
Balance at the end at Mar. 31, 2022 $ 224   (1,980,430) (1,980,206)
Balance at the end (in shares) at Mar. 31, 2022 2,241,500      
Balance at the beginning at Dec. 31, 2021 $ 173 $ 24,827 (85,388) (60,388)
Balance at the beginning (in shares) at Dec. 31, 2021 1,725,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       (103,813)
Balance at the end at Jun. 30, 2022 $ 224   (2,136,464) (2,136,240)
Balance at the end (in shares) at Jun. 30, 2022 2,241,500      
Balance at the beginning at Mar. 31, 2022 $ 224   (1,980,430) (1,980,206)
Balance at the beginning (in shares) at Mar. 31, 2022 2,241,500      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Deduction for increases of carrying value of redeemable shares     (99,603) (99,603)
Net loss     (56,431) (56,431)
Balance at the end at Jun. 30, 2022 $ 224   $ (2,136,464) $ (2,136,240)
Balance at the end (in shares) at Jun. 30, 2022 2,241,500      
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Unaudited Condensed Statements of Changes in Shareholders' Deficit (Parenthetical) - shares
4 Months Ended
Mar. 11, 2022
Dec. 31, 2021
Dec. 20, 2021
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2021
Unaudited Condensed Statements of Changes in Shareholders' Deficit            
Nonredeemable founder shares subject to forfeiture   225,500   187,500 187,500 187,500
Percentage of share dividend on each founder share     20.00%      
Founder shares     1,725,000      
Nonredeemable founder shares forfeited 225,000   225,000      
Nonredeemable founder shares no longer subject to forfeiture 225,000          
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2
Unaudited Condensed Statements of Cash Flows - USD ($)
4 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2022
Cash flow from operating activities    
Net loss $ (21,574) $ (103,813)
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest income earned in trust account 0 (99,603)
Change in operating assets and liabilities:    
Change in prepaid expenses   (40,000)
Change in accrued expense and other current liabilities 18,000 25,000
Net cash used in operating activities (3,574) (218,416)
Cash flow from investing activities    
Cash deposited in trust account 0 (70,035,000)
Net cash used in investing activities 0 (70,035,000)
Cash flow from financing activities    
Proceeds from sale of ordinary shares 25,000  
Proceeds from note payable to a related party 300,000 200,000
Proceeds from issuance of public units   69,000,000
Proceeds from issuance of private units (1) 0 3,015,000
Payment of underwriting fee 0 (1,380,000)
Payment of other offering costs (110,000) (383,614)
Net cash provided by financing activities 215,000 70,451,386
Net change in cash 211,426 197,970
Cash at beginning of period 0 65,790
Cash at end of period 211,426 263,760
Non-cash investing and financial activities:    
Deferred offering costs accrued 50,000  
Note payable to a related party converted to subscription of private units 0 500,000
Deferred underwriting commission charged to additional paid in capital 0 2,415,000
Issuance of representative shares charged to additional paid in capital 0 1,262,250
Initial value of public shares subject to possible redemption 0 62,790,000
Reclassification of offering cost related to public shares 0 (5,109,364)
Subsequent measurement of public shares subject to possible redemption $ 0 $ 12,453,967
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.2
Unaudited Condensed Statements of Cash Flows (Parenthetical) - USD ($)
4 Months Ended 6 Months Ended
Mar. 11, 2022
Jun. 30, 2021
Jun. 30, 2022
Unaudited Condensed Statements of Cash Flows      
Note payable to a related party converted to subscription of private units $ 500,000 $ 0 $ 500,000
Proceeds from private placement $ 3,515,000    
Price per unit $ 10.00    
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.2
Organization and Business Operations
6 Months Ended
Jun. 30, 2022
Organization and Business Operations  
Organization and Business Operations

Note 1 — Organization and Business Operations

Organization and General

Lakeshore Acquisition II Corp. (the “Company”) was incorporated in the Cayman Islands on February 19, 2021 as a blank check company whose objective is to acquire, through a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The Company’s efforts to identify a prospective target business will not be limited to any particular industry or geographic region except that according to the Company’s amended and restated memorandum and articles of association, the Company will not effectuate its initial Business Combination with a company that is headquartered in the People’s Republic of China (“China”), the Hong Kong Special Administrative Region of China (“Hong Kong”) or the Macau Special Administrative Region of China (“Macau”) or conducts a majority of its operations in China, Hong Kong or Macau.

As of June 30, 2022, the Company had not yet commenced any operations and had not generated revenue. All activity for the period from February 19, 2021 (inception) through June 30, 2022 relates to the Company’s formation and the initial public offering (the “IPO”) described below and its effort in seeking a target business. The Company will not generate any operating revenue until after its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year-end.

The Company’s sponsor is RedOne Investment Limited, a BVI limited liability company (the “sponsor”).

Financing

The registration statement for the Company’s IPO (as described in Note 3) was declared effective on March 8, 2022 (the “Effective Date”). On March 11, 2022, the Company consummated an IPO of 6,900,000 units, which includes the full exercise of the over-allotment option by the underwriter in the IPO, at $10.00 per unit (the “Public Units”), generating total gross proceeds of $69,000,000.

Simultaneously with the IPO, the Company sold to its sponsor 351,500 units at $10.00 per unit (the “Private Units”) in a private placement (as described in Note 4), generating total gross proceeds of $ 3,515,000.

Offering costs amounted to $5,614,686 consisting of $1,380,000 of underwriting commissions, $2,415,000 of deferred underwriting commissions, and $1,819,686 of other offering costs (which includes $1,262,250 of representative shares, as described in Note 8). Except for the $25,000 of subscription of founder shares, the Company received net proceeds of $68,162,564 from the IPO and the private placement.

Trust Account

Upon the closing of the IPO and the private placement, $70,035,000 was placed in a trust account (the “Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee.

The funds held in the trust account can be invested in United States government treasury bills, notes or bonds having a maturity of 185 days or less or in money market funds meeting the applicable conditions under Rule 2a-7 promulgated under the Investment Company Act of 1940, as amended, until the earlier of the consummation of its first business combination and the Company’s failure to consummate a business combination within 12 months (or 15 months as applicable) from the consummation of the IPO.

Placing funds in the trust account may not protect those funds from third party claims against the Company. Although the Company will seek to have all vendors, service providers, prospective target businesses or other entities it engages, execute agreements with the Company waiving any claim of any kind in or to any monies held in the Trust Account, there is no guarantee that such persons will execute such agreements.

In addition, interest income earned on the funds in the Trust account may be released to the Company to pay its income or other tax obligations. With these exceptions, expenses incurred by the Company may be paid prior to a business combination only from the net proceeds of the IPO and private placement not held in the Trust account.

Business Combination

Pursuant to Nasdaq listing rules, the Company’s initial business combination must occur with one or more target businesses having an aggregate fair market value equal to at least 80% of the value of the funds in the Trust account (excluding any deferred underwriting commissions payable and any taxes payable on the income earned on the Trust account), which the Company refers to as the 80% test, at the time of the execution of a definitive agreement for its initial business combination, although the Company may structure a business combination with one or more target businesses whose fair market value significantly exceeds 80% of the trust account balance. If the Company is no longer listed on Nasdaq, it will not be required to satisfy the 80% test.

The Company currently anticipates structuring a business combination to acquire 100% of the equity interests or assets of the target business or businesses. The Company may, however, structure a business combination where the Company merges directly with the target business or where the Company acquires less than 100% of such interests or assets of the target business in order to meet certain objectives of the target management team or shareholders or for other reasons, but the Company will only complete such business combination if the post-transaction company owns 50% or more of the outstanding voting securities of the target or otherwise owns a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. If less than 100% of the equity interests or assets of a target business or businesses are owned or acquired by the post-transaction company, the portion of such business or businesses that is owned or acquired is what will be valued for purposes of the 80% test.

The Company will either seek shareholder approval of any business combination at a meeting called for such purpose at which shareholders may seek to convert their shares into their pro rata share of the aggregate amount then on deposit in the Trust account, less any taxes then due but not yet paid, or provide shareholders with the opportunity to sell their shares to the Company by means of a tender offer for an amount equal to their pro rata share of the aggregate amount then on deposit in the trust account, less any taxes then due but not yet paid.

The Company will proceed with a business combination only if it will have net tangible assets of at least $5,000,001 upon consummation of the business combination and, solely if shareholder approval is sought, an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company will be required to approve the business combination.

Notwithstanding the foregoing, a public shareholder, together with any affiliate of his or any other person with whom he is acting in concert or as a “group” (as defined in Section 13(d)(3) of the Exchange Act) will be restricted from seeking conversion rights with respect to 20% or more of the ordinary shares sold in this offering without the Company’s prior written consent.

In connection with any shareholder vote required to approve any business combination, the initial shareholders will agree (i) to vote any of their respective shares in favor of the initial business combination and (ii) not to convert such respective shares into a pro rata portion of the trust account or seek to sell their shares in connection with any tender offer the Company engages in.

Liquidation

Pursuant to the amended and restated memorandum and articles of association, if the Company is unable to complete its initial business combination within 12 months (or 15 months, as applicable) from the effective date of the IPO, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than five business days thereafter, redeem 100% of the outstanding public shares and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining holders of ordinary shares and the Company’s board of directors, liquidate and dissolve.

Liquidity and Capital Resources

As of June 30, 2022, the Company had $263,760 in cash held outside its Trust Account available for the Company’s working capital purposes.

The Company’s liquidity needs prior to the consummation of the IPO had been satisfied through a payment from the sponsor of $25,000 (see Note 8) for the founder shares and the loan under several unsecured promissory notes from the sponsor of $500,000 in total (see Note 5). On March 11, 2022, the $500,000 loan was converted into part of the subscription of $3,515,000 private placement at a price of $10.00 per unit. The promissory notes were canceled and no amounts were owed under the notes at June 30, 2022.

Upon the consummation of the IPO and the full exercise of over-allotment and associated private placements (see Note 3 and Note 4) on March 11, 2022, $70,035,000 of cash was placed in the Trust Account.

In order to meet its working capital needs following the consummation of the IPO, the Company’s initial shareholders, officers and directors or their affiliates may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each working capital loan would be evidenced by a promissory note and would either be paid upon consummation of the Company’s initial business combination, without interest, or, at the lender’s discretion, up to certain amount of the working capital loan may be converted upon consummation of the Company’s business combination into additional private units at a price of $10.00 per unit. If the Company does not complete a business combination, the working capital loan will only be repaid with funds not held in the trust account and only to the extent available (see Note 5). To date, there were no amounts outstanding under any working capital loans.

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a business combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the business combination.

Going Concern

The Company performed an assessment on its ability to continue as a going concern in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern”. There is no assurance that the Company will be able to consummate the initial business combination within 12 months (or 15 months, as applicable) from the date of the IPO. In the event that the Company fails to consummate business combination within the required period, the Company will face mandatory liquidation and dissolution subject to certain obligations under applicable laws or regulations. This uncertainty raises substantial doubt about the Company’s ability as a going concern one year from the date the financial statement is issued. No adjustments have been made to the carrying amounts of assets or liabilities regarding the possibility of the Company not continuing as a going concern, as a result of failing to consummate business combination within 12 months (or 15 months, as applicable) from the date of the IPO. Management plans to continue its efforts to consummate a business combination within 12 months (or 15 months, as applicable) from the date of the IPO.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.2
Significant Accounting Policies
6 Months Ended
Jun. 30, 2022
Significant Accounting Policies  
Significant Accounting Policies

Note 2 — Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements are presented in U.S. Dollars and in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three months and for the six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and the final prospectus filed by the Company with the SEC on March 17, 2022 and March 10, 2022, respectively.

Emerging Growth Company

Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) permits emerging growth companies to delay complying with new or revised financial accounting standards that do not yet apply to private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act). The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company, which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of June 30, 2022 and December 31, 2021.

Marketable Securities Held in the Trust Account

As of June 30, 2022 and December 31, 2021, The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. (See Note 6).

Ordinary Shares Subject to Possible Redemption

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s public shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital equals to zero. Accordingly, as of June 30, 2022, ordinary shares subject to possible redemption are presented at redemption value of $10.16 per share as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

Offering Costs Associated with the IPO

Offering costs consist of underwriting, legal, accounting, registration and other expenses incurred through the balance sheet date that are directly related to the IPO. As of March 11, 2022, offering costs totaled $5,614,686. The amount was consisted of $1,380,000 of underwriting commissions, $2,415,000 of deferred underwriting commissions, and $1,819,686 of other offering costs (which includes $1,262,250 of representative shares, as described in Note 8. The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A – “Expenses of Offering”. Offering costs were charged to shareholders’ equity upon the completion of the IPO. The Company allocates offering costs between public shares, public warrants and public rights based on the estimated fair values of them at the date of issuance. Accordingly, $5,109,364 was allocated to public shares and was charged to temporary equity, and a sum of $505,322 was allocated to public warrants and public rights, and was charged to shareholders’ equity.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 825, “Financial Instruments,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution that at times may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Net Income (Loss) per Share

The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less interest income in trust account less any dividends paid. We then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public shareholders. For the six months ended June 30, 2022 and for the period from February 19, 2021 (inception) to June 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary

shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.

The net income (loss) per share presented in the condensed statement of operations is based on the following:

    

    

    

    

For The 

Period From

February 19,

For The

For The

For The

2021

 Three Months

Six Months

Three Months

(Inception)

Ended

Ended

Ended

To

June 30,

June 30,

June 30,

June 30,

2022

2022

2021

2021

Net loss

$

(56,431)

$

(103,813)

$

(17,997)

$

(21,574)

Accretion of temporary equity to initial redemption value ($10.15 per share)

 

(12,354,364)

 

Interest earned from trust account

(94,587)

(99,603)

Net loss including accretion of temporary equity to redemption value

$

(151,018)

$

(12,557,780)

$

(17,997)

$

(21,574)

    

For The Three Months 

    

For The Six Months 

    

For The Three Months 

    

For The Period From February 19,

Ended

Ended

Ended

2021

June 30, 2022

June 30, 2022

June 30, 2021

 (Inception) To June 30, 2021

Redeemable

Non-redeemable

Redeemable 

Non-redeemable 

Redeemable

    

Non-redeemable

Redeemable

 

Non-redeemable

shares

    

shares

    

shares

    

shares

    

shares

    

shares

    

shares

    

shares

Basic and diluted net income/(loss) per share:

 

  

 

  

 

  

 

  

Numerators:

 

  

 

  

 

  

 

  

Allocation of net loss including accretion of temporary equity

$

(113,988)

$

(37,030)

$

(8,491,458)

$

(4,066,322)

$

$

(17,997)

$

$

(21,574)

Accretion of temporary equity to initial redemption value ($10.15 per share)

 

 

12,354,364

 

 

Interest earned from trust account

94,587

99,603

Allocation of net income/(loss)

$

(19,401)

$

(37,030)

$

3,962,509

$

(4,066,322)

$

$

(17,997)

$

$

(21,574)

Denominators:

 

  

 

  

 

  

 

  

Weighted-average shares outstanding

 

6,900,000

2,241,500

 

4,269,613

2,044,602

 

1,250,000

 

1,250,000

Basic and diluted net income/(loss) per share

$

$

(0.02)

$

0.93

$

(1.99)

$

N/A

$

(0.01)

$

N/A

$

(0.02)

The number of weighted-average shares outstanding for the period from February 19, 2021 (Inception) to June 30, 2021 excludes an aggregate of up to 187,500 shares of non-redeemable shares that are subject to forfeiture if the underwriter does not exercise over-allotment option.

In connection with the increase in the size of the offering, on December 20, 2021, the Company declared a 20% share dividend on each founder share, thereby increasing the number of issued and outstanding founder shares to 1,725,000, including up to an aggregate of 225,000 founder shares subject to forfeiture.

In connection with the closing of the IPO and the underwriter’s full exercise of over-allotment option on March 11, 2022, the 225,000 founder shares were no longer subject to forfeiture. These shares were excluded from the calculation of weighted average shares outstanding until they were no longer subject to forfeiture.

Warrants

The Company evaluates the public and private warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. Pursuant to such evaluation, both public and private warrants are classified in shareholders’ equity.

Income Taxes

The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company has identified Cayman Islands as its only “major” tax jurisdiction, as defined. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. Since the Company was incorporated on February 19, 2021, the evaluation was performed for the period ended December 31, 2021 and the upcoming 2022 tax year. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in a material changes to its financial position. The Company’s policy for recording interest and penalties associated with audits is to record such items as a component of income tax expense.

The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws.

The Company’s tax provision was nil and it had no deferred tax assets for the period presented. The Company is considered to be an exempted Cayman Islands Company, and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States.

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.2
Initial Public Offering
6 Months Ended
Jun. 30, 2022
Initial Public Offering  
Initial Public Offering

Note 3 — Initial Public Offering

Pursuant to the IPO on March 11, 2022, the Company sold 6,900,000 Public Units, which includes the full exercise of the underwriter’s over-allotment option, at a price of $10.00 per Public Unit. Each unit consists of one ordinary share, one-half of one redeemable warrant and one right. Each whole warrant entitles the holder thereof to purchase one ordinary share for $11.50 per share, subject to certain adjustment. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Each right entitles the holder to receive one-tenth of one ordinary share upon consummation of the Company’s initial business combination (See Note 8).

All of the 6,900,000 public shares sold as part of the Public Units in the IPO contain a redemption feature which allows for the redemption of such public shares if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation, or in connection with the Company’s liquidation. In accordance with the Securities and Exchange Commission (the “SEC”) and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity.

As of June 30, 2022, the ordinary shares reflected on the balance sheet are reconciled in the following table.

    

As of June 30, 2022

Gross proceeds

$

69,000,000

Less:

 

  

Proceeds allocated to public warrants and public rights

 

(6,210,000)

Offering costs of public shares

 

(5,109,364)

Plus:

 

  

Accretion of carrying value to redemption value

 

12,453,967

Ordinary share subject to possible redemption

$

70,134,603

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.2
Private Placement
6 Months Ended
Jun. 30, 2022
Private Placement  
Private Placement

Note 4 — Private Placement

Simultaneously with the closing of the IPO, RedOne Investment Limited, the Company’s sponsor, purchased an aggregate of 351,500 Private Units in a private placement at $10.00 per Private Unit. The Private Units are identical to the units sold in the IPO, as each private unit consists of one share of ordinary shares in the Company, and one right to receive one tenth (1/10) of a share of ordinary shares automatically upon the consummation of an initial business combination, and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one ordinary share for $11.50 per share.

The holders of the private units have agreed (A) to vote the shares underlying their private units in favor of any proposed business combination, (B) not to propose, or vote in favor of, an amendment to the Company’s amended and restated certificate of incorporation with respect to the Company’s pre-business combination activities prior to the consummation of such a business combination unless the Company provides public shareholders with the opportunity to convert their public shares in connection with any such vote, (C) not to convert any shares underlying the private units into the right to receive cash from the trust account in connection with a shareholder vote to approve an initial business combination or a vote to amend the provisions of the Company’s amended and restated certificate of incorporation relating to shareholders’ rights or pre-business combination activity or sell their shares to the Company in connection with a tender offer the Company engages in and (D) that the shares underlying the private units shall not participate in any liquidating distribution upon winding up if a business combination is not consummated. Subject to certain limited exceptions, the purchasers have also agreed not to transfer, assign or sell any of the private units or underlying securities (except to transferees that agree to the same terms and restrictions) until 30 days after the completion of an initial business combination.

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2
Related Party Transactions
6 Months Ended
Jun. 30, 2022
Related Party Transactions  
Related Party Transactions

Note 5 — Related Party Transactions

Founder Shares

On February 19, 2021, 1,437,500 shares of the Company’s ordinary shares were issued to the sponsor at a price of approximately $0.017 per share for an aggregate amount of $25,000. In connection with the increase in the size of the offering, on December 20, 2021, the Company declared a 20% share dividend on each founder share thereby increasing the number of issued and outstanding founder shares to 1,725,000 (up to 225,000 of which are subject to forfeiture) so as to maintain the number of founder shares at 20% of the outstanding ordinary shares upon the consummation of this offering, resulting in an effective purchase price per founder share after the share dividend of approximately $0.014. The per share purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the aggregate number of founder shares issued. The number of founder shares issued was determined based on the expectation that the founder shares would represent 20% of the outstanding shares after this offering (not including the shares issued to the underwriter at closing or the shares underlying the private placement units). Since the over-allotment option has been fully exercised, the 225,000 founder shares were no longer subject to forfeiture on March 11, 2022.

Administrative Service Fee

The Company has agreed, commencing on the signing of the engagement letter with the underwriter on May 6, 2021, to pay the sponsor a monthly fee of up to $10,000 up to the consummation of business combination, for the Company’s use of its personnel and other administrative resources. Since inception through June 30, 2022, the Company had paid an aggregate of $138,000 to the sponsor.

Related Party Loans

On May 11, 2021, the Company issued a $300,000 principal amount unsecured promissory note to the Company’s sponsor, On January 31, 2022, the Company issued a $100,000 principal amount unsecured promissory note to the Company’s sponsor, On March 7, 2022, the Company issued a $100,000 principal amount unsecured promissory note to the Company’s sponsor, and the Company had received such amounts as of issuance dates. The notes are non-interest bearing, and due after the date on which this offering is consummated or the Company determines to abandon this offering. On March 11, 2022, the $500,000 loan was converted into part of the subscription of $3,515,000 private placement at a price of $10.00 per unit. The promissory notes were canceled and no amounts were owed under the notes.

As mentioned in Note 1, in order to meet its working capital needs following the consummation of the IPO, the Company’s initial shareholders, officers and directors or their affiliates may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each working capital loan would be evidenced by a promissory note and would either be paid upon consummation of the Company’s initial business combination, without interest, or, at the lender’s discretion, up to $500,000 of the working capital loan may be converted upon consummation of the Company’s business combination into additional private units at a price of $10.00 per unit. If the Company does not complete a business combination, the working capital loan will only be repaid with funds not held in the trust account and only to the extent available. As of June 30, 2022, there was nil working capital loan outstanding.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2022
Fair Value Measurements  
Fair Value Measurements

Note 6 — Fair Value Measurements

The Company follows the guidance in FASB ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1:Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2:Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3:Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at June 30, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

Description

    

Level

    

June 30, 2022

Assets:

 

  

 

  

Marketable securities held in Trust Account

 

1

$

70,134,603

Except for the foregoing, the Company does not have any assets measured at fair value on a recurring basis at June 30, 2022 and December  31, 2021.

Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. No such transfers took place for the period presented.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2022
Commitments and Contingencies  
Commitments and Contingencies

Note 7 — Commitments and Contingencies

Risks and Uncertainties

Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of this financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Underwriting Agreement

A deferred underwriting commission of $0.35 per Public Unit sold, totaling $2,415,000 will be payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, without accrued interest. In the event that the Company does not close a Business Combination, the representative underwriter forfeits its right to receive the commission.

Registration Rights

The initial shareholders will be entitled to registration rights with respect to their initial shares, as well as the holders of the Private Units and holders of any securities issued to the Company’s initial shareholders, officers, directors or their affiliates in payment of working capital loans or extension loans made to the Company, will be entitled to registration rights with respect to the Private Units (and underlying securities), pursuant to an agreement signed on the effective date of the IPO. The holders of such securities are entitled to demand that the Company register these securities at any time after the Company consummates a business combination. In addition, the holders have certain “piggy-back” registration rights on registration statements filed after the Company’s consummation of a business combination.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.2
Shareholders' Equity
6 Months Ended
Jun. 30, 2022
Shareholders' Equity  
Shareholder's Equity

Note 8 — Shareholder’s Equity

Ordinary shares

The Company is authorized to issue 500,000,000 ordinary shares with a par value of $0.0001 per share.

On February 19, 2021, 1,437,500 shares of the Company’s ordinary shares were issued to the sponsor at a price of approximately $0.017 per share for an aggregate of $25,000. In connection with the increase in the size of the offering, on December 20, 2021, the Company declared a 20% share dividend on each founder share thereby increasing the number of issued and outstanding founder shares to 1,725,000 (up to 225,000 of which are subject to forfeiture) so as to maintain the number of founder shares at 20% of the outstanding shares of our ordinary shares upon the consummation of this offering, resulting in an effective purchase price per founder share after the share dividend of approximately $0.014. The per share purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the aggregate number of founder shares issued. The number of founder shares issued was determined based on the expectation that the founder shares would represent 20% of the outstanding shares after this offering (not including the

shares issued to the underwriter at closing or the shares underlying the private placement units). Since the over-allotment option has been fully exercised, the 225,000 founder shares were no longer subject to forfeiture on March 11, 2022.

On March 11, 2022, the Company sold 6,900,000 units, which includes the full exercise of the over-allotment option by the underwriter of in the IPO at a price of $10.00 per Public Unit in the IPO; and the Company sold to its sponsor an aggregate of 351,500 Private Units at $10.00 per Private Unit. Each Public Unit and Private Unit consists of one ordinary share, one-half of one redeemable warrant and one right.

The Company issued to the underwriter 165,000 shares of ordinary shares (the “Representative Shares”) upon the closing of the IPO on March 11, 2022. The Company estimates the fair value of Representative Shares to be $1,262,250 in total, or $7.65 per Representative Share. The Company accounted for the Representative Shares as an expense of the IPO, resulting in a charge directly to stockholder’s equity. The underwriter has agreed not to transfer, assign, sell, pledge, or hypothecate any such Representative Shares, or subject such Representative Shares to hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person until the completion of our initial business combination. In addition, the underwriter has agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of our initial business combination and (ii) to waive its rights to liquidating distributions from the trust account with respect to such shares if we fail to complete our initial business combination within 12 months (or 15 months, as applicable) from the closing of this offering.

As of June 30, 2022, there were 2,241,500 shares of ordinary shares issued and outstanding excluding 6,900,000 shares subject to possible redemption.

Warrants

Each whole warrant entitles the holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment as described below, commencing 30 days after the completion of its initial business combination, and expiring five years from after the completion of an initial business combination. No fractional warrant will be issued and only whole warrants will trade.

The Company may redeem the warrants at a price of $0.01 per warrant upon 30 days’ notice, only in the event that the last sale price of the ordinary shares is at least $18.00 (as adjusted for share sub-divisions, share dividends, reorganizations and recapitalizations) per share for any 20 trading days within a 30-trading day period ending on the third day prior to the date on which notice of redemption is given, provided there is an effective registration statement and current prospectus in effect with respect to the ordinary shares underlying such warrants during the 30 day redemption period. If the Company redeems the warrants as described above, management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” If a registration statement is not effective within 90 days following the consummation of a business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their warrants on a cashless basis and in no event (whether in the case of a registration statement being effective or otherwise) will the Company be required to net cash settle the warrant exercise. If an initial business combination is not consummated, the warrants will expire and will be worthless.

In addition, if (a) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at a newly issued price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by our board of directors and, in the case of any such issuance to our initial shareholders or their affiliates, without taking into account any founders’ shares held by the Company’s initial shareholders or such affiliates, as applicable, prior to such issuance), (b) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination on the date of the consummation of the Company’s initial business combination (net of redemptions), and (c) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial business combination is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the market value and the newly issued price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the market value and the newly issued price.

Rights

Except in cases where the Company is not the surviving company in a business combination, each holder of a right will automatically receive one-tenth (1/10) of an ordinary share upon consummation of an initial business combination, even if the holder of a public right converted all ordinary shares held by him, her or it in connection with the initial business combination or an amendment to our certificate of incorporation with respect to the Company’s pre-business combination activities. In the event the Company will not be the surviving company upon completion of our initial business combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one- tenth (1/10) of a share underlying each right upon consummation of the business combination. No additional consideration will be required to be paid by a holder of rights in order to receive his, her or its additional ordinary shares upon consummation of an initial business combination. The shares issuable upon exchange of the rights will be freely tradable (except to the extent held by affiliates of the Company). If the Company enters into a definitive agreement for a business combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the holders of the ordinary shares will receive in the transaction on an as-converted into ordinary share basis.

The Company will not issue fractional shares in connection with an exchange of rights. As a result, holders of rights must hold rights in multiples of 10 in order to receive shares for all of the holders’ rights upon closing of a business combination. If the Company are unable to complete an initial business combination within the required time period and liquidate the funds held in the trust account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from our assets held outside of the trust account with respect to such rights, and the rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of an initial business combination. Additionally, in no event will the Company be required to net cash settle the rights.

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.2
Subsequent Events
6 Months Ended
Jun. 30, 2022
Subsequent Events  
Subsequent Events

Note 9 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to August 1, 2022, the date that the unaudited condensed financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.2
Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2022
Significant Accounting Policies  
Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed financial statements are presented in U.S. Dollars and in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three months and for the six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and the final prospectus filed by the Company with the SEC on March 17, 2022 and March 10, 2022, respectively.

Emerging Growth Company

Emerging Growth Company

Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) permits emerging growth companies to delay complying with new or revised financial accounting standards that do not yet apply to private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act). The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company, which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of June 30, 2022 and December 31, 2021.

Marketable Securities Held in Trust Account

Marketable Securities Held in the Trust Account

As of June 30, 2022 and December 31, 2021, The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. (See Note 6).

Ordinary Shares Subject to Possible Redemption

Ordinary Shares Subject to Possible Redemption

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s public shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital equals to zero. Accordingly, as of June 30, 2022, ordinary shares subject to possible redemption are presented at redemption value of $10.16 per share as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

Offering Costs Associated with the IPO

Offering Costs Associated with the IPO

Offering costs consist of underwriting, legal, accounting, registration and other expenses incurred through the balance sheet date that are directly related to the IPO. As of March 11, 2022, offering costs totaled $5,614,686. The amount was consisted of $1,380,000 of underwriting commissions, $2,415,000 of deferred underwriting commissions, and $1,819,686 of other offering costs (which includes $1,262,250 of representative shares, as described in Note 8. The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A – “Expenses of Offering”. Offering costs were charged to shareholders’ equity upon the completion of the IPO. The Company allocates offering costs between public shares, public warrants and public rights based on the estimated fair values of them at the date of issuance. Accordingly, $5,109,364 was allocated to public shares and was charged to temporary equity, and a sum of $505,322 was allocated to public warrants and public rights, and was charged to shareholders’ equity.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 825, “Financial Instruments,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Concentration of Credit Risk

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution that at times may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Warrants

Warrants

The Company evaluates the public and private warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. Pursuant to such evaluation, both public and private warrants are classified in shareholders’ equity.

Income Taxes

Income Taxes

The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company has identified Cayman Islands as its only “major” tax jurisdiction, as defined. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. Since the Company was incorporated on February 19, 2021, the evaluation was performed for the period ended December 31, 2021 and the upcoming 2022 tax year. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in a material changes to its financial position. The Company’s policy for recording interest and penalties associated with audits is to record such items as a component of income tax expense.

The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws.

The Company’s tax provision was nil and it had no deferred tax assets for the period presented. The Company is considered to be an exempted Cayman Islands Company, and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2
Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2022
Significant Accounting Policies  
Schedule of basic and diluted loss per ordinary share

The net income (loss) per share presented in the condensed statement of operations is based on the following:

    

    

    

    

For The 

Period From

February 19,

For The

For The

For The

2021

 Three Months

Six Months

Three Months

(Inception)

Ended

Ended

Ended

To

June 30,

June 30,

June 30,

June 30,

2022

2022

2021

2021

Net loss

$

(56,431)

$

(103,813)

$

(17,997)

$

(21,574)

Accretion of temporary equity to initial redemption value ($10.15 per share)

 

(12,354,364)

 

Interest earned from trust account

(94,587)

(99,603)

Net loss including accretion of temporary equity to redemption value

$

(151,018)

$

(12,557,780)

$

(17,997)

$

(21,574)

    

For The Three Months 

    

For The Six Months 

    

For The Three Months 

    

For The Period From February 19,

Ended

Ended

Ended

2021

June 30, 2022

June 30, 2022

June 30, 2021

 (Inception) To June 30, 2021

Redeemable

Non-redeemable

Redeemable 

Non-redeemable 

Redeemable

    

Non-redeemable

Redeemable

 

Non-redeemable

shares

    

shares

    

shares

    

shares

    

shares

    

shares

    

shares

    

shares

Basic and diluted net income/(loss) per share:

 

  

 

  

 

  

 

  

Numerators:

 

  

 

  

 

  

 

  

Allocation of net loss including accretion of temporary equity

$

(113,988)

$

(37,030)

$

(8,491,458)

$

(4,066,322)

$

$

(17,997)

$

$

(21,574)

Accretion of temporary equity to initial redemption value ($10.15 per share)

 

 

12,354,364

 

 

Interest earned from trust account

94,587

99,603

Allocation of net income/(loss)

$

(19,401)

$

(37,030)

$

3,962,509

$

(4,066,322)

$

$

(17,997)

$

$

(21,574)

Denominators:

 

  

 

  

 

  

 

  

Weighted-average shares outstanding

 

6,900,000

2,241,500

 

4,269,613

2,044,602

 

1,250,000

 

1,250,000

Basic and diluted net income/(loss) per share

$

$

(0.02)

$

0.93

$

(1.99)

$

N/A

$

(0.01)

$

N/A

$

(0.02)

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.2
Initial Public Offering (Tables)
6 Months Ended
Jun. 30, 2022
Initial Public Offering  
Schedule of ordinary shares reflected on the balance sheet

As of June 30, 2022, the ordinary shares reflected on the balance sheet are reconciled in the following table.

    

As of June 30, 2022

Gross proceeds

$

69,000,000

Less:

 

  

Proceeds allocated to public warrants and public rights

 

(6,210,000)

Offering costs of public shares

 

(5,109,364)

Plus:

 

  

Accretion of carrying value to redemption value

 

12,453,967

Ordinary share subject to possible redemption

$

70,134,603

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2022
Fair Value Measurements  
Schedule of Company's assets that are measured at fair value on a recurring basis

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at June 30, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

Description

    

Level

    

June 30, 2022

Assets:

 

  

 

  

Marketable securities held in Trust Account

 

1

$

70,134,603

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.2
Organization and Business Operations (Details)
1 Months Ended 3 Months Ended 4 Months Ended 6 Months Ended
Mar. 11, 2022
USD ($)
$ / shares
shares
Feb. 19, 2021
item
Mar. 31, 2021
USD ($)
Mar. 31, 2022
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
Subsidiary, Sale of Stock [Line Items]              
Condition for future business combination number of businesses minimum | item   1          
Price per unit | $ / shares $ 10.00            
Transaction Costs $ 5,614,686            
Underwriting fees 1,380,000            
Deferred underwriting fee payable 2,415,000         $ 2,415,000  
Other offering costs 1,819,686            
Representative shares 1,262,250            
Aggregate purchase price     $ 25,000 $ 69,000,000      
Investment of proceeds in Trust account 70,035,000         $ 70,035,000  
Anticipating equity interest to be acquired (In Percentage)           100.00%  
Minimum percentage of equity interest to be acquired ( in percentage)           100.00%  
Post transaction voting interest to be acquired ( in percentage)           50.00%  
Minimum net tangible assets upon consummation of the Business Combination           $ 5,000,001  
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)           100.00%  
Cash held outside the Trust account           $ 263,760 $ 65,790
Note payable to a related party converted to subscription of private units 500,000       $ 0 $ 500,000  
Proceeds from private placement $ 3,515,000            
Substantial doubt about going concern within one year           true  
IPO              
Subsidiary, Sale of Stock [Line Items]              
Sale of Units, net of underwriting discounts (in shares) | shares 6,900,000            
Price per unit | $ / shares $ 10.00         $ 10.00  
Proceeds from issuance initial public offering. $ 69,000,000            
Representative shares           $ 1,262,250  
Sponsor              
Subsidiary, Sale of Stock [Line Items]              
Aggregate purchase price           25,000  
Maximum borrowing capacity of related party promissory note           $ 500,000  
Sponsor | Private Placement Offering              
Subsidiary, Sale of Stock [Line Items]              
Sale of Units, net of underwriting discounts (in shares) | shares 351,500            
Price per unit | $ / shares $ 10.00            
Proceeds from issuance initial public offering. $ 3,515,000            
Sponsor | IPO and Private Placement              
Subsidiary, Sale of Stock [Line Items]              
Proceeds from issuance initial public offering. 68,162,564            
Aggregate purchase price $ 25,000            
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2
Significant Accounting Policies (Details) - USD ($)
Mar. 11, 2022
Jun. 30, 2022
Dec. 31, 2021
Cash equivalents   $ 0 $ 0
Temporary equity redemption price per share     $ 10.16
Transaction Costs $ 5,614,686    
Deferred underwriting fee payable 2,415,000 2,415,000  
Underwriting fees 1,380,000    
Other offering costs 1,819,686    
Representative shares 1,262,250    
Federal Depository Insurance Coverage   250,000  
Unrecognized tax benefits   0  
Deferred tax assets   $ 0  
Proceeds from issuance of private placement 3,515,000    
Public Shares      
Allocation of offering costs to ordinary shares subject to redemption 5,109,364    
Public Warrants      
Allocation of offering costs to ordinary shares subject to redemption $ 505,322    
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.2
Significant Accounting Policies - Reconciliation of Net Income (Loss) per Share (Details) - USD ($)
1 Months Ended 3 Months Ended 4 Months Ended 6 Months Ended
Mar. 11, 2022
Dec. 20, 2021
Mar. 31, 2021
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2021
Jun. 30, 2021
Jun. 30, 2022
Dec. 31, 2021
Net loss     $ (3,577) $ (56,431) $ (47,382) $ (17,997) $ (21,574) $ (103,813)  
Accretion of temporary equity to initial redemption value ($10.15 per share)               (12,354,364)  
Interest earned from trust account       (94,587)       (99,603)  
Net loss including accretion of temporary equity to redemption value       (151,018)   (17,997) (21,574)    
Numerators:                  
Net Loss     $ (3,577) (56,431) $ (47,382) (17,997) $ (21,574) (103,813)  
Denominators:                  
Shares that are no longer subject to forfeiture             187,500    
Percentage of share dividend on each founder share   20.00%              
Founder shares   1,725,000              
Nonredeemable founder shares forfeited 225,000 225,000              
Temporary Equity, Redemption Price Per Share                 $ 10.16
Redeemable ordinary shares                  
Net loss       (19,401)       3,962,509  
Interest earned from trust account       94,587       99,603  
Numerators:                  
Allocation of net loss including accretion of temporary equity       (113,988)       (8,491,458)  
Accretion of temporary equity to initial redemption value ($10.15 per share)               12,354,364  
Net Loss       $ (19,401)       $ 3,962,509  
Denominators:                  
Weighted-average shares outstanding, basic       6,900,000       4,269,613  
Weighted-average shares outstanding, diluted       6,900,000       4,269,613  
Basic net income/(loss) per share               $ 0.93  
Diluted net income/(loss) per share               $ 0.93  
Non-redeemable ordinary shares                  
Net loss       $ (37,030)   (17,997) $ (21,574) $ (4,066,322)  
Numerators:                  
Allocation of net loss including accretion of temporary equity       (37,030)   (17,997) (21,574) (4,066,322)  
Net Loss       $ (37,030)   $ (17,997) $ (21,574) $ (4,066,322)  
Denominators:                  
Weighted-average shares outstanding, basic       2,241,500   1,250,000 1,250,000 2,044,602  
Weighted-average shares outstanding, diluted       2,241,500   1,250,000 1,250,000 2,044,602  
Basic net income/(loss) per share       $ (0.02)   $ (0.01) $ (0.02) $ (1.99)  
Diluted net income/(loss) per share       $ (0.02)   $ (0.01) $ (0.02) $ (1.99)  
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2
Initial Public Offering (Details) - $ / shares
Mar. 11, 2022
Jun. 30, 2022
Dec. 31, 2021
Subsidiary, Sale of Stock [Line Items]      
Price per unit $ 10.00    
Temporary equity, shares outstanding 6,900,000 6,900,000 6,900,000
IPO      
Subsidiary, Sale of Stock [Line Items]      
Number of units sold 6,900,000    
Price per unit $ 10.00 $ 10.00  
Number of shares in a unit 1    
Number of warrants in a unit 0.5    
Purchase price per share $ 11.50    
Number of ordinary shares per each right 0.1    
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2
Initial Public Offering - Ordinary shares reflected on the balance sheet (Details)
6 Months Ended
Jun. 30, 2022
USD ($)
Initial Public Offering  
Gross proceeds $ 69,000,000
Proceeds allocated to public warrants and public rights (6,210,000)
Offering costs of public shares (5,109,364)
Accretion of carrying value to redemption value 12,453,967
Ordinary share subject to possible redemption $ 70,134,603
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2
Private Placement (Details) - Private Placement Offering - Private Placement Warrants
6 Months Ended
Jun. 30, 2022
$ / shares
shares
Subsidiary, Sale of Stock [Line Items]  
Number of warrants to purchase shares issued 351,500
Price of warrants | $ / shares $ 10.00
Number of shares in a unit 1
Number of ordinary shares per each right 0.1
Number of redeemable warrants per unit 0.5
Purchase price per share | $ / shares $ 11.50
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.2
Related Party Transactions - Founder Shares (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 11, 2022
Dec. 20, 2021
Feb. 19, 2021
Mar. 31, 2021
Mar. 31, 2022
Jun. 30, 2022
Related Party Transaction [Line Items]            
Percentage of share dividend on each founder share   20.00%        
Founder shares   1,725,000        
Nonredeemable founder shares forfeited 225,000 225,000        
Percentage of founder shares on outstanding shares   20.00%        
Share dividend   $ 0.014        
Nonredeemable founder shares no longer subject to forfeiture 225,000          
Aggregate purchase price       $ 25,000 $ 69,000,000  
Sponsor            
Related Party Transaction [Line Items]            
Aggregate purchase price           $ 25,000
Founder Shares            
Related Party Transaction [Line Items]            
Percentage of share dividend on each founder share   20.00%        
Founder shares   1,725,000        
Nonredeemable founder shares forfeited   225,000        
Percentage of founder shares on outstanding shares   20.00%        
Share dividend   $ 0.014        
Nonredeemable founder shares no longer subject to forfeiture 225,000          
Founder Shares | Sponsor            
Related Party Transaction [Line Items]            
Number of shares issued     1,437,500      
Share Price     $ 0.017      
Aggregate purchase price     $ 25,000      
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2
Related Party Transactions - Additional Information (Details) - USD ($)
4 Months Ended 6 Months Ended
Mar. 11, 2022
May 06, 2021
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Mar. 07, 2022
Jan. 31, 2022
May 11, 2021
Related Party Transaction [Line Items]                
Note payable to a related party converted to subscription of private units $ 500,000     $ 0 $ 500,000      
Proceeds from private placement $ 3,515,000              
Price per unit $ 10.00              
Promissory Note with Related Party                
Related Party Transaction [Line Items]                
Note payable to a related party converted to subscription of private units $ 500,000              
Proceeds from private placement $ 3,515,000              
Price per unit $ 10.00              
Maximum borrowing capacity of related party promissory note           $ 100,000 $ 100,000 $ 300,000
Administrative Support Agreement                
Related Party Transaction [Line Items]                
Monthly fee to Sponsor   $ 10,000            
Amount paid to Sponsor     $ 138,000          
Related Party Loans                
Related Party Transaction [Line Items]                
Loan conversion agreement warrant     $ 500,000   $ 500,000      
Price of warrant     $ 10.00   $ 10.00      
Amount owed under the notes to related party     $ 0   $ 0      
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements (Details)
6 Months Ended
Jun. 30, 2022
USD ($)
Assets:  
Fair value assets level 1 to level 2 transfers $ 0
Fair value assets level 2 to level 1 transfers 0
Fair value assets transferred into (out of) level 3 0
Level 1 | Recurring | Marketable securities  
Assets:  
Marketable securities held in Trust Account $ 70,134,603
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2
Commitments and Contingencies (Details) - USD ($)
6 Months Ended
Jun. 30, 2022
Mar. 11, 2022
Commitments and Contingencies    
Deferred underwriters commission per public unit sold $ 0.35  
Deferred underwriting fee payable $ 2,415,000 $ 2,415,000
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2
Shareholders' Equity - Common Stock Shares (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 11, 2022
Dec. 20, 2021
Feb. 19, 2021
Mar. 31, 2021
Mar. 31, 2022
Jun. 30, 2022
Dec. 31, 2021
Class of Stock [Line Items]              
Percentage of share dividend on each founder share   20.00%          
Founder shares   1,725,000          
Nonredeemable founder shares forfeited 225,000 225,000          
Share dividend   $ 0.014          
Nonredeemable founder shares no longer subject to forfeiture 225,000            
Common shares, shares authorized (in shares)           500,000,000 500,000,000
Common shares, par value (in dollars per share)           $ 0.0001 $ 0.0001
Common shares, shares issued (in shares)     1,437,500     2,241,500 1,725,000
Aggregate purchase price       $ 25,000 $ 69,000,000    
Fair value of representative shares $ 1,262,250            
Price per unit $ 10.00            
Common shares, shares outstanding (in shares)           2,241,500 1,725,000
Temporary equity, shares outstanding 6,900,000         6,900,000 6,900,000
Sponsor              
Class of Stock [Line Items]              
Aggregate purchase price           $ 25,000  
Class A Common Stock              
Class of Stock [Line Items]              
Share Price     $ 0.017        
Aggregate purchase price     $ 25,000        
IPO              
Class of Stock [Line Items]              
Number of units sold 6,900,000            
Fair value of representative shares           $ 1,262,250  
Price per unit $ 10.00         $ 10.00  
Representative share price per share           $ 7.65  
IPO | Class A Common Stock              
Class of Stock [Line Items]              
Number of units sold 165,000            
Private Placement Offering | Sponsor              
Class of Stock [Line Items]              
Number of units sold 351,500            
Price per unit $ 10.00            
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.2
Shareholders' Equity - Warrants (Details)
6 Months Ended
Jun. 30, 2022
$ / shares
item
Class of Warrant or Right [Line Items]  
Public Warrants expiration term 5 years
Adjustment one of redemption price of stock based on market value and newly issued price (as a percent) 180.00%
Warrants  
Class of Warrant or Right [Line Items]  
Warrant redemption condition minimum share price $ 11.50
Maximum period after business combination in which to file registration statement 30 days
Redemption price per public warrant (in dollars per share) $ 0.01
Minimum threshold written notice period for redemption of public warrants 30 days
Threshold trading days for redemption of public warrants 20 days
Threshold consecutive trading days for redemption of public warrants | item 30
Redemption period 30 days
Period of time within which registration statement is expected to become effective 90 days
Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant 60
Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00  
Class of Warrant or Right [Line Items]  
Redemption price per public warrant (in dollars per share) $ 18.00
Share price trigger used to measure dilution of warrant 18.00
Warrants | Redemption Of Warrants When Price Per Class Ordinary Share Equals Or Exceeds 9.20  
Class of Warrant or Right [Line Items]  
Share price trigger used to measure dilution of warrant 9.20
Adjustment one of redemption price of stock based on market value and newly issued price (as a percent) 115.00%
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.2
Shareholders' Equity - Rights (Details)
6 Months Ended
Jun. 30, 2022
shares
Rights  
Class of Stock [Line Items]  
Number of ordinary shares per each right 0.1
XML 46 lbbbu-20220630x10q_htm.xml IDEA: XBRL DOCUMENT 0001867287 lbbb:SponsorMember 2022-01-01 2022-06-30 0001867287 us-gaap:CommonClassAMember 2021-02-19 2021-02-19 0001867287 lbbb:FounderSharesMember lbbb:SponsorMember 2021-02-19 2021-02-19 0001867287 us-gaap:RetainedEarningsMember 2022-06-30 0001867287 us-gaap:RetainedEarningsMember 2022-03-31 0001867287 2022-03-31 0001867287 us-gaap:RetainedEarningsMember 2021-12-31 0001867287 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001867287 us-gaap:RetainedEarningsMember 2021-06-30 0001867287 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001867287 us-gaap:RetainedEarningsMember 2021-03-31 0001867287 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001867287 2021-03-31 0001867287 us-gaap:RetainedEarningsMember 2021-02-18 0001867287 us-gaap:AdditionalPaidInCapitalMember 2021-02-18 0001867287 lbbb:SponsorMember us-gaap:PrivatePlacementMember 2022-03-11 0001867287 lbbb:PromissoryNoteWithRelatedPartyMember 2022-03-11 0001867287 us-gaap:CommonStockMember 2022-06-30 0001867287 us-gaap:CommonStockMember 2022-03-31 0001867287 us-gaap:CommonStockMember 2021-12-31 0001867287 us-gaap:CommonStockMember 2021-06-30 0001867287 us-gaap:CommonStockMember 2021-03-31 0001867287 us-gaap:CommonStockMember 2021-02-18 0001867287 lbbb:FounderSharesMember lbbb:SponsorMember 2021-02-19 0001867287 us-gaap:CommonClassAMember 2021-02-19 0001867287 us-gaap:IPOMember 2022-03-11 0001867287 lbbb:SponsorMember lbbb:IpoAndPrivatePlacementMember 2022-03-11 2022-03-11 0001867287 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001867287 us-gaap:RetainedEarningsMember 2021-02-19 2021-03-31 0001867287 2021-02-19 2021-03-31 0001867287 2021-04-01 2021-06-30 0001867287 lbbb:FounderSharesMember 2021-12-20 0001867287 2021-12-20 0001867287 2021-02-19 0001867287 2021-06-30 0001867287 2021-02-18 0001867287 lbbb:MarketableSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001867287 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-03-11 2022-03-11 0001867287 lbbb:SponsorMember us-gaap:PrivatePlacementMember 2022-03-11 2022-03-11 0001867287 lbbb:AdministrativeSupportAgreementMember 2021-05-06 2021-05-06 0001867287 us-gaap:AdditionalPaidInCapitalMember 2021-02-19 2021-03-31 0001867287 us-gaap:CommonStockMember 2021-02-19 2021-03-31 0001867287 us-gaap:IPOMember 2022-03-11 2022-03-11 0001867287 lbbb:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2022-01-01 2022-06-30 0001867287 lbbb:PromissoryNoteWithRelatedPartyMember 2022-03-11 2022-03-11 0001867287 2021-12-31 2021-12-31 0001867287 2021-06-30 2021-06-30 0001867287 2021-03-31 2021-03-31 0001867287 lbbb:FounderSharesMember 2022-03-11 2022-03-11 0001867287 lbbb:NonRedeemableOrdinarySharesMember 2022-04-01 2022-06-30 0001867287 lbbb:NonRedeemableOrdinarySharesMember 2022-01-01 2022-06-30 0001867287 lbbb:NonRedeemableOrdinarySharesMember 2021-04-01 2021-06-30 0001867287 lbbb:NonRedeemableOrdinarySharesMember 2021-02-19 2021-06-30 0001867287 lbbb:SponsorMember 2022-06-30 0001867287 lbbb:PromissoryNoteWithRelatedPartyMember 2022-03-07 0001867287 lbbb:PromissoryNoteWithRelatedPartyMember 2022-01-31 0001867287 lbbb:PromissoryNoteWithRelatedPartyMember 2021-05-11 0001867287 2022-03-11 2022-03-11 0001867287 lbbb:RedeemableOrdinarySharesMember 2022-04-01 2022-06-30 0001867287 lbbb:RedeemableOrdinarySharesMember 2022-01-01 2022-06-30 0001867287 lbbb:FounderSharesMember 2021-12-20 2021-12-20 0001867287 2021-12-20 2021-12-20 0001867287 us-gaap:IPOMember 2022-06-30 0001867287 2022-03-11 0001867287 2021-02-19 2021-06-30 0001867287 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001867287 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001867287 2022-04-01 2022-06-30 0001867287 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001867287 2021-02-19 2021-02-19 0001867287 lbbb:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member us-gaap:WarrantMember 2022-01-01 2022-06-30 0001867287 lbbb:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2022-06-30 0001867287 lbbb:RelatedPartyLoansMember 2022-06-30 0001867287 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001867287 lbbb:RedemptionOfWarrantsIfPricePerClassOrdinaryShareEqualsOrExceeds9.20Member us-gaap:WarrantMember 2022-01-01 2022-06-30 0001867287 lbbb:AdministrativeSupportAgreementMember 2022-02-19 2022-06-30 0001867287 lbbb:PublicWarrantsMember 2022-03-11 2022-03-11 0001867287 lbbb:PublicSharesMember 2022-03-11 2022-03-11 0001867287 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001867287 2022-01-01 2022-03-31 0001867287 2022-06-30 0001867287 2021-12-31 0001867287 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001867287 us-gaap:RightsMember 2022-01-01 2022-06-30 0001867287 us-gaap:MemberUnitsMember 2022-01-01 2022-06-30 0001867287 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001867287 2022-08-01 0001867287 2022-01-01 2022-06-30 shares iso4217:USD pure iso4217:USD shares lbbb:item 6900000 2241500 2044602 1250000 1250000 0.93 -0.02 -1.99 -0.01 6900000 2241500 4269613 2044602 1250000 1250000 -0.02 0.93 -1.99 -0.01 -0.02 00-0000000 0001867287 --12-31 2022 Q2 false 2241500 1725000 0.5 0.1 0.1 0.5 0 0 2241500 0.1 true 10-Q true 2022-06-30 false 001-41317 LAKESHORE ACQUISITION II CORP. E9 667 Madison Avenue New York NY 10065 917 327-9933 Ordinary Shares LBBB NASDAQ Warrants LBBBW NASDAQ Rights LBBBR NASDAQ Units LBBBU NASDAQ Yes Yes Non-accelerated Filer true true false true 9141500 263760 65790 223822 40000 70134603 70438363 289612 70438363 289612 300000 2415000 25000 50000 2440000 350000 2440000 350000 6900000 6900000 10.16 70134603 0.0001 0.0001 500000000 500000000 2241500 1725000 224 173 24827 -2136464 -85388 -2136240 -60388 70438363 289612 225500 225000 151018 203416 17997 21574 -151018 -17997 -21574 94587 99603 -56431 -103813 -17997 -21574 6900000 4269613 2241500 2044602 1250000 1250000 0.93 -0.02 -1.99 -0.01 -0.02 187500 0.20 1725000 225000 225000 0 0 0 0 0 1437500 144 24856 25000 287500 29 -29 -3577 -3577 1725000 173 24827 -3577 21423 -17997 -17997 1725000 173 24827 -21574 3426 1725000 173 24827 -85388 -60388 6900000 690 68999310 69000000 351500 35 3514965 3515000 165000 16 1262234 1262250 5614686 5614686 -6900000 -690 -62789310 -62790000 5109364 5109364 10506704 1847660 12354364 -47382 -47382 2241500 224 -1980430 -1980206 99603 99603 -56431 -56431 2241500 224 -2136464 -2136240 187500 187500 0.20 1725000 225000 225000 -103813 -21574 99603 0 40000 25000 18000 -218416 -3574 70035000 0 -70035000 0 25000 200000 300000 69000000 3015000 0 1380000 0 383614 110000 70451386 215000 197970 211426 65790 0 263760 211426 50000 500000 0 2415000 0 1262250 0 62790000 0 -5109364 0 12453967 0 500000 3515000 10.00 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 1 — Organization and Business Operations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Organization and General</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Lakeshore Acquisition II Corp. (the “Company”) was incorporated in the Cayman Islands on February 19, 2021 as a blank check company whose objective is to acquire, through a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The Company’s efforts to identify a prospective target business will not be limited to any particular industry or geographic region except that according to the Company’s amended and restated memorandum and articles of association, the Company will not effectuate its initial Business Combination with a company that is headquartered in the People’s Republic of China (“China”), the Hong Kong Special Administrative Region of China (“Hong Kong”) or the Macau Special Administrative Region of China (“Macau”) or conducts a majority of its operations in China, Hong Kong or Macau.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of June 30, 2022, the Company had not yet commenced any operations and had not generated revenue. All activity for the period from February 19, 2021 (inception) through June 30, 2022 relates to the Company’s formation and the initial public offering (the “IPO”) described below and its effort in seeking a target business. The Company will not generate any operating revenue until after its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year-end.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s sponsor is RedOne Investment Limited, a BVI limited liability company (the “sponsor”).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Financing</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The registration statement for the Company’s IPO (as described in Note 3) was declared effective on March 8, 2022 (the “Effective Date”). On March 11, 2022, the Company consummated an IPO of 6,900,000 units, which includes the full exercise of the over-allotment option by the underwriter in the IPO, at $10.00 per unit (the “Public Units”), generating total gross proceeds of $69,000,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Simultaneously with the IPO, the Company sold to its sponsor 351,500 units at $10.00 per unit (the “Private Units”) in a private placement (as described in Note 4), generating total gross proceeds of $ 3,515,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Offering costs amounted to $5,614,686 consisting of $1,380,000 of underwriting commissions, $2,415,000 of deferred underwriting commissions, and $1,819,686 of other offering costs (which includes $1,262,250 of representative shares, as described in Note 8). Except for the $25,000 of subscription of founder shares, the Company received net proceeds of $68,162,564 from the IPO and the private placement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Trust Account</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Upon the closing of the IPO and the private placement, $70,035,000 was placed in a trust account (the “Trust Account”) with Continental Stock Transfer &amp; Trust Company acting as trustee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The funds held in the trust account can be invested in United States government treasury bills, notes or bonds having a maturity of 185 days or less or in money market funds meeting the applicable conditions under Rule 2a-7 promulgated under the Investment Company Act of 1940, as amended, until the earlier of the consummation of its first business combination and the Company’s failure to consummate a business combination within 12 months (or 15 months as applicable) from the consummation of the IPO.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Placing funds in the trust account may not protect those funds from third party claims against the Company. Although the Company will seek to have all vendors, service providers, prospective target businesses or other entities it engages, execute agreements with the Company waiving any claim of any kind in or to any monies held in the Trust Account, there is no guarantee that such persons will execute such agreements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In addition, interest income earned on the funds in the Trust account may be released to the Company to pay its income or other tax obligations. With these exceptions, expenses incurred by the Company may be paid prior to a business combination only from the net proceeds of the IPO and private placement not held in the Trust account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Business Combination</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Pursuant to Nasdaq listing rules, the Company’s initial business combination must occur with one or more target businesses having an aggregate fair market value equal to at least 80% of the value of the funds in the Trust account (excluding any deferred underwriting commissions payable and any taxes payable on the income earned on the Trust account), which the Company refers to as the 80% test, at the time of the execution of a definitive agreement for its initial business combination, although the Company may structure a business combination with one or more target businesses whose fair market value significantly exceeds 80% of the trust account balance. If the Company is no longer listed on Nasdaq, it will not be required to satisfy the 80% test.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company currently anticipates structuring a business combination to acquire 100% of the equity interests or assets of the target business or businesses. The Company may, however, structure a business combination where the Company merges directly with the target business or where the Company acquires less than 100% of such interests or assets of the target business in order to meet certain objectives of the target management team or shareholders or for other reasons, but the Company will only complete such business combination if the post-transaction company owns 50% or more of the outstanding voting securities of the target or otherwise owns a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. If less than 100% of the equity interests or assets of a target business or businesses are owned or acquired by the post-transaction company, the portion of such business or businesses that is owned or acquired is what will be valued for purposes of the 80% test.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company will either seek shareholder approval of any business combination at a meeting called for such purpose at which shareholders may seek to convert their shares into their pro rata share of the aggregate amount then on deposit in the Trust account, less any taxes then due but not yet paid, or provide shareholders with the opportunity to sell their shares to the Company by means of a tender offer for an amount equal to their pro rata share of the aggregate amount then on deposit in the trust account, less any taxes then due but not yet paid.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company will proceed with a business combination only if it will have net tangible assets of at least $5,000,001 upon consummation of the business combination and, solely if shareholder approval is sought, an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company will be required to approve the business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Notwithstanding the foregoing, a public shareholder, together with any affiliate of his or any other person with whom he is acting in concert or as a “group” (as defined in Section 13(d)(3) of the Exchange Act) will be restricted from seeking conversion rights with respect to 20% or more of the ordinary shares sold in this offering without the Company’s prior written consent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In connection with any shareholder vote required to approve any business combination, the initial shareholders will agree (i) to vote any of their respective shares in favor of the initial business combination and (ii) not to convert such respective shares into a pro rata portion of the trust account or seek to sell their shares in connection with any tender offer the Company engages in.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Liquidation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Pursuant to the amended and restated memorandum and articles of association, if the Company is unable to complete its initial business combination within 12 months (or 15 months, as applicable) from the effective date of the IPO, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than five business days thereafter, redeem 100% of the outstanding public shares and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining holders of ordinary shares and the Company’s board of directors, liquidate and dissolve.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Liquidity and Capital Resources</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of June 30, 2022, the Company had $263,760 in cash held outside its Trust Account available for the Company’s working capital purposes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s liquidity needs prior to the consummation of the IPO had been satisfied through a payment from the sponsor of $25,000 (see Note 8) for the founder shares and the loan under several unsecured promissory notes from the sponsor of $500,000 in total (see Note 5). On March 11, 2022, the $500,000 loan was converted into part of the subscription of $3,515,000 private placement at a price of $10.00 per unit. The promissory notes were canceled and no amounts were owed under the notes at June 30, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Upon the consummation of the IPO and the full exercise of over-allotment and associated private placements (see Note 3 and Note 4) on March 11, 2022, $70,035,000 of cash was placed in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In order to meet its working capital needs following the consummation of the IPO, the Company’s initial shareholders, officers and directors or their affiliates may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each working capital loan would be evidenced by a promissory note and would either be paid upon consummation of the Company’s initial business combination, without interest, or, at the lender’s discretion, up to certain amount of the working capital loan may be converted upon consummation of the Company’s business combination into additional private units at a price of $10.00 per unit. If the Company does not complete a business combination, the working capital loan will only be repaid with funds not held in the trust account and only to the extent available (see Note 5). To date, there were no amounts outstanding under any working capital loans.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a business combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Going Concern</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company performed an assessment on its ability to continue as a going concern in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern”. There is no assurance that the Company will be able to consummate the initial business combination within 12 months (or 15 months, as applicable) from the date of the IPO. In the event that the Company fails to consummate business combination within the required period, the Company will face mandatory liquidation and dissolution subject to certain obligations under applicable laws or regulations. This uncertainty raises substantial doubt about the Company’s ability as a going concern <span style="-sec-ix-hidden:Hidden_Th8JH4EaskmLuraSvl2fLw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one year</span></span> from the date the financial statement is issued. No adjustments have been made to the carrying amounts of assets or liabilities regarding the possibility of the Company not continuing as a going concern, as a result of failing to consummate business combination within 12 months (or 15 months, as applicable) from the date of the IPO. Management plans to continue its efforts to consummate a business combination within 12 months (or 15 months, as applicable) from the date of the IPO.</p> 1 6900000 10.00 69000000 351500 10.00 3515000 5614686 1380000 2415000 1819686 1262250 25000 68162564 70035000 1 1 0.50 5000001 1 263760 25000 500000 500000 3515000 10.00 70035000 10.00 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 2 — Significant Accounting Policies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Basis of Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed financial statements are presented in U.S. Dollars and in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three months and for the six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and the final prospectus filed by the Company with the SEC on March 17, 2022 and March 10, 2022, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Emerging Growth Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) permits emerging growth companies to delay complying with new or revised financial accounting standards that do not yet apply to private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act). The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company, which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cash and Cash Equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of June 30, 2022 and December 31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Marketable Securities Held in the Trust Account</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of June 30, 2022 and December 31, 2021, The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. (See Note 6).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Ordinary Shares Subject to Possible Redemption</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s public shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital equals to zero. Accordingly, as of June 30, 2022, ordinary shares subject to possible redemption are presented at redemption value of $10.16 per share as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Offering Costs Associated with the IPO</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Offering costs consist of underwriting, legal, accounting, registration and other expenses incurred through the balance sheet date that are directly related to the IPO. As of March 11, 2022, offering costs totaled $5,614,686. The amount was consisted of $1,380,000 of underwriting commissions, $2,415,000 of deferred underwriting commissions, and $1,819,686 of other offering costs (which includes $1,262,250 of representative shares, as described in Note 8. The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A – “Expenses of Offering”. Offering costs were charged to shareholders’ equity upon the completion of the IPO. The Company allocates offering costs between public shares, public warrants and public rights based on the estimated fair values of them at the date of issuance. Accordingly, $5,109,364 was allocated to public shares and was charged to temporary equity, and a sum of $505,322 was allocated to public warrants and public rights, and was charged to shareholders’ equity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Fair Value of Financial Instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 825, “Financial Instruments,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution that at times may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Net Income (Loss) per Share</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less interest income in trust account less any dividends paid. We then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public shareholders. For the six months ended June 30, 2022 and for the period from February 19, 2021 (inception) to June 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The net income (loss) per share presented in the condensed statement of operations is based on the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For The </b></p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period From</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">February 19,</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For The</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For The</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For The</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> Three Months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Six Months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Inception)</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">To</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30,</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (56,431)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (103,813)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (17,997)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (21,574)</p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Accretion of temporary equity to initial redemption value ($10.15 per share)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12,354,364)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Interest earned from trust account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (94,587)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (99,603)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net loss including accretion of temporary equity to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (151,018)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12,557,780)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (17,997)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (21,574)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For The Three Months  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:21.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For The Six Months  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For The Three Months  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For The Period From February 19,</b></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:21.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:21.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (Inception) To June 30, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-redeemable </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-redeemable</b></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income/(loss) per share:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Numerators:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Allocation of net loss including accretion of temporary equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (113,988)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (37,030)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8,491,458)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,066,322)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (17,997)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (21,574)</p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Accretion of temporary equity to initial redemption value ($10.15 per share)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,354,364</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Interest earned from trust account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 94,587</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 99,603</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Allocation of net income/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (19,401)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (37,030)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,962,509</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,066,322)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (17,997)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (21,574)</p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Denominators:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Weighted-average shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,900,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,241,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,269,613</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,044,602</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,250,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,250,000</p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income/(loss) per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_Rvo8rA2EFECcBP7NzU9DJA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.02)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_r281vAji3020BbsOWnb0Qw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.93</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_wEBqELlU3ESCmRs_R0UhBA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1.99)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_QD8EBl8BMk-5uFACPUpTaw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_rBMnw_oejEiPl56EhF9P5w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.02)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The number of weighted-average shares outstanding for the period from February 19, 2021 (Inception) to June 30, 2021 excludes an aggregate of up to 187,500 shares of non-redeemable shares that are subject to forfeiture if the underwriter does not exercise over-allotment option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In connection with the increase in the size of the offering, on December 20, 2021, the Company declared a 20% share dividend on each founder share, thereby increasing the number of issued and outstanding founder shares to 1,725,000, including up to an aggregate of 225,000 founder shares subject to forfeiture.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In connection with the closing of the IPO and the underwriter’s full exercise of over-allotment option on March 11, 2022, the 225,000 founder shares were no longer subject to forfeiture. These shares were excluded from the calculation of weighted average shares outstanding until they were no longer subject to forfeiture.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Warrants</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company evaluates the public and private warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. Pursuant to such evaluation, both public and private warrants are classified in shareholders’ equity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Income Taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company has identified Cayman Islands as its only “major” tax jurisdiction, as defined. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. Since the Company was incorporated on February 19, 2021, the evaluation was performed for the period ended December 31, 2021 and the upcoming 2022 tax year. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in a material changes to its financial position. The Company’s policy for recording interest and penalties associated with audits is to record such items as a component of income tax expense.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s tax provision was nil and it had no deferred tax assets for the period presented. The Company is considered to be an exempted Cayman Islands Company, and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Recent Accounting Pronouncements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Basis of Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed financial statements are presented in U.S. Dollars and in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three months and for the six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and the final prospectus filed by the Company with the SEC on March 17, 2022 and March 10, 2022, respectively.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Emerging Growth Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) permits emerging growth companies to delay complying with new or revised financial accounting standards that do not yet apply to private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act). The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company, which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cash and Cash Equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of June 30, 2022 and December 31, 2021.</p> 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Marketable Securities Held in the Trust Account</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of June 30, 2022 and December 31, 2021, The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. (See Note 6).</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Ordinary Shares Subject to Possible Redemption</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s public shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital equals to zero. Accordingly, as of June 30, 2022, ordinary shares subject to possible redemption are presented at redemption value of $10.16 per share as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Offering Costs Associated with the IPO</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Offering costs consist of underwriting, legal, accounting, registration and other expenses incurred through the balance sheet date that are directly related to the IPO. As of March 11, 2022, offering costs totaled $5,614,686. The amount was consisted of $1,380,000 of underwriting commissions, $2,415,000 of deferred underwriting commissions, and $1,819,686 of other offering costs (which includes $1,262,250 of representative shares, as described in Note 8. The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A – “Expenses of Offering”. Offering costs were charged to shareholders’ equity upon the completion of the IPO. The Company allocates offering costs between public shares, public warrants and public rights based on the estimated fair values of them at the date of issuance. Accordingly, $5,109,364 was allocated to public shares and was charged to temporary equity, and a sum of $505,322 was allocated to public warrants and public rights, and was charged to shareholders’ equity.</p> 5614686 1380000 2415000 1819686 1262250 5109364 505322 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Fair Value of Financial Instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 825, “Financial Instruments,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution that at times may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p> 250000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The net income (loss) per share presented in the condensed statement of operations is based on the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For The </b></p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period From</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">February 19,</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For The</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For The</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For The</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> Three Months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Six Months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Inception)</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">To</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30,</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (56,431)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (103,813)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (17,997)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (21,574)</p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Accretion of temporary equity to initial redemption value ($10.15 per share)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12,354,364)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Interest earned from trust account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (94,587)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (99,603)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:53.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net loss including accretion of temporary equity to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (151,018)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12,557,780)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (17,997)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (21,574)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For The Three Months  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:21.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For The Six Months  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For The Three Months  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For The Period From February 19,</b></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:21.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:21.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (Inception) To June 30, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-redeemable </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-redeemable</b></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income/(loss) per share:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Numerators:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Allocation of net loss including accretion of temporary equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (113,988)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (37,030)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8,491,458)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,066,322)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (17,997)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (21,574)</p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Accretion of temporary equity to initial redemption value ($10.15 per share)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,354,364</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Interest earned from trust account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 94,587</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 99,603</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Allocation of net income/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (19,401)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (37,030)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,962,509</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,066,322)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (17,997)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (21,574)</p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Denominators:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Weighted-average shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,900,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,241,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,269,613</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,044,602</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,250,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,250,000</p></td></tr><tr><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income/(loss) per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_Rvo8rA2EFECcBP7NzU9DJA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.02)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_r281vAji3020BbsOWnb0Qw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.93</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_wEBqELlU3ESCmRs_R0UhBA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1.99)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_QD8EBl8BMk-5uFACPUpTaw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_rBMnw_oejEiPl56EhF9P5w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.02)</p></td></tr></table> -56431 -103813 -17997 -21574 12354364 -94587 -99603 -151018 -17997 -21574 -113988 -37030 -8491458 -4066322 -17997 -21574 12354364 94587 99603 -19401 -37030 3962509 -4066322 -17997 -21574 6900000 2241500 4269613 2044602 1250000 1250000 -0.02 0.93 -1.99 -0.01 -0.02 187500 0.20 1725000 225000 225000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Warrants</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company evaluates the public and private warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. Pursuant to such evaluation, both public and private warrants are classified in shareholders’ equity.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Income Taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company has identified Cayman Islands as its only “major” tax jurisdiction, as defined. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. Since the Company was incorporated on February 19, 2021, the evaluation was performed for the period ended December 31, 2021 and the upcoming 2022 tax year. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in a material changes to its financial position. The Company’s policy for recording interest and penalties associated with audits is to record such items as a component of income tax expense.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s tax provision was nil and it had no deferred tax assets for the period presented. The Company is considered to be an exempted Cayman Islands Company, and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States.</p> 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Recent Accounting Pronouncements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 3 — Initial Public Offering</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Pursuant to the IPO on March 11, 2022, the Company sold 6,900,000 Public Units, which includes the full exercise of the underwriter’s over-allotment option, at a price of $10.00 per Public Unit. Each unit consists of one ordinary share, <span style="-sec-ix-hidden:Hidden_Z4W_IUkVfEahBk5O-q88oQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span>-half of one redeemable warrant and one right. Each whole warrant entitles the holder thereof to purchase one ordinary share for $11.50 per share, subject to certain adjustment. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Each right entitles the holder to receive <span style="-sec-ix-hidden:Hidden_am3gaACUD0SwRbOYMZNlkQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one-tenth</span></span> of one ordinary share upon consummation of the Company’s initial business combination (See Note 8).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">All of the 6,900,000 public shares sold as part of the Public Units in the IPO contain a redemption feature which allows for the redemption of such public shares if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation, or in connection with the Company’s liquidation. In accordance with the Securities and Exchange Commission (the “SEC”) and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">As of June 30, 2022, the ordinary shares reflected on the balance sheet are reconciled in the following table.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:83.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of June 30, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:83.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross proceeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 69,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:83.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:83.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Proceeds allocated to public warrants and public rights</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,210,000)</p></td></tr><tr><td style="vertical-align:bottom;width:83.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Offering costs of public shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,109,364)</p></td></tr><tr><td style="vertical-align:bottom;width:83.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:83.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accretion of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 12,453,967</p></td></tr><tr><td style="vertical-align:bottom;width:83.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Ordinary share subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 70,134,603</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 6900000 10.00 1 11.50 6900000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">As of June 30, 2022, the ordinary shares reflected on the balance sheet are reconciled in the following table.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:83.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of June 30, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:83.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross proceeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 69,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:83.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:83.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Proceeds allocated to public warrants and public rights</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,210,000)</p></td></tr><tr><td style="vertical-align:bottom;width:83.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Offering costs of public shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,109,364)</p></td></tr><tr><td style="vertical-align:bottom;width:83.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:83.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accretion of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 12,453,967</p></td></tr><tr><td style="vertical-align:bottom;width:83.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Ordinary share subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 70,134,603</p></td></tr></table> 69000000 6210000 5109364 12453967 70134603 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 4 — Private Placement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Simultaneously with the closing of the IPO, RedOne Investment Limited, the Company’s sponsor, purchased an aggregate of 351,500 Private Units in a private placement at $10.00 per Private Unit. The Private Units are identical to the units sold in the IPO, as each private unit consists of one share of ordinary shares in the Company, and one right to receive <span style="-sec-ix-hidden:Hidden_kSBYKQKGOUatA62FZhKifw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span> tenth (1/10) of a share of ordinary shares automatically upon the consummation of an initial business combination, and <span style="-sec-ix-hidden:Hidden_b2Od0t0vGkumdJOiRrzYDg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one-half</span></span> of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one ordinary share for $11.50 per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The holders of the private units have agreed (A) to vote the shares underlying their private units in favor of any proposed business combination, (B) not to propose, or vote in favor of, an amendment to the Company’s amended and restated certificate of incorporation with respect to the Company’s pre-business combination activities prior to the consummation of such a business combination unless the Company provides public shareholders with the opportunity to convert their public shares in connection with any such vote, (C) not to convert any shares underlying the private units into the right to receive cash from the trust account in connection with a shareholder vote to approve an initial business combination or a vote to amend the provisions of the Company’s amended and restated certificate of incorporation relating to shareholders’ rights or pre-business combination activity or sell their shares to the Company in connection with a tender offer the Company engages in and (D) that the shares underlying the private units shall not participate in any liquidating distribution upon winding up if a business combination is not consummated. Subject to certain limited exceptions, the purchasers have also agreed not to transfer, assign or sell any of the private units or underlying securities (except to transferees that agree to the same terms and restrictions) until 30 days after the completion of an initial business combination.</p> 351500 10.00 1 11.50 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 5 — Related Party Transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Founder Shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On February 19, 2021, 1,437,500 shares of the Company’s ordinary shares were issued to the sponsor at a price of approximately $0.017 per share for an aggregate amount of $25,000. In connection with the increase in the size of the offering, on December 20, 2021, the Company declared a 20% share dividend on each founder share thereby increasing the number of issued and outstanding founder shares to 1,725,000 (up to 225,000 of which are subject to forfeiture) so as to maintain the number of founder shares at 20% of the outstanding ordinary shares upon the consummation of this offering, resulting in an effective purchase price per founder share after the share dividend of approximately $0.014. The per share purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the aggregate number of founder shares issued. The number of founder shares issued was determined based on the expectation that the founder shares would represent 20% of the outstanding shares after this offering (not including the shares issued to the underwriter at closing or the shares underlying the private placement units). Since the over-allotment option has been fully exercised, the 225,000 founder shares were no longer subject to forfeiture on March 11, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Administrative Service Fee</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company has agreed, commencing on the signing of the engagement letter with the underwriter on May 6, 2021, to pay the sponsor a monthly fee of up to $10,000 up to the consummation of business combination, for the Company’s use of its personnel and other administrative resources. Since inception through June 30, 2022, the Company had paid an aggregate of $138,000 to the sponsor.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Related Party Loans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On May 11, 2021, the Company issued a $300,000 principal amount unsecured promissory note to the Company’s sponsor, On January 31, 2022, the Company issued a $100,000 principal amount unsecured promissory note to the Company’s sponsor, On March 7, 2022, the Company issued a $100,000 principal amount unsecured promissory note to the Company’s sponsor, and the Company had received such amounts as of issuance dates. The notes are non-interest bearing, and due after the date on which this offering is consummated or the Company determines to abandon this offering. On March 11, 2022, the $500,000 loan was converted into part of the subscription of $3,515,000 private placement at a price of $10.00 per unit. The promissory notes were canceled and no amounts were owed under the notes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">As mentioned in Note 1, in order to meet its working capital needs following the consummation of the IPO, the Company’s initial shareholders, officers and directors or their affiliates may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each working capital loan would be evidenced by a promissory note and would either be paid upon consummation of the Company’s initial business combination, without interest, or, at the lender’s discretion, up to $500,000 of the working capital loan may be converted upon consummation of the Company’s business combination into additional private units at a price of $10.00 per unit. If the Company does not complete a business combination, the working capital loan will only be repaid with funds not held in the trust account and only to the extent available. As of June 30, 2022, there was nil working capital loan outstanding.</p> 1437500 0.017 25000 0.20 1725000 225000 0.20 0.014 0.20 225000 10000 138000 300000 100000 100000 500000 3515000 10.00 500000 10.00 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 6 — Fair Value Measurements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company follows the guidance in FASB ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Level 1:</span></span>Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Level 2:</span></span>Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Level 3:</span></span>Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at June 30, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:72.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Marketable securities held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 70,134,603</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Except for the foregoing, the Company does not have any assets measured at fair value on a recurring basis at June 30, 2022 and December  31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. No <span style="-sec-ix-hidden:Hidden_0rjhQUaeO0G-6DSDk27IUg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">such</span></span> <span style="-sec-ix-hidden:Hidden_fV3ybyrv2E2aWJmFz3l44Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">transfers</span></span> took place for the period presented.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at June 30, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:72.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Marketable securities held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 70,134,603</p></td></tr></table> 70134603 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 7 — Commitments and Contingencies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Risks and Uncertainties</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of this financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Underwriting Agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">A deferred underwriting commission of $0.35 per Public Unit sold, totaling $2,415,000 will be payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, without accrued interest. In the event that the Company does not close a Business Combination, the representative underwriter forfeits its right to receive the commission.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Registration Rights</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The initial shareholders will be entitled to registration rights with respect to their initial shares, as well as the holders of the Private Units and holders of any securities issued to the Company’s initial shareholders, officers, directors or their affiliates in payment of working capital loans or extension loans made to the Company, will be entitled to registration rights with respect to the Private Units (and underlying securities), pursuant to an agreement signed on the effective date of the IPO. The holders of such securities are entitled to demand that the Company register these securities at any time after the Company consummates a business combination. In addition, the holders have certain “piggy-back” registration rights on registration statements filed after the Company’s consummation of a business combination.</p> 0.35 2415000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 8 — Shareholder’s Equity</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Ordinary shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company is authorized to issue 500,000,000 ordinary shares with a par value of $0.0001 per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On February 19, 2021, 1,437,500 shares of the Company’s ordinary shares were issued to the sponsor at a price of approximately $0.017 per share for an aggregate of $25,000. In connection with the increase in the size of the offering, on December 20, 2021, the Company declared a 20% share dividend on each founder share thereby increasing the number of issued and outstanding founder shares to 1,725,000 (up to 225,000 of which are subject to forfeiture) so as to maintain the number of founder shares at 20% of the outstanding shares of our ordinary shares upon the consummation of this offering, resulting in an effective purchase price per founder share after the share dividend of approximately $0.014. The per share purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the aggregate number of founder shares issued. The number of founder shares issued was determined based on the expectation that the founder shares would represent 20% of the outstanding shares after this offering (not including the </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">shares issued to the underwriter at closing or the shares underlying the private placement units). Since the over-allotment option has been fully exercised, the 225,000 founder shares were no longer subject to forfeiture on March 11, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On March 11, 2022, the Company sold 6,900,000 units, which includes the full exercise of the over-allotment option by the underwriter of in the IPO at a price of $10.00 per Public Unit in the IPO; and the Company sold to its sponsor an aggregate of 351,500 Private Units at $10.00 per Private Unit. Each Public Unit and Private Unit consists of one ordinary share, one-half of one redeemable warrant and one right.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company issued to the underwriter 165,000 shares of ordinary shares (the “Representative Shares”) upon the closing of the IPO on March 11, 2022. The Company estimates the fair value of Representative Shares to be $1,262,250 in total, or $7.65 per Representative Share. The Company accounted for the Representative Shares as an expense of the IPO, resulting in a charge directly to stockholder’s equity. The underwriter has agreed not to transfer, assign, sell, pledge, or hypothecate any such Representative Shares, or subject such Representative Shares to hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person until the completion of our initial business combination. In addition, the underwriter has agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of our initial business combination and (ii) to waive its rights to liquidating distributions from the trust account with respect to such shares if we fail to complete our initial business combination within 12 months (or 15 months, as applicable) from the closing of this offering.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of June 30, 2022, there were 2,241,500 shares of ordinary shares issued and <span style="-sec-ix-hidden:Hidden_zjZa5Um5cUGwJDoehelc9A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">outstanding</span></span> excluding 6,900,000 shares subject to possible redemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Warrants</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Each whole warrant entitles the holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment as described below, commencing 30 days after the completion of its initial business combination, and expiring five years from after the completion of an initial business combination. No fractional warrant will be issued and only whole warrants will trade.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company may redeem the warrants at a price of $0.01 per warrant upon 30 days’ notice, only in the event that the last sale price of the ordinary shares is at least $18.00 (as adjusted for share sub-divisions, share dividends, reorganizations and recapitalizations) per share for any 20 trading days within a 30-trading day period ending on the third day prior to the date on which notice of redemption is given, provided there is an effective registration statement and current prospectus in effect with respect to the ordinary shares underlying such warrants during the 30 day redemption period. If the Company redeems the warrants as described above, management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” If a registration statement is not effective within 90 days following the consummation of a business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their warrants on a cashless basis and in no event (whether in the case of a registration statement being effective or otherwise) will the Company be required to net cash settle the warrant exercise. If an initial business combination is not consummated, the warrants will expire and will be worthless.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In addition, if (a) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at a newly issued price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by our board of directors and, in the case of any such issuance to our initial shareholders or their affiliates, without taking into account any founders’ shares held by the Company’s initial shareholders or such affiliates, as applicable, prior to such issuance), (b) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination on the date of the consummation of the Company’s initial business combination (net of redemptions), and (c) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial business combination is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the market value and the newly issued price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the market value and the newly issued price.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Rights</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Except in cases where the Company is not the surviving company in a business combination, each holder of a right will automatically receive <span style="-sec-ix-hidden:Hidden_8_Syn3dO6U6-GoOfpqpVRw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span>-tenth (1/10) of an ordinary share upon consummation of an initial business combination, even if the holder of a public right converted all ordinary shares held by him, her or it in connection with the initial business combination or an amendment to our certificate of incorporation with respect to the Company’s pre-business combination activities. In the event the Company will not be the surviving company upon completion of our initial business combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one- tenth (1/10) of a share underlying each right upon consummation of the business combination. No additional consideration will be required to be paid by a holder of rights in order to receive his, her or its additional ordinary shares upon consummation of an initial business combination. The shares issuable upon exchange of the rights will be freely tradable (except to the extent held by affiliates of the Company). If the Company enters into a definitive agreement for a business combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the holders of the ordinary shares will receive in the transaction on an as-converted into ordinary share basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company will not issue fractional shares in connection with an exchange of rights. As a result, holders of rights must hold rights in multiples of 10 in order to receive shares for all of the holders’ rights upon closing of a business combination. If the Company are unable to complete an initial business combination within the required time period and liquidate the funds held in the trust account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from our assets held outside of the trust account with respect to such rights, and the rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of an initial business combination. Additionally, in no event will the Company be required to net cash settle the rights.</p> 500000000 0.0001 1437500 0.017 25000 0.20 1725000 225000 0.20 0.014 0.20 225000 6900000 10.00 351500 10.00 165000 1262250 7.65 2241500 6900000 11.50 P30D P5Y 0.01 P30D 18.00 P20D 30 P30D P90D 9.20 60 P20D 9.20 1.15 18.00 1.80 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 9 — Subsequent Events</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to August 1, 2022, the date that the unaudited condensed financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.</p> EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 88 190 1 false 26 0 false 5 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Condensed Balance Sheets Sheet http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Unaudited Condensed Statements of Operations Sheet http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations Unaudited Condensed Statements of Operations Statements 4 false false R5.htm 00205 - Statement - Unaudited Condensed Statements of Operations (Parenthetical) Sheet http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperationsParenthetical Unaudited Condensed Statements of Operations (Parenthetical) Statements 5 false false R6.htm 00300 - Statement - Unaudited Condensed Statements of Changes in Shareholders' Deficit Sheet http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit Unaudited Condensed Statements of Changes in Shareholders' Deficit Statements 6 false false R7.htm 00305 - Statement - Unaudited Condensed Statements of Changes in Shareholders' Deficit (Parenthetical) Sheet http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficitParenthetical Unaudited Condensed Statements of Changes in Shareholders' Deficit (Parenthetical) Statements 7 false false R8.htm 00400 - Statement - Unaudited Condensed Statements of Cash Flows Sheet http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows Unaudited Condensed Statements of Cash Flows Statements 8 false false R9.htm 00405 - Statement - Unaudited Condensed Statements of Cash Flows (Parenthetical) Sheet http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlowsParenthetical Unaudited Condensed Statements of Cash Flows (Parenthetical) Statements 9 false false R10.htm 10101 - Disclosure - Organization and Business Operations Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperations Organization and Business Operations Notes 10 false false R11.htm 10201 - Disclosure - Significant Accounting Policies Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPolicies Significant Accounting Policies Notes 11 false false R12.htm 10301 - Disclosure - Initial Public Offering Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOffering Initial Public Offering Notes 12 false false R13.htm 10401 - Disclosure - Private Placement Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacement Private Placement Notes 13 false false R14.htm 10501 - Disclosure - Related Party Transactions Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 14 false false R15.htm 10601 - Disclosure - Fair Value Measurements Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 10701 - Disclosure - Commitments and Contingencies Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 16 false false R17.htm 10801 - Disclosure - Shareholders' Equity Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquity Shareholders' Equity Notes 17 false false R18.htm 10901 - Disclosure - Subsequent Events Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSubsequentEvents Subsequent Events Notes 18 false false R19.htm 20202 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPolicies 19 false false R20.htm 30203 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesTables Significant Accounting Policies (Tables) Tables http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPolicies 20 false false R21.htm 30303 - Disclosure - Initial Public Offering (Tables) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingTables Initial Public Offering (Tables) Tables http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOffering 21 false false R22.htm 30603 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurements 22 false false R23.htm 40101 - Disclosure - Organization and Business Operations (Details) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails Organization and Business Operations (Details) Details http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperations 23 false false R24.htm 40201 - Disclosure - Significant Accounting Policies (Details) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails Significant Accounting Policies (Details) Details http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesTables 24 false false R25.htm 40202 - Disclosure - Significant Accounting Policies - Reconciliation of Net Income (Loss) per Share (Details) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails Significant Accounting Policies - Reconciliation of Net Income (Loss) per Share (Details) Details 25 false false R26.htm 40301 - Disclosure - Initial Public Offering (Details) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingDetails Initial Public Offering (Details) Details http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingTables 26 false false R27.htm 40302 - Disclosure - Initial Public Offering - Ordinary shares reflected on the balance sheet (Details) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingOrdinarySharesReflectedOnBalanceSheetDetails Initial Public Offering - Ordinary shares reflected on the balance sheet (Details) Details 27 false false R28.htm 40401 - Disclosure - Private Placement (Details) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacementDetails Private Placement (Details) Details http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacement 28 false false R29.htm 40501 - Disclosure - Related Party Transactions - Founder Shares (Details) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails Related Party Transactions - Founder Shares (Details) Details 29 false false R30.htm 40502 - Disclosure - Related Party Transactions - Additional Information (Details) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails Related Party Transactions - Additional Information (Details) Details 30 false false R31.htm 40601 - Disclosure - Fair Value Measurements (Details) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsTables 31 false false R32.htm 40701 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.lakeshoreacquisitionicorpii.com/role/DisclosureCommitmentsAndContingencies 32 false false R33.htm 40801 - Disclosure - Shareholders' Equity - Common Stock Shares (Details) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails Shareholders' Equity - Common Stock Shares (Details) Details 33 false false R34.htm 40802 - Disclosure - Shareholders' Equity - Warrants (Details) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails Shareholders' Equity - Warrants (Details) Details 34 false false R35.htm 40803 - Disclosure - Shareholders' Equity - Rights (Details) Sheet http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityRightsDetails Shareholders' Equity - Rights (Details) Details 35 false false All Reports Book All Reports lbbbu-20220630x10q.htm lbbbu-20220630.xsd lbbbu-20220630_cal.xml lbbbu-20220630_def.xml lbbbu-20220630_lab.xml lbbbu-20220630_pre.xml lbbbu-20220630xex31d1.htm lbbbu-20220630xex31d2.htm lbbbu-20220630xex32d1.htm lbbbu-20220630xex32d2.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 53 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "lbbbu-20220630x10q.htm": { "axisCustom": 0, "axisStandard": 10, "contextCount": 88, "dts": { "calculationLink": { "local": [ "lbbbu-20220630_cal.xml" ] }, "definitionLink": { "local": [ "lbbbu-20220630_def.xml" ] }, "inline": { "local": [ "lbbbu-20220630x10q.htm" ] }, "labelLink": { "local": [ "lbbbu-20220630_lab.xml" ] }, "presentationLink": { "local": [ "lbbbu-20220630_pre.xml" ] }, "schema": { "local": [ "lbbbu-20220630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 282, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 27, "http://www.lakeshoreacquisitionicorpii.com/20220630": 6, "http://xbrl.sec.gov/dei/2022": 6, "total": 39 }, "keyCustom": 80, "keyStandard": 110, "memberCustom": 14, "memberStandard": 11, "nsprefix": "lbbb", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - Organization and Business Operations", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperations", "shortName": "Organization and Business Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - Significant Accounting Policies", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "lbbb:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - Initial Public Offering", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOffering", "shortName": "Initial Public Offering", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "lbbb:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "lbbb:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - Private Placement", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacement", "shortName": "Private Placement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "lbbb:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - Related Party Transactions", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10601 - Disclosure - Fair Value Measurements", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10701 - Disclosure - Commitments and Contingencies", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10801 - Disclosure - Shareholders' Equity", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquity", "shortName": "Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10901 - Disclosure - Subsequent Events", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "20202 - Disclosure - Significant Accounting Policies (Policies)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesPolicies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_HgtXd_x8G0qkJc9Hi__FmQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - Condensed Balance Sheets", "role": "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets", "shortName": "Condensed Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "As_Of_12_31_2021_0sq5-e01pk2a6Z3ek5qt7g", "decimals": "0", "lang": null, "name": "us-gaap:DeferredOfferingCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30203 - Disclosure - Significant Accounting Policies (Tables)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesTables", "shortName": "Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharesSubjectToMandatoryRedemptionDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30303 - Disclosure - Initial Public Offering (Tables)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingTables", "shortName": "Initial Public Offering (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharesSubjectToMandatoryRedemptionDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30603 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "p", "us-gaap:NatureOfOperations", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_2_19_2021_To_2_19_2021_BUHyx7ECIUyseP9PYlaCuQ", "decimals": "INF", "first": true, "lang": null, "name": "lbbb:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_vMxio4ElNEW9jQtrNt33LQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40101 - Disclosure - Organization and Business Operations (Details)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "shortName": "Organization and Business Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:NatureOfOperations", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_2_19_2021_To_2_19_2021_BUHyx7ECIUyseP9PYlaCuQ", "decimals": "INF", "first": true, "lang": null, "name": "lbbb:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_vMxio4ElNEW9jQtrNt33LQ", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_HgtXd_x8G0qkJc9Hi__FmQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - Significant Accounting Policies (Details)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails", "shortName": "Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_HgtXd_x8G0qkJc9Hi__FmQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_2_19_2021_To_3_31_2021_wX6wj0evfEa3e5tuPZPEag", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40202 - Disclosure - Significant Accounting Policies - Reconciliation of Net Income (Loss) per Share (Details)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "shortName": "Significant Accounting Policies - Reconciliation of Net Income (Loss) per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": "0", "lang": null, "name": "us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "As_Of_3_11_2022_oWoQwA2U0E6I8v4FHdhh-w", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unitRef": "Unit_Divide_USD_shares_Qori04-cAkazB-Wzo-6TwQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - Initial Public Offering (Details)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingDetails", "shortName": "Initial Public Offering (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "lbbb:InitialPublicOfferingTextBlock", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_3_11_2022_To_3_11_2022_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_ng1sd1nglkSMEwafE4XuVg", "decimals": "INF", "lang": null, "name": "lbbb:NumberOfSharesIssuedPerUnit", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_4QRYL6a980-4nqARqgs8pA", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:SharesSubjectToMandatoryRedemptionDisclosureTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": "0", "first": true, "lang": null, "name": "lbbb:UnitsIssuedDuringPeriodValueNewIssuesIncludingFairValueOfPublicWarrantsAtIssuance", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40302 - Disclosure - Initial Public Offering - Ordinary shares reflected on the balance sheet (Details)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingOrdinarySharesReflectedOnBalanceSheetDetails", "shortName": "Initial Public Offering - Ordinary shares reflected on the balance sheet (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:SharesSubjectToMandatoryRedemptionDisclosureTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": "0", "first": true, "lang": null, "name": "lbbb:UnitsIssuedDuringPeriodValueNewIssuesIncludingFairValueOfPublicWarrantsAtIssuance", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "lbbb:PrivatePlacementTextBlock", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_us-gaap_ClassOfWarrantOrRightAxis_lbbb_PrivatePlacementWarrantsMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_X__6E278kk6EJniJejhs6w", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_4QRYL6a980-4nqARqgs8pA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - Private Placement (Details)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacementDetails", "shortName": "Private Placement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "lbbb:PrivatePlacementTextBlock", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_us-gaap_ClassOfWarrantOrRightAxis_lbbb_PrivatePlacementWarrantsMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_X__6E278kk6EJniJejhs6w", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_4QRYL6a980-4nqARqgs8pA", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_12_20_2021_To_12_20_2021_Oi3BpBPyfki9Rf_iclD5Aw", "decimals": "2", "first": true, "lang": null, "name": "lbbb:PercentageOfShareDividendOnEachFounderShare", "reportCount": 1, "unitRef": "Unit_Standard_pure_O2-_P5E5fk-PCcRdDYCYjA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - Related Party Transactions - Founder Shares (Details)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "shortName": "Related Party Transactions - Founder Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_12_20_2021_To_12_20_2021_Oi3BpBPyfki9Rf_iclD5Aw", "decimals": "2", "lang": null, "name": "lbbb:PercentageOfFounderSharesOnOutstandingShares", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_O2-_P5E5fk-PCcRdDYCYjA", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "As_Of_12_31_2021_0sq5-e01pk2a6Z3ek5qt7g", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_Divide_USD_shares_Qori04-cAkazB-Wzo-6TwQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00105 - Statement - Condensed Balance Sheets (Parenthetical)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheetsParenthetical", "shortName": "Condensed Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_3_11_2022_To_3_11_2022_zPtN4E4lAkOByW16losiRQ", "decimals": "0", "first": true, "lang": null, "name": "lbbb:NotePayableToRelatedPartyConvertedToSubscriptionOfPrivateUnits", "reportCount": 1, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40502 - Disclosure - Related Party Transactions - Additional Information (Details)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "shortName": "Related Party Transactions - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_3_11_2022_To_3_11_2022_us-gaap_RelatedPartyTransactionAxis_lbbb_PromissoryNoteWithRelatedPartyMember_l7pAOnvTFkOT-_s0iyqt7Q", "decimals": "0", "lang": null, "name": "lbbb:NotePayableToRelatedPartyConvertedToSubscriptionOfPrivateUnits", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_HgtXd_x8G0qkJc9Hi__FmQ", "decimals": "0", "first": true, "lang": null, "name": "lbbb:FairValueAssetsLevel1ToLevel2TransfersAmount1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40601 - Disclosure - Fair Value Measurements (Details)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails", "shortName": "Fair Value Measurements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_HgtXd_x8G0qkJc9Hi__FmQ", "decimals": "0", "first": true, "lang": null, "name": "lbbb:FairValueAssetsLevel1ToLevel2TransfersAmount1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": "2", "first": true, "lang": null, "name": "lbbb:DeferredUnderwritersCommissionPerPublicUnitSold", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_Qori04-cAkazB-Wzo-6TwQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40701 - Disclosure - Commitments and Contingencies (Details)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureCommitmentsAndContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_m-aqnc4WCEe3yCy85isssA", "decimals": "2", "first": true, "lang": null, "name": "lbbb:DeferredUnderwritersCommissionPerPublicUnitSold", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_Qori04-cAkazB-Wzo-6TwQ", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_12_20_2021_To_12_20_2021_Oi3BpBPyfki9Rf_iclD5Aw", "decimals": "2", "first": true, "lang": null, "name": "lbbb:PercentageOfShareDividendOnEachFounderShare", "reportCount": 1, "unitRef": "Unit_Standard_pure_O2-_P5E5fk-PCcRdDYCYjA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40801 - Disclosure - Shareholders' Equity - Common Stock Shares (Details)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "shortName": "Shareholders' Equity - Common Stock Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "As_Of_2_19_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_gC4DkUkJEEOClhuwQ8QDqg", "decimals": "3", "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_Qori04-cAkazB-Wzo-6TwQ", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_HgtXd_x8G0qkJc9Hi__FmQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:WarrantsAndRightsOutstandingTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40802 - Disclosure - Shareholders' Equity - Warrants (Details)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails", "shortName": "Shareholders' Equity - Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_HgtXd_x8G0qkJc9Hi__FmQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:WarrantsAndRightsOutstandingTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": null, "groupType": "disclosure", "isDefault": "false", "longName": "40803 - Disclosure - Shareholders' Equity - Rights (Details)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityRightsDetails", "shortName": "Shareholders' Equity - Rights (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_4_1_2022_To_6_30_2022_l1xVFL7IrkeXWwPYqWe-AQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - Unaudited Condensed Statements of Operations", "role": "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations", "shortName": "Unaudited Condensed Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_4_1_2022_To_6_30_2022_l1xVFL7IrkeXWwPYqWe-AQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_12_31_2021_To_12_31_2021_b4yFpr2cBkSZ5dWXGntYUg", "decimals": "INF", "first": true, "lang": null, "name": "lbbb:NonredeemableFounderSharesSubjectToForfeiture", "reportCount": 1, "unitRef": "Unit_Standard_shares_4QRYL6a980-4nqARqgs8pA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00205 - Statement - Unaudited Condensed Statements of Operations (Parenthetical)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperationsParenthetical", "shortName": "Unaudited Condensed Statements of Operations (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "As_Of_2_18_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_yd9orj__wECR2Me6AubiDA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - Unaudited Condensed Statements of Changes in Shareholders' Deficit", "role": "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit", "shortName": "Unaudited Condensed Statements of Changes in Shareholders' Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_2_19_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_E6dvJFMrLUevOJK_3_KVOw", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_12_31_2021_To_12_31_2021_b4yFpr2cBkSZ5dWXGntYUg", "decimals": "INF", "first": true, "lang": null, "name": "lbbb:NonredeemableFounderSharesSubjectToForfeiture", "reportCount": 1, "unitRef": "Unit_Standard_shares_4QRYL6a980-4nqARqgs8pA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00305 - Statement - Unaudited Condensed Statements of Changes in Shareholders' Deficit (Parenthetical)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficitParenthetical", "shortName": "Unaudited Condensed Statements of Changes in Shareholders' Deficit (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R8": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_2_19_2021_To_6_30_2021_yfQWzsM8F0KzGYHM7daDPw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - Unaudited Condensed Statements of Cash Flows", "role": "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows", "shortName": "Unaudited Condensed Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_2_19_2021_To_6_30_2021_yfQWzsM8F0KzGYHM7daDPw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "lbbbu-20220630x10q.htm", "contextRef": "Duration_3_11_2022_To_3_11_2022_zPtN4E4lAkOByW16losiRQ", "decimals": "0", "first": true, "lang": null, "name": "lbbb:NotePayableToRelatedPartyConvertedToSubscriptionOfPrivateUnits", "reportCount": 1, "unitRef": "Unit_Standard_USD_CPKhtwre8E2fcM5ZYy7Gpg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00405 - Statement - Unaudited Condensed Statements of Cash Flows (Parenthetical)", "role": "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlowsParenthetical", "shortName": "Unaudited Condensed Statements of Cash Flows (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null } }, "segmentCount": 26, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document and Entity Information" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r266" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "lbbb_AccretionOfCarryingValueToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accretion of carrying value to redemption value", "label": "Accretion of carrying value to redemption value" } } }, "localname": "AccretionOfCarryingValueToRedemptionValue", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingOrdinarySharesReflectedOnBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_AccruedOfferingCostsAndOtherExpensesCurrent": { "auth_ref": [], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued offering costs and other expenses current.", "label": "Accrued Offering Costs and Other Expenses Current", "terseLabel": "Accrued offering costs and other expenses" } } }, "localname": "AccruedOfferingCostsAndOtherExpensesCurrent", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "lbbb_AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) to additional paid in capital (APIC) resulting from allocation of offering costs to ordinary shares subject to redemption.", "label": "Adjustments to Additional Paid in Capital, Allocation of Offering Costs to Ordinary Shares Subject to Redemption", "terseLabel": "Allocation of offering costs to ordinary shares subject to redemption" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "lbbb_AdministrativeSupportAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Administrative Support Agreement.", "label": "Administrative Support Agreement" } } }, "localname": "AdministrativeSupportAgreementMember", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "lbbb_AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Allocation of offering costs to ordinary shares", "label": "Allocation of offering costs to ordinary shares subject to redemption", "terseLabel": "Allocation of offering costs to ordinary shares subject to redemption" } } }, "localname": "AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_AmountPaidToSponsor": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount paid to sponsor.", "label": "Amount Paid to Sponsor", "terseLabel": "Amount paid to Sponsor" } } }, "localname": "AmountPaidToSponsor", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_AssetsHeldInTrustAccountPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of accounting policy for assets held in trust.", "label": "Assets Held In Trust Account, Policy [Policy Text Block]", "terseLabel": "Marketable Securities Held in Trust Account" } } }, "localname": "AssetsHeldInTrustAccountPolicyPolicyTextBlock", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "lbbb_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of adjustment of redemption price of stock based on market value and newly issued price.", "label": "Class of Warrant or Right, Adjustment of Redemption Price of Warrants or Rights, Percent, Based On Market Value And Newly Issued Price 1", "terseLabel": "Adjustment one of redemption price of stock based on market value and newly issued price (as a percent)" } } }, "localname": "ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "percentItemType" }, "lbbb_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum threshold period during which a written notice is required for redemption of warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Class Of Warrant Or Right, Minimum Threshold Written Notice Period For Redemption Of Warrants", "terseLabel": "Minimum threshold written notice period for redemption of public warrants" } } }, "localname": "ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "durationItemType" }, "lbbb_ClassOfWarrantOrRightPriceOfWarrantsOrRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Price of Warrants or Rights", "terseLabel": "Price of warrant", "verboseLabel": "Price of warrants" } } }, "localname": "ClassOfWarrantOrRightPriceOfWarrantsOrRights", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacementDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "lbbb_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Consecutive Trading Days", "terseLabel": "Threshold consecutive trading days for redemption of public warrants" } } }, "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "integerItemType" }, "lbbb_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days for stock price trigger considered for redemption of warrants.", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Trading Days", "terseLabel": "Threshold trading days for redemption of public warrants" } } }, "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "durationItemType" }, "lbbb_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption price per share or per unit of warrants or rights outstanding.", "label": "Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights", "terseLabel": "Redemption price per public warrant (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "perShareItemType" }, "lbbb_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.", "label": "Condition for future business combination number of businesses minimum.", "terseLabel": "Condition for future business combination number of businesses minimum" } } }, "localname": "ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails" ], "xbrltype": "integerItemType" }, "lbbb_DeductionForIncreasesOfCarryingValueOfRedeemableShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of redeemable shares", "label": "Deduction for increases of carrying value of redeemable shares", "negatedLabel": "Deduction for increases of carrying value of redeemable shares" } } }, "localname": "DeductionForIncreasesOfCarryingValueOfRedeemableShares", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "lbbb_DeductionForValueOfOrdinarySharesSubjectToRedemptionShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deduction for value of ordinary shares subject to redemption, shares.", "label": "Deduction for Value of Ordinary Shares Subject to Redemption, Shares", "terseLabel": "Deduction for value of ordinary shares subject to redemption (in shares)" } } }, "localname": "DeductionForValueOfOrdinarySharesSubjectToRedemptionShares", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "sharesItemType" }, "lbbb_DeductionForValueOfOrdinarySharesSubjectToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deduction for value of ordinary shares subject to redemption.", "label": "Deduction for Value of Ordinary Shares Subject to Redemption, Value", "terseLabel": "Deduction for value of ordinary shares subject to redemption" } } }, "localname": "DeductionForValueOfOrdinarySharesSubjectToRedemptionValue", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "lbbb_DeferredOfferingCostsAccrued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs accrued.", "label": "Deferred Offering Costs Accrued", "terseLabel": "Deferred offering costs accrued" } } }, "localname": "DeferredOfferingCostsAccrued", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "lbbb_DeferredOfferingCostsNoncurrent": { "auth_ref": [], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails": { "order": 2.0, "parentTag": "lbbb_TransactionCosts", "weight": 1.0 }, "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent.", "label": "Deferred underwriting fee payable", "terseLabel": "Deferred underwriting fee payable" } } }, "localname": "DeferredOfferingCostsNoncurrent", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureCommitmentsAndContingenciesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "lbbb_DeferredUnderwritersCommissionPerPublicUnitSold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred underwriters commission per public unit sold.", "label": "Deferred Underwriters Commission Per Public Unit Sold", "terseLabel": "Deferred underwriters commission per public unit sold" } } }, "localname": "DeferredUnderwritersCommissionPerPublicUnitSold", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureCommitmentsAndContingenciesDetails" ], "xbrltype": "perShareItemType" }, "lbbb_DeferredUnderwritingCommissionChargedToAdditionalPaidInCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriting commission charged to additional paid in capital", "label": "Deferred Underwriting Commission Charged to Additional Paid In Capital", "terseLabel": "Deferred underwriting commission charged to additional paid in capital" } } }, "localname": "DeferredUnderwritingCommissionChargedToAdditionalPaidInCapital", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "lbbb_EmergingGrowthCompanyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the accounting policy on Emerging Growth Company.", "label": "Emerging Growth Company [Policy Text Block]", "terseLabel": "Emerging Growth Company" } } }, "localname": "EmergingGrowthCompanyPolicyTextBlock", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "lbbb_FairValueAssetsLevel1ToLevel2TransfersAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.", "label": "Fair Value Assets Level 1 To Level 2 Transfers Amount 1", "terseLabel": "Fair value assets level 1 to level 2 transfers" } } }, "localname": "FairValueAssetsLevel1ToLevel2TransfersAmount1", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_FairValueAssetsLevel2ToLevel1TransfersAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.", "label": "Fair Value Assets Level 2 To Level 1 Transfers Amount 1", "terseLabel": "Fair value assets level 2 to level 1 transfers" } } }, "localname": "FairValueAssetsLevel2ToLevel1TransfersAmount1", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_FairValueOfRepresentativeShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of representative shares", "label": "Fair Value of Representative Shares", "terseLabel": "Fair value of representative shares", "verboseLabel": "Representative shares" } } }, "localname": "FairValueOfRepresentativeShares", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents founder shares.", "label": "Founder Shares" } } }, "localname": "FounderSharesMember", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "lbbb_FounderSharesNotSubjectToForfeitureInConnectionWithClosingOfUnderwritersPartialExerciseOfOverAllotmentOption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares that are no longer subject to forfeiture.", "label": "Founder Shares, Not Subject to Forfeiture, In Connection with Closing of Underwriters Partial Exercise of Over Allotment Option", "terseLabel": "Shares that are no longer subject to forfeiture" } } }, "localname": "FounderSharesNotSubjectToForfeitureInConnectionWithClosingOfUnderwritersPartialExerciseOfOverAllotmentOption", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "lbbb_FounderSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of founder shares outstanding.", "label": "Founder Shares Outstanding", "terseLabel": "Founder shares" } } }, "localname": "FounderSharesOutstanding", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficitParenthetical", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperationsParenthetical" ], "xbrltype": "sharesItemType" }, "lbbb_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the accrued expense and other current liabilities.", "label": "Increase (Decrease) in Accrued Expenses and Other Current liabilities", "terseLabel": "Change in accrued expense and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "lbbb_InitialPublicOfferingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Initial Public Offering" } } }, "localname": "InitialPublicOfferingAbstract", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "xbrltype": "stringItemType" }, "lbbb_InitialPublicOfferingTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on information about initial public offering.", "label": "Initial Public Offering [Text Block]", "terseLabel": "Initial Public Offering" } } }, "localname": "InitialPublicOfferingTextBlock", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "lbbb_InitialValueOfPublicSharesSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Initial value of public shares subject to possible redemption", "label": "Initial Value of Public Shares Subject to Possible Redemption", "terseLabel": "Initial value of public shares subject to possible redemption" } } }, "localname": "InitialValueOfPublicSharesSubjectToPossibleRedemption", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "lbbb_InterestIncomeOnAssetsHeldInTrustAccount": { "auth_ref": [], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income from assets held in trust account", "label": "Interest Income On Assets Held in Trust Account", "terseLabel": "Interest earned from trust account" } } }, "localname": "InterestIncomeOnAssetsHeldInTrustAccount", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_InvestmentOfProceedsInTrustAccount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the investment of proceeds in trust account.", "label": "Investment Of Proceeds In Trust Account", "terseLabel": "Investment of proceeds in Trust account" } } }, "localname": "InvestmentOfProceedsInTrustAccount", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_IpoAndPrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for initial public offering and private placement.", "label": "IPO and Private Placement" } } }, "localname": "IpoAndPrivatePlacementMember", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "lbbb_IssuanceOfRepresentativeSharesChargedToAdditionalPaidInCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Issuance of representative shares charged to additional paid in capital", "label": "Issuance of Representative Shares Charged to Additional Paid In Capital", "terseLabel": "Issuance of representative shares charged to additional paid in capital" } } }, "localname": "IssuanceOfRepresentativeSharesChargedToAdditionalPaidInCapital", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "lbbb_MarketableSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to marketable securities.", "label": "Marketable Securities [Member]", "verboseLabel": "Marketable securities" } } }, "localname": "MarketableSecuritiesMember", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "lbbb_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of maximum borrowing capacity of related party promissory note.", "label": "Maximum Borrowing Capacity of Related Party Promissory Note", "terseLabel": "Maximum borrowing capacity of related party promissory note" } } }, "localname": "MaximumBorrowingCapacityOfRelatedPartyPromissoryNote", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_MaximumLoansConvertibleIntoWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The maximum amount which a potential loan could have repaid through issuance of warrants.", "label": "maximum Loans Convertible Into Warrants", "terseLabel": "Loan conversion agreement warrant" } } }, "localname": "MaximumLoansConvertibleIntoWarrants", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after completion of a business combination in which the reporting entity is required to file a registration statement with the SEC.", "label": "Maximum Period After Business Combination In Which To File Registration Statement", "terseLabel": "Maximum period after business combination in which to file registration statement" } } }, "localname": "MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "durationItemType" }, "lbbb_MinimumNetTangibleAssetsUponConsummationOfBusinessCombination": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the minimum net tangible assets upon consummation of the Business Combination.", "label": "Minimum Net Tangible Assets Upon Consummation of Business Combination", "terseLabel": "Minimum net tangible assets upon consummation of the Business Combination" } } }, "localname": "MinimumNetTangibleAssetsUponConsummationOfBusinessCombination", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_MinimumPercentageOfEquityInterestToBeAcquiredToCompleteBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent the minimum equity interest to be acquired to complete the business combination transaction.", "label": "Minimum Percentage Of Equity Interest To Be Acquired To Complete Business Combination", "terseLabel": "Minimum percentage of equity interest to be acquired ( in percentage)" } } }, "localname": "MinimumPercentageOfEquityInterestToBeAcquiredToCompleteBusinessCombination", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails" ], "xbrltype": "percentItemType" }, "lbbb_NetIncomeLossIncludingTemporaryEquityAccretionToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net income (loss) including temporary equity accretion to redemption value.", "label": "Net Income (Loss) Including Temporary Equity Accretion to Redemption Value", "terseLabel": "Allocation of net loss including accretion of temporary equity" } } }, "localname": "NetIncomeLossIncludingTemporaryEquityAccretionToRedemptionValue", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_NonRedeemableOrdinarySharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents non-redeemable ordinary shares.", "label": "Non-redeemable ordinary shares" } } }, "localname": "NonRedeemableOrdinarySharesMember", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "lbbb_NonredeemableFounderSharesForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nonredeemable founder shares forfeited.", "label": "Nonredeemable Founder Shares Forfeited", "terseLabel": "Nonredeemable founder shares forfeited" } } }, "localname": "NonredeemableFounderSharesForfeited", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficitParenthetical", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperationsParenthetical" ], "xbrltype": "sharesItemType" }, "lbbb_NonredeemableFounderSharesNoLongerSubjectToForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nonredeemable founder shares no longer subject to forfeiture", "label": "Nonredeemable Founder Shares No Longer Subject to Forfeiture", "terseLabel": "Nonredeemable founder shares no longer subject to forfeiture" } } }, "localname": "NonredeemableFounderSharesNoLongerSubjectToForfeiture", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheetsParenthetical", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficitParenthetical", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperationsParenthetical" ], "xbrltype": "sharesItemType" }, "lbbb_NonredeemableFounderSharesSubjectToForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nonredeemable founder shares subject to forfeiture", "label": "Nonredeemable Founder Shares Subject to Forfeiture", "terseLabel": "Nonredeemable founder shares subject to forfeiture" } } }, "localname": "NonredeemableFounderSharesSubjectToForfeiture", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheetsParenthetical", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficitParenthetical", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperationsParenthetical" ], "xbrltype": "sharesItemType" }, "lbbb_NotePayableToRelatedPartyConvertedToSubscriptionOfPrivateUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Note payable to a related party converted to subscription of private units.", "label": "Note Payable to Related Party Converted to Subscription of Private Units", "terseLabel": "Note payable to a related party converted to subscription of private units" } } }, "localname": "NotePayableToRelatedPartyConvertedToSubscriptionOfPrivateUnits", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "lbbb_NumberOfOrdinarySharesPerEachRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of ordinary shares per each right.", "label": "Number of Ordinary Shares Per Each Right", "terseLabel": "Number of ordinary shares per each right" } } }, "localname": "NumberOfOrdinarySharesPerEachRight", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacementDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityRightsDetails" ], "xbrltype": "sharesItemType" }, "lbbb_NumberOfRedeemableWarrantsIssuedPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of redeemable warrants in a unit.", "label": "Number of Redeemable Warrants issued Per Unit", "terseLabel": "Number of redeemable warrants per unit" } } }, "localname": "NumberOfRedeemableWarrantsIssuedPerUnit", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "sharesItemType" }, "lbbb_NumberOfSharesIssuedPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of shares in a unit.", "label": "Number of Shares Issued Per Unit", "terseLabel": "Number of shares in a unit" } } }, "localname": "NumberOfSharesIssuedPerUnit", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "sharesItemType" }, "lbbb_NumberOfWarrantsIssuedPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of warrants in a unit.", "label": "Number of Warrants Issued Per Unit", "terseLabel": "Number of warrants in a unit" } } }, "localname": "NumberOfWarrantsIssuedPerUnit", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingDetails" ], "xbrltype": "sharesItemType" }, "lbbb_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of offering costs associated with the initial public offering.", "label": "Offering Costs Associated With The Initial Public Offering [Policy Text Block]", "terseLabel": "Offering Costs Associated with the IPO" } } }, "localname": "OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "lbbb_OfferingCostsOfPublicShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Offering costs of public shares", "label": "Offering costs of public shares", "negatedLabel": "Offering costs of public shares" } } }, "localname": "OfferingCostsOfPublicShares", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingOrdinarySharesReflectedOnBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_PaymentsForInvestmentOfCashInTrustAccount": { "auth_ref": [], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash outflow for investment of cash in trust account.", "label": "Payments for investment of cash in Trust Account", "negatedLabel": "Cash deposited in trust account" } } }, "localname": "PaymentsForInvestmentOfCashInTrustAccount", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "lbbb_PaymentsOfUnderwritingFee": { "auth_ref": [], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from payment of underwriting fee.", "label": "Payments of Underwriting Fee", "negatedLabel": "Payment of underwriting fee" } } }, "localname": "PaymentsOfUnderwritingFee", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "lbbb_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of shares which the reporting entity is obligated to redeem if a business combination is not consummated using the offering proceeds within a specified period.", "label": "Percentage Obligation To Redeem Public Shares If Entity Does Not Complete A Business Combination", "terseLabel": "Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)" } } }, "localname": "PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails" ], "xbrltype": "percentItemType" }, "lbbb_PercentageOfFounderSharesOnOutstandingShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of founder shares on outstanding shares.", "label": "Percentage of Founder Shares on Outstanding Shares", "terseLabel": "Percentage of founder shares on outstanding shares" } } }, "localname": "PercentageOfFounderSharesOnOutstandingShares", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "percentItemType" }, "lbbb_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The ratio of gross proceeds from a future offering to total equity proceeds which is used to measure whether dilution of the warrant has occurred. If aggregate gross proceeds from a new offering exceeds a specified percentage of total equity proceeds, the warrant exercise price will be adjusted.", "label": "Percentage Of Gross New Proceeds To Total Equity Proceeds Used To Measure Dilution Of Warrant", "terseLabel": "Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant" } } }, "localname": "PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "pureItemType" }, "lbbb_PercentageOfShareDividendOnEachFounderShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of share dividend on each founder share.", "label": "Percentage of share dividend on each founder share", "terseLabel": "Percentage of share dividend on each founder share" } } }, "localname": "PercentageOfShareDividendOnEachFounderShare", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficitParenthetical", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperationsParenthetical" ], "xbrltype": "percentItemType" }, "lbbb_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after filing within which the registration statement filed with the SEC is expected to become effective.", "label": "Period Of Time Within Which Registration Statement Is Expected To Become Effective", "terseLabel": "Period of time within which registration statement is expected to become effective" } } }, "localname": "PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "durationItemType" }, "lbbb_PrivatePlacementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Private Placement" } } }, "localname": "PrivatePlacementAbstract", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "xbrltype": "stringItemType" }, "lbbb_PrivatePlacementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on information about private placement.", "label": "Private Placement [Text Block]", "terseLabel": "Private Placement" } } }, "localname": "PrivatePlacementTextBlock", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacement" ], "xbrltype": "textBlockItemType" }, "lbbb_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents a redeemable warrant (Private Placement Warrant) that entitles the holder to purchase shares of common stock if the underwriter's option is exercised in full.", "label": "Private Placement Warrants" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "domainItemType" }, "lbbb_ProceedsAllocatedToPublicWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Proceeds allocated to public warrants", "label": "Proceeds allocated to public warrants", "negatedLabel": "Proceeds allocated to public warrants and public rights" } } }, "localname": "ProceedsAllocatedToPublicWarrants", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingOrdinarySharesReflectedOnBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_ProceedsFromIssuanceOfPrivateUnits": { "auth_ref": [], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of private units.", "label": "Proceeds from Issuance of Private Units", "terseLabel": "Proceeds from issuance of private units (1)" } } }, "localname": "ProceedsFromIssuanceOfPrivateUnits", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "lbbb_PromissoryNoteWithRelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for promissory note with related party.", "label": "Promissory Note with Related Party" } } }, "localname": "PromissoryNoteWithRelatedPartyMember", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "lbbb_PublicSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to public shares.", "label": "Public Shares" } } }, "localname": "PublicSharesMember", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "lbbb_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents a redeemable warrant (Public Warrant) that entitles the holder to purchase shares of common stock subject to adjustment.", "label": "Public Warrants" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "lbbb_ReclassificationOfOfferingCostRelatedToPublicShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reclassification of offering cost related to public shares.", "label": "Reclassification of Offering Cost Related to Public Shares", "terseLabel": "Reclassification of offering cost related to public shares" } } }, "localname": "ReclassificationOfOfferingCostRelatedToPublicShares", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "lbbb_RedeemableOrdinarySharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents redeemable ordinary shares", "label": "Redeemable ordinary shares" } } }, "localname": "RedeemableOrdinarySharesMember", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "lbbb_RedemptionOfWarrantsIfPricePerClassOrdinaryShareEqualsOrExceeds9.20Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member stands for Redemption Of Warrants When Price Per Share Of Class Common Stock Equals Or Exceeds 9.20.", "label": "Redemption Of Warrants When Price Per Class Ordinary Share Equals Or Exceeds 9.20" } } }, "localname": "RedemptionOfWarrantsIfPricePerClassOrdinaryShareEqualsOrExceeds9.20Member", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "domainItemType" }, "lbbb_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $18.00.", "label": "Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00" } } }, "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "domainItemType" }, "lbbb_RedemptionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption period.", "label": "Redemption Period", "terseLabel": "Redemption period" } } }, "localname": "RedemptionPeriod", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "durationItemType" }, "lbbb_RelatedPartyLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for related party loans.", "label": "Related Party Loans" } } }, "localname": "RelatedPartyLoansMember", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "lbbb_RepresentativeSharePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Representative share price per share", "label": "Representative Share Price Per share", "terseLabel": "Representative share price per share" } } }, "localname": "RepresentativeSharePricePerShare", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "perShareItemType" }, "lbbb_SaleOfStockOtherOfferingCosts": { "auth_ref": [], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails": { "order": 3.0, "parentTag": "lbbb_TransactionCosts", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of other offering costs incurred.", "label": "Sale of Stock, Other Offering Costs", "terseLabel": "Other offering costs" } } }, "localname": "SaleOfStockOtherOfferingCosts", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_SaleOfStockUnderwritingFees": { "auth_ref": [], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails": { "order": 1.0, "parentTag": "lbbb_TransactionCosts", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of offering fees incurred and paid for underwriters.", "label": "Sale of Stock, Underwriting fees", "terseLabel": "Underwriting fees" } } }, "localname": "SaleOfStockUnderwritingFees", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_ShareDividendForEachOutstandingShareShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares for which share dividend provided for each outstanding shares.", "label": "Share Dividend for Each Outstanding Share, Shares", "terseLabel": "Share dividend of 0.2 shares for each outstanding share in December 2021 (in shares)" } } }, "localname": "ShareDividendForEachOutstandingShareShares", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "sharesItemType" }, "lbbb_ShareDividendForEachOutstandingShareValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share dividend provided for each outstanding share.", "label": "Share Dividend for Each Outstanding Share, Value", "terseLabel": "Share dividend of 0.2 shares for each outstanding share in December 2021" } } }, "localname": "ShareDividendForEachOutstandingShareValue", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "lbbb_SharePriceTriggerUsedToMeasureDilutionOfWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The cutoff price used to measure whether dilution of the warrant has occurred. Shares issued below this price will cause the exercise price of the warrant to be adjusted.", "label": "Share Price Trigger Used To Measure Dilution Of Warrant", "terseLabel": "Share price trigger used to measure dilution of warrant" } } }, "localname": "SharePriceTriggerUsedToMeasureDilutionOfWarrant", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "decimalItemType" }, "lbbb_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for sponsor.", "label": "Sponsor" } } }, "localname": "SponsorMember", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "domainItemType" }, "lbbb_SponsorMonthlyFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Monthly fee to sponsor", "label": "Sponsor Monthly Fee", "terseLabel": "Monthly fee to Sponsor" } } }, "localname": "SponsorMonthlyFee", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_StockIssuedDuringPeriodSharesIssuanceOfRepresentativeShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of representative shares issued during the period.", "label": "Stock Issued During Period, Shares, Issuance of Representative Shares", "terseLabel": "Issuance of representative shares (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuanceOfRepresentativeShares", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "sharesItemType" }, "lbbb_StockIssuedDuringPeriodSharesNewIssuesPrivate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued in private during the period.", "label": "Stock Issued During Period, Shares, New Issues Private", "terseLabel": "Issuance of private units (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssuesPrivate", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "sharesItemType" }, "lbbb_StockIssuedDuringPeriodValueIssuanceOfRepresentativeShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of issuance of representative shares during the period.", "label": "Stock Issued During Period, Value, Issuance of Representative Shares", "terseLabel": "Issuance of representative shares" } } }, "localname": "StockIssuedDuringPeriodValueIssuanceOfRepresentativeShares", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "lbbb_StockIssuedDuringPeriodValueNewIssuesPrivate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offerings.", "label": "Stock Issued During Period, Value, New Issues Private", "terseLabel": "Issuance of private units" } } }, "localname": "StockIssuedDuringPeriodValueNewIssuesPrivate", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "lbbb_SubsequentMeasurementOfOrdinarySharesSubjectToRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of Subsequent measurement of ordinary shares subject to redemption.", "label": "Subsequent Measurement of Ordinary Shares Subject to Redemption", "terseLabel": "Subsequent measurement of public shares subject to possible redemption" } } }, "localname": "SubsequentMeasurementOfOrdinarySharesSubjectToRedemption", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "lbbb_TemporaryEquityAttributableToParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity Attributable To Parent", "label": "Redeemable Ordinary Shares" } } }, "localname": "TemporaryEquityAttributableToParent", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "lbbb_TemporaryEquityPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of accounting policy for temporary equity.", "label": "Temporary Equity, Policy [Policy Text Block]", "terseLabel": "Ordinary Shares Subject to Possible Redemption" } } }, "localname": "TemporaryEquityPolicyPolicyTextBlock", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "lbbb_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination.", "label": "Threshold Percentage Of Outstanding Voting Securities Of Target To Be Acquired By Post Transaction Company To Complete Business Combination", "terseLabel": "Anticipating equity interest to be acquired (In Percentage)" } } }, "localname": "ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails" ], "xbrltype": "percentItemType" }, "lbbb_ThresholdPercentageOfVotingInterestToBeAcquiredPostTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the voting interest to be acquired under the post business combination transaction.", "label": "Threshold Percentage of Voting Interest To be Acquired, Post Transaction", "terseLabel": "Post transaction voting interest to be acquired ( in percentage)" } } }, "localname": "ThresholdPercentageOfVotingInterestToBeAcquiredPostTransaction", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails" ], "xbrltype": "percentItemType" }, "lbbb_TransactionCosts": { "auth_ref": [], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of transaction costs incurred.", "label": "Transaction Costs", "totalLabel": "Transaction Costs" } } }, "localname": "TransactionCosts", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_UnitsIssuedDuringPeriodSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of new units issued during the period.", "label": "Units Issued During Period, Shares, New Issues", "terseLabel": "Sale of Units, net of underwriting discounts (in shares)", "verboseLabel": "Number of units sold" } } }, "localname": "UnitsIssuedDuringPeriodSharesNewIssues", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "sharesItemType" }, "lbbb_UnitsIssuedDuringPeriodValueNewIssuesIncludingFairValueOfPublicWarrantsAtIssuance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of value received from units issued during period including fair value of warrants at issuance date.", "label": "Units Issued During Period, Value, New Issues Including Fair Value of Public Warrants at Issuance", "terseLabel": "Gross proceeds" } } }, "localname": "UnitsIssuedDuringPeriodValueNewIssuesIncludingFairValueOfPublicWarrantsAtIssuance", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingOrdinarySharesReflectedOnBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "lbbb_WarrantRedemptionConditionMinimumSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum trading price for the reporting entity's stock which must be achieved as a condition for redemption of the warrant.", "label": "Warrant Redemption Condition Minimum Share Price", "terseLabel": "Warrant redemption condition minimum share price" } } }, "localname": "WarrantRedemptionConditionMinimumSharePrice", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "perShareItemType" }, "lbbb_WarrantsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the accounting policy on warrants.", "label": "Warrants Policy [Text Block]", "terseLabel": "Warrants" } } }, "localname": "WarrantsPolicyTextBlock", "nsuri": "http://www.lakeshoreacquisitionicorpii.com/20220630", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r61", "r66", "r110", "r168" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r61", "r66", "r110", "r168", "r228" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r13", "r226" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r53", "r54", "r55", "r170", "r171", "r172", "r194" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "auth_ref": [ "r149", "r156" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "negatedLabel": "Deduction of offering costs" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r9", "r50", "r93", "r95", "r99", "r102", "r112", "r113", "r114", "r115", "r116", "r117", "r118", "r119", "r120", "r121", "r122", "r185", "r189", "r207", "r224", "r226", "r246", "r253" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r19", "r50", "r102", "r112", "r113", "r114", "r115", "r116", "r117", "r118", "r119", "r120", "r121", "r122", "r185", "r189", "r207", "r224", "r226" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r197" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "verboseLabel": "Marketable securities held in Trust Account" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrustCurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Assets Held-in-trust, Current", "terseLabel": "Marketable securities held in trust account" } } }, "localname": "AssetsHeldInTrustCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [TEXT BLOCK]", "terseLabel": "Significant Accounting Policies" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r8", "r43" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash held outside the Trust Account", "terseLabel": "Cash and cash equivalent", "verboseLabel": "Cash held outside the Trust account" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r39", "r43", "r46" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash at end of period", "periodStartLabel": "Cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r39", "r208" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r8" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount", "terseLabel": "Federal Depository Insurance Coverage" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of noncash activities:", "terseLabel": "Non-cash investing and financial activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r10", "r11", "r12", "r48", "r50", "r69", "r70", "r71", "r73", "r75", "r79", "r80", "r81", "r102", "r112", "r116", "r117", "r118", "r121", "r122", "r133", "r134", "r138", "r142", "r149", "r207", "r271" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityRightsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r157", "r169" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacementDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacementDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r150" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "verboseLabel": "Number of warrants to purchase shares issued" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r157", "r169" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r23", "r248", "r256" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies.", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r107", "r108", "r109", "r111", "r265" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Class A Common Stock" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r53", "r54", "r194" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Ordinary Shares" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common shares, par value, (per share)", "verboseLabel": "Common shares, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common shares, shares authorized", "verboseLabel": "Common shares, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common shares, shares issued", "verboseLabel": "Common shares, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r12", "r149" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common shares, shares outstanding", "verboseLabel": "Common shares, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r12", "r226" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Ordinary share, $0.0001 par value; 500,000,000 shares authorized; 2,241,500 and 1,725,000 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively (1)" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r85", "r252" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredOfferingCosts": { "auth_ref": [ "r106" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.", "label": "Deferred Offering Costs", "terseLabel": "Deferred offering costs" } } }, "localname": "DeferredOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r179" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "terseLabel": "Deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableAmountPerShare": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.", "label": "Dividends Payable, Amount Per Share", "terseLabel": "Share dividend" } } }, "localname": "DividendsPayableAmountPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted net loss per share", "verboseLabel": "Basic and diluted net income/(loss) per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r32", "r58", "r59", "r60", "r61", "r62", "r67", "r69", "r73", "r74", "r75", "r76", "r77", "r195", "r196", "r250", "r259" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Basic net income/(loss) per share", "verboseLabel": "Ordinary shares-basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r32", "r58", "r59", "r60", "r61", "r62", "r69", "r73", "r74", "r75", "r76", "r77", "r195", "r196", "r250", "r259" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted net income/(loss) per share", "verboseLabel": "Ordinary shares-diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r28", "r29", "r30", "r53", "r54", "r55", "r57", "r63", "r65", "r78", "r103", "r149", "r156", "r170", "r171", "r172", "r182", "r183", "r194", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r260", "r261", "r262" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r197", "r198", "r203" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r197", "r198" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Company's assets that are measured at fair value on a recurring basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityRightsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r197", "r203" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityRightsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r123", "r124", "r125", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r167", "r198", "r230", "r231", "r232" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r197", "r198", "r199", "r200", "r204" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r202" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "verboseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r123", "r159", "r160", "r165", "r167", "r198", "r230" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net", "terseLabel": "Fair value assets transferred into (out of) level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r123", "r124", "r125", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r167", "r230", "r231", "r232" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r202", "r204" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r205", "r206" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r33" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expense", "verboseLabel": "Formation, general and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unaudited Condensed Statements of Operations" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r27", "r174", "r175", "r177", "r178", "r180", "r181" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r41" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Change in prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r34", "r92" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "negatedLabel": "Interest income earned in trust account", "terseLabel": "Interest income on marketable securities held in trust account" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r21", "r50", "r96", "r102", "r112", "r113", "r114", "r116", "r117", "r118", "r119", "r120", "r121", "r122", "r186", "r189", "r190", "r207", "r224", "r225" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r17", "r50", "r102", "r207", "r226", "r247", "r255" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Shareholders' Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND SHAREHOLDERS' DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r6", "r22", "r50", "r102", "r112", "r113", "r114", "r116", "r117", "r118", "r119", "r120", "r121", "r122", "r186", "r189", "r190", "r207", "r224", "r225", "r226" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_MemberUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ownership interest in limited liability company (LLC).", "label": "Units" } } }, "localname": "MemberUnitsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r82", "r91" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS [TEXT BLOCK]", "terseLabel": "Organization and Business Operations" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r39" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flow from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r39" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Investing Activities:", "terseLabel": "Cash flow from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r39", "r40", "r42" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Operating Activities:", "terseLabel": "Cash flow from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r25", "r26", "r30", "r31", "r42", "r50", "r56", "r58", "r59", "r60", "r61", "r64", "r65", "r72", "r93", "r94", "r97", "r98", "r100", "r102", "r112", "r113", "r114", "r116", "r117", "r118", "r119", "r120", "r121", "r122", "r196", "r207", "r249", "r258" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 }, "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net Loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]", "terseLabel": "Numerators:" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r20", "r51", "r220" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes Payable, Related Parties, Current", "verboseLabel": "Notes payable - related party" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r51", "r219", "r257" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties.", "label": "Notes Payable, Related Parties", "verboseLabel": "Amount owed under the notes to related party" } } }, "localname": "NotesPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r93", "r94", "r97", "r98", "r100" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations", "verboseLabel": "Net loss including accretion of temporary equity to redemption value" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization and Business Operations" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r37" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Payment of other offering costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r4", "r18", "r104", "r105" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement Offering" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacementDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r35" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from issuance initial public offering", "terseLabel": "Proceeds from issuance initial public offering." } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r35" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "verboseLabel": "Proceeds from issuance of public units" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r35" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Proceeds from issuance of private placement", "verboseLabel": "Proceeds from private placement" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r35" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Proceeds from Issuance or Sale of Equity", "terseLabel": "Proceeds from sale of ordinary shares" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r36" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "terseLabel": "Proceeds from note payable to a related party" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r25", "r26", "r30", "r38", "r50", "r56", "r64", "r65", "r93", "r94", "r97", "r98", "r100", "r102", "r112", "r113", "r114", "r116", "r117", "r118", "r119", "r120", "r121", "r122", "r184", "r187", "r188", "r191", "r192", "r196", "r207", "r251" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net loss", "terseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r166", "r218", "r219" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r166", "r218", "r219", "r221" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r166", "r218", "r221", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r216", "r217", "r219", "r222", "r223" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r14", "r156", "r226", "r254", "r263", "r264" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r53", "r54", "r55", "r57", "r63", "r65", "r103", "r170", "r171", "r172", "r182", "r183", "r194", "r260", "r262" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RightsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A security giving shareholders entitlement to acquire new shares issued by the entity at an established price in proportion to the number of shares already owned. Generally, rights expire within in a short time after issuance.", "label": "Rights" } } }, "localname": "RightsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityRightsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacementDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Purchase price per share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of basic and diluted loss per ordinary share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r220", "r221" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r10", "r11", "r12", "r48", "r79", "r80", "r129", "r131", "r132", "r133", "r134", "r135", "r136", "r138", "r142", "r147", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityRightsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share Price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r149" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Balance at the end (in shares)", "periodStartLabel": "Balance at the beginning (in shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Purchase price, per unit", "terseLabel": "Price per unit" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfCashFlowsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionDisclosureTextBlock": { "auth_ref": [ "r126", "r127", "r128" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature and terms of the financial instruments and the rights and obligations embodied in those instruments, information about settlement alternatives, if any, in the contract and identification of the entity that controls the settlement alternatives including: a. The amount that would be paid, or the number of shares that would be issued and their fair value, determined under the conditions specified in the contract if the settlement were to occur at the reporting date b. How changes in the fair value of the issuer's equity shares would affect those settlement amounts (for example, \"the issuer is obligated to issue an additional x shares or pay an additional y dollars in cash for each $1 decrease in the fair value of one share\") c. The maximum amount that the issuer could be required to pay to redeem the instrument by physical settlement, if applicable d. The maximum number of shares that could be required to be issued, if applicable e. That a contract does not limit the amount that the issuer could be required to pay or the number of shares that the issuer could be required to issue, if applicable f. For a forward contract or an option indexed to the issuer's equity shares, the forward price or option strike price, the number of issuer's shares to which the contract is indexed, and the settlement date or dates of the contract, as applicable. g. The components of the liability that would otherwise be related to shareholders' interest and other comprehensive income (if any) subject to the redemption feature (for example, par value and other paid in amounts of mandatorily redeemable instruments are disclosed separately from the amount of retained earnings or accumulated deficit).", "label": "Financial Instruments Subject to Mandatory Redemption Disclosure [Table Text Block]", "terseLabel": "Schedule of ordinary shares reflected on the balance sheet" } } }, "localname": "SharesSubjectToMandatoryRedemptionDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r10", "r11", "r12", "r48", "r50", "r69", "r70", "r71", "r73", "r75", "r79", "r80", "r81", "r102", "r112", "r116", "r117", "r118", "r121", "r122", "r133", "r134", "r138", "r142", "r149", "r207", "r271" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r24", "r28", "r29", "r30", "r53", "r54", "r55", "r57", "r63", "r65", "r78", "r103", "r149", "r156", "r170", "r171", "r172", "r182", "r183", "r194", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r260", "r261", "r262" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unaudited Condensed Statements of Cash Flows" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Balance Sheets" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unaudited Condensed Statements of Changes in Shareholders' Deficit" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r53", "r54", "r55", "r78", "r233" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r11", "r12", "r149", "r156" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of public units (in shares)", "verboseLabel": "Number of shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r11", "r12", "r149", "r156" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of public units", "verboseLabel": "Aggregate purchase price" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r12", "r15", "r16", "r50", "r101", "r102", "r207", "r226" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance at the end", "periodStartLabel": "Balance at the beginning", "totalLabel": "Total Shareholders' Deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholder's Equity", "terseLabel": "Shareholders' Deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders' Equity" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r49", "r134", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r146", "r148", "r156", "r158", "r193" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Shareholder's Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r227", "r229" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacementDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernWithinOneYear": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether there was substantial doubt about ability to continue as going concern within one year after date financial statements are issued.", "label": "Substantial Doubt about Going Concern, within One Year [true false]", "terseLabel": "Substantial doubt about going concern within one year" } } }, "localname": "SubstantialDoubtAboutGoingConcernWithinOneYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureOrganizationAndBusinessOperationsDetails" ], "xbrltype": "booleanItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of accretion of temporary equity to its redemption value during the period.", "label": "Temporary Equity, Accretion to Redemption Value", "terseLabel": "Accretion of temporary equity to initial redemption value ($10.15 per share)" } } }, "localname": "TemporaryEquityAccretionToRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": { "auth_ref": [], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.", "label": "Temporary Equity, Accretion to Redemption Value, Adjustment", "negatedLabel": "Accretion of temporary equity to initial redemption value ($10.15 per share)" } } }, "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r112", "r116", "r117", "r118", "r121", "r122" ], "calculation": { "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "totalLabel": "Ordinary share subject to possible redemption", "verboseLabel": "Ordinary share subject to possible redemption: 6,900,000 shares (at redemption value of $10.16 per share)" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingOrdinarySharesReflectedOnBalanceSheetDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "auth_ref": [ "r7", "r130" ], "lang": { "en-us": { "role": { "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Redemption Price Per Share", "terseLabel": "Temporary equity, par value (per share)", "verboseLabel": "Temporary equity redemption price per share" } } }, "localname": "TemporaryEquityRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary equity, shares outstanding", "verboseLabel": "Temporary equity, shares outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureInitialPublicOfferingDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityCommonStockSharesDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r173", "r176" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r83", "r84", "r86", "r87", "r88", "r89", "r90" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails", "http://www.lakeshoreacquisitionicorpii.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Public Warrants expiration term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureShareholdersEquityWarrantsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r68", "r75" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted-average shares outstanding, diluted", "verboseLabel": "Ordinary shares-diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted weighted average shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r67", "r75" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted-average shares outstanding, basic", "verboseLabel": "Ordinary shares-basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails", "http://www.lakeshoreacquisitionicorpii.com/role/StatementUnauditedCondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]", "verboseLabel": "Denominators:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.lakeshoreacquisitionicorpii.com/role/DisclosureSignificantAccountingPoliciesReconciliationOfNetIncomeLossPerShareDetails" ], "xbrltype": "stringItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.A)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r109": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r111": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=118255708&loc=SL5909891-110878" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22026-110879" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r158": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=116846462&loc=SL51888449-203568" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r223": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r229": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r266": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r267": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r268": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r269": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r270": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r271": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r272": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r273": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r52": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r91": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" } }, "version": "2.1" } ZIP 54 0001410578-22-002008-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001410578-22-002008-xbrl.zip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�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end